Professional Documents
Culture Documents
Rpt. 63005827 THE UNITED INDIA INSURANCE COMPANY LIMITED - MERGERS & ACQUISI 2 - 77
22-Sep-2018 MARKETLINE - COMPANY RESEARCH
- DATAMONITOR INDEPENDENT RESEARCH
Rpt. 63007113 THE ORIENTAL INSURANCE COMPANY LTD. - MERGERS & ACQUISITIONS ( 78 - 116
22-Sep-2018 MARKETLINE - COMPANY RESEARCH
- DATAMONITOR INDEPENDENT RESEARCH
Rpt. 62363893 GENERAL INSURANCE CORPORATION OF INDIA - MERGERS & ACQUISITION 117 - 234
22-Sep-2018 MARKETLINE - COMPANY RESEARCH
- DATAMONITOR INDEPENDENT RESEARCH
Rpt. 62364275 RELIANCE GROUP - MERGERS & ACQUISITIONS (M&A), PARTNERSHIPS & 235 - 278
22-Sep-2018 MARKETLINE - COMPANY RESEARCH
- DATAMONITOR INDEPENDENT RESEARCH
1
MarketLine Financial Deals
Vendor, acquirer, target and partner report for The United India Insurance Company Limited
and its subsidiaries. Includes Mergers & Acquisitions, Private equity, Venture capital, Joint
ventures, Alliances and Investments
2
COMPANY OVERVIEW AND KEY FACTS
The United India Insurance Company Limited (UIIC) is a general insurance provider. It offers a range of personal and
commercial general insurance products. The company’s personal insurance solutions include motor insurance, fire
insurance, health insurance, liability insurance, micro insurance, credit insurance, home insurance, personal accident
insurance, and travel insurance. Its commercial policies include fire insurance policies, marine policies, motor
insurance, industry equipments insurance. It also offers accident and hospitalization policies; social policies, rural
policies, travel policies, package policies, and business policies. In addition, the company provides advisory and
brokerage services. It has presence across various cities in India. UIIC is headquartered at Chennai, India.
The company reported gross premium income of INR106,917.3 million in FY2015, compare to INR97,089.3 million in
FY2013, representing an annual increase of 10.1%. The net earned premium of the company was INR88,162.3
million in FY2015, compare to INR76,033 million in FY2014, representing an annual increase of 16%.
Key facts
Country India
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Telephone 91 44 28520161
Website www.uiic.co.in
3
COMPANY OVERVIEW AND KEY FACTS
The United India Insurance Company Limited activity by deal The United India Insurance Company Limited M&A activity by
type - volume (trailing twelve months (TTM)) geography (TTM)
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquisition 1 North America -
Capital raising 1 Europe -
Corporate venturing - Asia-Pacific 1
Divestments - Middle East and Africa -
Partnership - South and Central America -
Private equity -
The United India Insurance Company Limited activity by deal The United India Insurance Company Limited M&A average
type - volume (2014-YTD2018) deal size - value ($m)
Deal type 2014 2015 2016 2017 2018 Year Number of deals Average deal size ($m)
Acquisition (ACQ) - - - - 1 2014 - -
Capital raising - - - 1 1 2015 - -
(CR) 2016 - -
2017 - -
2018 1 -
Note: Zero deal value indicates transactions with undisclosed deal values
4
COMPANY OVERVIEW AND KEY FACTS
Deal value
Target/Partner (Country) Announcement date Deal status Deal Type
($m)
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
5
TABLE OF CONTENTS
TABLE OF CONTENTS
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
CORPORATE VENTURING .................................................................. 12
Corporate Venturing – Deal reports ................................................................................................. 12
PARTNERSHIP ..................................................................................... 19
Partnership – Deal reports ................................................................................................................ 19
APPENDIX............................................................................................. 66
Contact Us ......................................................................................................................................... 66
6
TABLE OF CONTENTS
LIST OF TABLES
Table 1: The United India Insurance Company Limited M&A volume and value trend (2014-YTD2018) 8
Table 2: The United India Insurance Company Limited M&A activity by geography (2014-YTD2018) 8
Table 3: The United India Insurance Company Limited capital raising volume and value trend (2014-
YTD2018) 21
Table 4: The United India Insurance Company Limited capital raising by deal type (2014-YTD2018) 21
LIST OF FIGURES
Figure 1: The United India Insurance Company Limited M&A volume and value trend (2014-YTD2018) 8
Figure 2: The United India Insurance Company Limited M&A activity by geography (2014-YTD2018) 8
Figure 3: The United India Insurance Company Limited capital raising volume and value trend (2014-
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
YTD2018) 21
Figure 4: The United India Insurance Company Limited capital raising by deal type (2014-YTD2018) 21
7
TARGETS AND PARTNERS
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
8
MERGERS & ACQUISITIONS
Figure 1: The United India Insurance Company Limited M&A Figure 2: The United India Insurance Company Limited M&A
volume and value trend (2014-YTD2018) activity by geography (2014-YTD2018)
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE
Note: Zero deal value indicates transactions with undisclosed deal values
Table 1: The United India Insurance Company Limited M&A Table 2: The United India Insurance Company Limited M&A
volume and value trend (2014-YTD2018) activity by geography (2014-YTD2018)
2015 - - Europe -
2016 - - Asia-Pacific 1
9
MERGERS & ACQUISITIONS
Deal Report: Oriental Insurance Company and National Insurance to Merge with United
India Insurance
Deal in brief
Oriental Insurance Company Ltd., a provider of general insurance services, and National Insurance
Company Limited., a provider of general insurance for urban and rural customers, to merge with United
India Insurance Co. Ltd., a provider of non-life insurance products and services. All the companies are
based in India.
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal status Announced
10
MERGERS & ACQUISITIONS
Casualty-->Personal Insurance
State Delhi
Country India
Website www.orientalinsurance.org.in
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
products include individual personal accident insurance,
householders insurance, and Janata personal accident
insurance. NIC’s rural insurance products comprise livestock
insurance, sheep and goat insurance, elephant insurance,
dog insurance, brackish water prawn insurance, silkworm
Business description
insurance, plantation insurance, and Kisan agriculture
pumpset insurance. The company also offers industrial risk
insurance, machinery insurance, electronic equipment
insurance, commercial risk insurance, workmen
compensation insurance, product liability insurance, and
public liability insurance. It has operations in Guwahati,
Hyderabad, Bangalore, Dharwad, Kolar, Gurgaon, Delhi, and
Naraina, India. NIC is headquartered in Kolkata, West
Bengal, India.
11
MERGERS & ACQUISITIONS
City Kolkata
Country India
Website www.nationalinsuranceindia.com
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
11
12
CORPORATE VENTURING
CORPORATE VENTURING
Corporate Venturing – Deal reports
Deal Report: Reliance – Anil Dhirubhai Ambani Group to invest INR80,000 million in
Reliance Energy
Deal in brief
Reliance – Anil Dhirubhai Ambani Group (Reliance ADA Group) has agreed to infuse new equity capital of
up to INR80,000 million ($2,018.67 million) into its power utility company Reliance Energy Limited. The new
equity capital infusion is proposed through a preferential offer of equity shares and/or equity related
securities at a price of INR1,812 ($45.72) per share.
Life Insurance Corporation of India, New India Assurance Co., Ltd., The Oriental Insurance Company
Limited, General Insurance Corporation of India, National Insurance Company Limited and United India
Insurance Company Limited have also been provided an opportunity to participate in the proposed offering
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
on the same terms and conditions.
Deal rationale
The new equity capital will substantially enhance Reliance Energy's net worth, and further augment its
borrowing capabilities, to enable greater participation in these growth opportunities in high growth areas. 12
13
CORPORATE VENTURING
Deal financials
EV/Revenues 2.41
EV/EBITDA 11.09
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Security type Common stock
14
CORPORATE VENTURING
Energy-->Production
City Mumbai
State Maharashtra
Country India
Website www.rel.co.in
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Post tax profit 8,014.50 184.57
Key ratios
Country India
Website www.relianceadagroup.com
14
15
CORPORATE VENTURING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
State Delhi
Country India
Website www.orientalinsurance.org.in
Financial Services
Industry
Financial Services-->General Insurance, Property and
Casualty
City Mumbai 15
16
CORPORATE VENTURING
Country India
Website www.niacl.com
Financial Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Casualty
Industry Financial Services-->Reinsurance
Financial Services-->Reinsurance
Financial Services-->Reinsurance-->Marine
Financial Services-->Reinsurance-->Other
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Retail Banking and Lending
Country India
Website www.gicofindia.com
City Mumbai
State Maharashtra
16
17
CORPORATE VENTURING
Country India
Website www.licindia.com
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
insurance, commercial risk insurance, workmen
compensation insurance, product liability insurance, and
public liability insurance. It has operations in Guwahati,
Hyderabad, Bangalore, Dharwad, Kolar, Gurgaon, Delhi, and
Naraina, India. NIC is headquartered in Kolkata, West
Bengal, India.
18
CORPORATE VENTURING
City Kolkata
Country India
Website www.nationalinsuranceindia.com
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
18
19
CORPORATE VENTURING
PARTNERSHIP
Partnership – Deal reports
Deal Report: Tata Motors partners with United India Insurance Company
Deal in brief
Tata Motors Limited, a manufacturer of medium and heavy commercial vehicles, has entered into a
partnership agreement with United India Insurance Company Limited, a general insurance company, to
offer insurance for the Tata Nano at a rate of 2.76% of the ex-showroom price of the car. Both the
companies are based in India.
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal status Completed
Automotive
Automotive-->Parts, Tires and Aftermarket
Industry Automotive-->Vehicle Manufacturing-->Automobiles
Automotive-->Vehicle Manufacturing-->Commercial
Vehicles-->Bus and Coach
Automotive-->Vehicle Manufacturing-->Commercial 19
20
CORPORATE VENTURING
City Mumbai
State Maharashtra
Country India
Website http://www.tatamotors.com/
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
20
21
CAPITAL RAISING
CAPITAL RAISING
Figure 3: The United India Insurance Company Limited Figure 4: The United India Insurance Company Limited
capital raising volume and value trend (2014-YTD2018) capital raising by deal type (2014-YTD2018)
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE
Note: Zero deal value indicates transactions with undisclosed deal values
Table 3: The United India Insurance Company Limited capital Table 4: The United India Insurance Company Limited capital
raising volume and value trend (2014-YTD2018) raising by deal type (2014-YTD2018)
2016 - -
2017 1 -
2018 1 139.86
21
22
CAPITAL RAISING
Deal Report: United India Insurance Raises USD139.86 Million in Bonds Offering
Deal in brief
United India Insurance Co. Ltd., an India-based provider of non-life insurance products and services, has
raised INR9 billion (USD139.86 million) in a subordinated debt offering.
The issued bonds bear an interest rate of 8.25%, for a 10-year period with a call option after five years.
United India Insurance had generated a net loss of INR9.14 billion (USD142.82 million) for the year ended
March 2017.
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal status Completed
23
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and 23
24
CAPITAL RAISING
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging 24
25
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and 25
26
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment 26
27
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare 27
28
CAPITAL RAISING
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices 28
29
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and 29
30
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy 30
31
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and 31
32
CAPITAL RAISING
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices 32
33
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing-->Packaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and 33
34
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices 34
35
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and 35
36
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging 36
37
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and 37
38
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Biomaterials and Tissue Regeneration 38
39
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and 39
40
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging 40
41
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and 41
42
CAPITAL RAISING
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics 42
43
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and 43
44
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices 44
45
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices 45
46
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and 46
47
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment 47
48
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
48
49
CAPITAL RAISING
Deal Report: Government of India to divest 25% stake in United India Insurance
Deal in brief
According to Moneycontrol, The Government of India (GOI) has agreed to divest a 25% stake in United
India Insurance Company Limited, an India-based general insurance company, through listing the company
on stock exchanges. The listing will be either by fresh equity or offer for sale.
Concurrently, GOI has agreed to sell a 25% stake in each of New India Assurance Co., Ltd., The Oriental
Insurance Company Ltd., National Insurance Company Limited and General Insurance Corporation of
India.
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal sub-category Filing , ipo
% to Public 25
50
CAPITAL RAISING
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics
State Delhi
Country India
50
51
DIVESTMENTS
Deal in brief
IDBI Bank Limited, a financial holding company, is planning to acquire 81% of stake in Stock Holding
Corporation of India Limited (SHCI), a depository participant. Both the companies are based in India.
IDBI is currently holding approximately a 19% stake in SHCI. The other shareholders of SHCI include IFCI
Ltd, Unit Trust of India, Life Insurance Corporation of India, General Insurance Corporation of India, New
India Assurance Co., Ltd., United India Assurance Co., Ltd., Oriental Insurance Co., Ltd., and National
Insurance Co., Ltd.
The transaction is valued at approximately INR14,000 million ($259.94 million), which will be paid in shares
of IDBI.
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
Acquirer IDBI Bank Limited
Acquired % 81
51
52
DIVESTMENTS
City Mumbai
State Maharashtra
Country India
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
through its subsidiaries, provides banking, payments,
Business description
investments, institutional banking, general and life insurance
products and services.
City Mumbai
State Maharashtra
Country India
Website www.idbi.com
52
53
DIVESTMENTS
Financial Services
Financial Services-->Private Equity and Venture Capital
Industry Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
State Delhi
Country India
Website www.ifciltd.com
Financial Services
Industry
Financial Services-->General Insurance, Property and
Casualty
City Mumbai
Country India
-2018
Website www.niacl.com
53
54
DIVESTMENTS
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
State Delhi
Country India
Website www.orientalinsurance.org.in
55
DIVESTMENTS
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations
City Kolkata
Country India
Website www.nationalinsuranceindia.com
56
DIVESTMENTS
City Mumbai
State Maharashtra
Country India
Website www.licindia.com
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
Business description aviation, fire, marine cargo and hull, agriculture and credit,
among others. The company operates in India, the UK, the
UAE, Malaysia, South Africa and Russia. It is headquartered
in Mumbai, India.
Financial Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Industry Financial Services-->Reinsurance
Financial Services-->Reinsurance
Financial Services-->Reinsurance-->Marine
Financial Services-->Reinsurance-->Other
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Retail Banking and Lending
Country India
Website www.gicofindia.com
56
57
DIVESTMENTS
Deal Report: Orbis Power Venture and India Power Corporation Acquires 93% Stake in
DPSC from Andrew Yule, Life Insurance Corporation of India and United India Insurance
Deal in brief
Orbis Power Venture Private Limited, power generation company and India Power Corporation Limited., a
power generation company, have acquired 93% stake in DPSC Limited (formerly Dishergarh Power Supply
Co. Ltd.), a company engaged in generation, transmission and distribution of electric energy, from Andrew
Yule & Company Ltd, Life Insurance Corporation of India (LIC) and The United India Insurance Co Ltd.
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
Deal category Acquisition
Acquired % 93
>Transmission
57
58
DIVESTMENTS
City Kolkata
Country India
Website www.dpscl.com
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Industry Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Energy and Utilities-->Utilities-->Power Generation-->Fossil
Fuels
Energy and Utilities-->Utilities-->Power Generation--
>Renewables-->Solar
Energy and Utilities-->Utilities-->Power Generation--
>Renewables-->Wind
Energy and Utilities-->Utilities-->Utilities Networks--
>Distribution
Energy and Utilities-->Utilities-->Utilities Networks--
>Transmission
Energy and Utilities-->Utilities-->Wholesale Energy
Energy and Utilities-->Utilities-->Power Generation
City Kolkata
Country India
Website www.indiapower.com
59
DIVESTMENTS
City Kolkata
Country India
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
offers insurance products in India through associates and
Business description agents. Internationally, LIC and its associates have
operations in Fiji, Mauritius, the UK, Bahrain, Dubai, Abu
Dhabi, Kuwait, Qatar, Oman, Nepal, Sri Lanka, Saudi Arabia
and Kenya. LIC is headquartered in Mumbai, Maharashtra,
India.
59
60
DIVESTMENTS
City Mumbai
State Maharashtra
Country India
Website www.licindia.in
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
telecommunication systems such as digital microwave radio,
fibre optic telecommunications and programmable digital
MUX. The company’s lubricants comprise automative
lubricants, industrial lubricants and greases. Andrew Yule is
headquartered in Kolkata, West Bengal, India.
City KOLKATA
Country India
Website www.andrewyule.com
60
61
DIVESTMENTS
Deal Report: SREI Infrastructure acquires 57.17% stake in Dishergarh Power Supply
Company (DPSC)
Deal in brief
SREI Infrastructure Finance Limited has acquired a 57.17% stake in Dishergarh Power Supply Company,
Ltd. (DPSC), a company engaged in generation, transmission and distribution of power, from Andrew Yule
& Co., Ltd. (7.12%), The Life Insurance Corporation of India (LIC) (30.61%), United India Insurance
Company Limited (11.36%), Bengal Coal Company, Ltd. (3.38%) and Katras Jherriah Coal Company, Ltd.
(4.70%). The transaction is valued at approximately INR1,720 million ($37 million). All the companies are
based in India.
SREI Infrastructure is an infrastructure equipment finance and infrastructure project finance company, and
a non-banking financial institution.
SREI Infrastructure plans to acquire a 57.17% stake in DPSC from Andrew Yule, LIC, United India
Insurance Company, Bengal Coal Company and Katras Jherriah Coal Company.
CESC Limited, Reliance Energy Limited, Patton International, Ltd., Coal India Limited, JSW Energy Limited
and Jessop & Co. Ltd. are also in the race to acquire the stake.
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
Andrew Yule has appointed Amarchand & Mangaldas & Suresh A. Shroff & Co. as legal advisor. Deloitte
Touche Tohmatsu would evaluate the bids.
Acquired % 57.17
61
62
DIVESTMENTS
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
City Kolkata
Country India
Website www.dpscl.com
Kolkata, India.
62
63
DIVESTMENTS
City Kolkata
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
State West Bengal
Country India
Website www.srei.com
Country India
63
64
DIVESTMENTS
City Mumbai
State Maharashtra
Country India
Website www.licindia.com
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
Country India
Country India
Website www.andrewyule.com
64
65
DIVESTMENTS
Advisor information
Legal advisors
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
-2018
65
66
APPENDIX
APPENDIX
Contact Us
We hope that the data and analysis in this profile will help you make informed and imaginative
business decisions. If you have further requirements feedback please contact us at
assistme@marketline.com.
For further information on MarketLine and our range of business information services please visit
www.marketline.com
• Financial Deals is the most extensive Deals database currently available in the market
• The database provides research and analysis on all types of financial deals including:
– merger and acquisition
– private equity backed buyout and investment
– venture capital investment
– initial public offering (IPO)
– secondary offering
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments
– private placement
– partnership deal
• The database is a ‘live’ database and is updated real-time with Deal information
• Database contains more than 250,000 Deal records across all industries
• Every year over 48,000 Deals are added to the database
• The database contains active details of more than 5,000 Advisors and 12,000 Advisor
executives
• 200,000 + companies; 10,000 + VC/ PE firms
• Five year archive of key companies across eight sectors; complete eight year archive of
healthcare companies
• Complete portfolio of top 50 venture firms
• What we offer
– detailed deal transaction data;
– sector/market specific analytical deal reports with analyst opinion;
– customized research and analysis.
• Coverage
– global coverage across all industries through a combination of secondary and primary
research;
– multi-lingual analyst capability ensures strong coverage from regional markets;
– track over 14,000 sources every day.
–
• Content
– detailed deal information with over 50 fields covering all of the key information required
to understand a deal comprehensively;
– detailed advisory information, financial information, deal multiple, deal rationale, and
information related to business operations in addition to basic fields;
– Value addition through a wide network of contacts with top advisors, law firms,
-2018
66
67
APPENDIX
• Want to know more? – Should you have any queries, send us an email at
reachus@marketline.com
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
67
68
APPENDIX
Merger
A deal will be classified as Merger when two or more companies combine to form one company.
An amalgamation in the nature of merger is an amalgamation which satisfies all the following
conditions:
All the assets and liabilities of the transferor company become, after amalgamation, the
assets and liabilities of the transferee company.
Shareholders holding not less than 90% of the face value of the equity shares of the
transferor company (other than the equity shares already held therein, immediately before
the amalgamation, by the transferee company or its subsidiaries or their nominees) become
equity shareholders of the transferee company by virtue of amalgamation.
The consideration for the amalgamation receivable by those equity shareholders of the
transferor company who agree to become equity shareholders of the transferee company is
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
discharged by the transferee company wholly by the issue of equity shares in the transferee
company, except that cash may be paid in respect of any fractional shares.
The business of the transferor company is intended to be carried on, after the amalgamation,
by the transferee company.
No adjustment is intended to be made to the book values of the assets and liabilities of the
transferor company when they are incorporated in the financial statements of the transferee
company except to ensure uniformity of accounting policies.
Acquisition
Transactions where a company acquires equity stake in another company. The following are the
different sub-categories under acquisition:
Minority acquisition: The acquisition of less than 50% equity stake in the target
Majority acquisition: The acquisition of 50% or more than 50% and less than 100% equity
stake in the target
100% acquisition: The acquisition of all of the issued capital or 100% of the issued share
capital of the target
Asset Purchase: The acquisition of a business unit or an asset which is a not a legal entity
Private equity
Private equity transactions capture equity investment / buyout by a private equity (PE) firm. The
following are the different sub-categories under private equity:
Institutional buyout: PE firm or a group of PE firms acquiring a company from non-PE firms
or another company
69
APPENDIX
Management buyout (MBO): The management of the target acquires the target with the
backing of a PE firm will back the management in the buyout by providing the necessary
funds
Management buy-in (MBI): A manager or a management team from outside the target
company (target) raises the necessary finance, buys the target and becomes the target's
new management. The necessary financing is provided by private equity firms.
Buy-In Management buyout (BIMBO): A BIMBO is a combination of MBO and MBI, where
an external group of managers buy into the business and joins forces with the internal
management team
Going Private: A public listed company being acquired by PE firms or with the management
and is de-listed form the stock exchange on which it was listed
Private placement
A private placement is a direct private offering of securities by the issuer to a limited number of
investors. Private placement is a primary market transaction.
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Venture financing
Investments made in a start-up or young company by a venture capital or private equity firm in the
primary market (i.e. the target company is issuing new shares and receiving the proceeds directly).
The following are the different sub-categories under venture financing:
Seed: Financing provided for companies which have still not started marketing their product
or services. The purpose of such funding will generally be to assess and develop an initial
business concept
Growth/Expansion: Financing provided for companies to increase their sales, marketing, and
production operations, which have developed and started marketing their products
Late stage: Financing provided for companies which have already established themselves in
the market and are looking for expanding their production capacities
Exit: This node is assigned when a venture capital is selling its stake in a portfolio company
Initial public offering (IPO) occurs when a company first sells its shares to the public. The
following are the different stages under initial public offering:
Filing: When a company announces its plans to go for an IPO or files the prospectus with the
concerned regulator about the IPO
Pricing: When the company fixes the issue price for its offering
69
70
APPENDIX
Secondary offering: When a public listed company’s existing shareholders are offering their
shares to general public or a public listed company itself is making a follow-on public offering
Partnership
A partnership is the relationship existing between two or more entities that join to carry on a trade or
business. The following are the different sub-categories under partnership:
Joint Venture (JV): Two or more companies forming a new entity to undertake an activity
Co-marketing: Two or more companies coming together to collaborate either for product
development, distribution, or for providing services. In a broader sense any alliance related
to products and / or services where products or service of one company are marketed jointly
with product or services of another company is tagged as co-marketing alliance. Agreements
with a distribution company are not considered as Co-Marketing.
Affinity marketing: An agreement by which one company is getting access to the customer
base of another for selling its products and the company which is providing access to its
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
customer base is not involved in the product/service development or any other obligations
relating to such product/service
Licensing agreement: An agreement in which one party gives the rights to another party to
use its technology, intellectual property, and brands. Financial Deals does not capture
licensing deal related to software.
Rumor: Neither of the parties involved in the transaction announces the deal but has been
reported by media/market sources
Announced: Either party involved in the transaction announces the deal
Completed: Involved parties complete the transaction
Terminated: Involved parties do not intend to complete the earlier announced transaction
and either terminates the agreement or withdraws the bid
Dead rumor: Rumor denied by either of the parties involved in the transaction
Deal value
Deal value is the consideration paid by the acquirer for acquiring the target.
Financial Deals uses a deal value estimation model (for cases where deal value is not available
through secondary and primary sources), which is based on comparables. The estimation model
analyzes deal values based on market capitalization of the target company on the day prior to the
announcement. In addition, it also includes approximation derived through inputs from advisors
involved in the deal, approximate enterprise value, gross consideration and share price and number
of shares.
All deals values which are mentioned as approximate consideration are tagged as estimated values.
71
APPENDIX
For M&A, private equity, IPO and private placement, FD focuses on transactions where deal value is
more than or equal to $5 million. For venture investment and partnership, FD captures all deals.
Payment type: Payment type indicates the mode by which the purchase consideration has been
paid to the vendor. It includes the following sub-categories:
Cash: It indicates the amount paid in cash (either in %age or absolute value) by the acquirer
Debt: It indicates the amount of debt (either in %age or absolute value) of the target
assumed by the acquirer
Shares: It indicates the amount of shares (either in %age or absolute value) issued by the
acquirer
Quantity type: It indicates the consideration by payment mode in terms of value and
percentage
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Share price paid: Price per share offered by the acquirer to the target
Debt-related fields
Below is the list of fields captured:
Debt provider: Field ‘provider type’ indicates the type of debt provider. It includes the following sub-
categories:
Debt amount: Amount of debt raised by the acquirer to finance the acquisition
Debt category: It represents the nature of the debt that has been used by the acquirer in financing
the acquisition. It includes the following categories:
Mezzanine: Debt that incorporates equity-based options such as warrants with a lower-
priority debt. Mezzanine debt is often used to finance acquisitions and buyouts, where it can
be used to prioritize new owners ahead of existing owners in the event of bankruptcy.
Second lien: Debts that are subordinate to the rights of other, more senior debts issued
against the same collateral, or a portion of the same collateral. If a borrower defaults, second
lien debts stand behind higher lien debts in terms of rights to collect proceeds from the
debt's underlying collateral.
Other debt: Any other debt facility other than the above mentioned debt categories.
71
72
APPENDIX
Capital increase type: It is the type of debt or equity securities issued by the acquirer to raise the
necessary funds to finance the transaction. It includes the following options:
Converted debt: Converted debt is a debt security which can be exchanged for a specified
amount of another, related security, usually shares of stock in the issuing company, at the
option of the issuer and/or the holder
Convertible bond: A convertible bond is a type of debt instrument that can be converted
into shares of stock in the issuing company, usually at some pre-announced ratio
Convertible loan: A convertible loan is a loan issued by companies that can be converted
into ordinary shares or preference shares at a given price at a future date
Open offer: Indicates the manner in which the company raised money by offering its shares
to the public (public offering)
Placing: General term to describe the process of raising money via the issue of new shares
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Private placing: Private placing is a process of raising money by the issue of new shares to
institutions and private clients rather than to the general public
Rights issue: Rights issue is the process of raising money by issuing rights to a company's
existing shareholders to buy a proportional number of additional securities at a given price
within a fixed period
Scrip issue: A scrip issue (also called a capitalization issue or a bonus issue) is the issue of
new shares to existing shareholders at no charge, on a pro-rata basis to their existing
shareholdings
Vendor placing: A method of using shares to fund an acquisition by allotting shares from
the purchaser to the vendor in exchange for shares in the target (or other assets). The
consideration shares are then placed on behalf of the vendor by the purchaser’s bank so
that the vendor receives cash (the proceeds of sale of shares by the purchaser’s bank).
Financial Deals captures all the key financial items from income statement, balance sheet including
key ratios and valuation multiples, which help in providing a detailed understanding of the deal. The
financial information is captured for target companies. All the financial fields are presented in local
currency as well as US Dollar. In addition to financial fields, Financial Deals also captures certain
operational parameters. Below is a list of key fields along with their definitions:
Fiscal year end: Refers to the fiscal year (or financial year or accounting reference date), a 12-
month period used for calculating annual (yearly) financial statements. All the financial fields in
MarketLine Financial Deals database are captured according to the fiscal year-end values.
72
73
APPENDIX
Revenue (non banking): Revenue is the amount of money that a company receives from its
activities in a given period, primarily from sales of products and/or services to customers
Revenue (banking): This value is sum of interest income and non interest income
Operating profit: Operating profit is the earnings before deduction of interest payments and income
taxes; also called EBIT (earnings before interest and taxes) or operating income. For banking
companies interest payments are not deducted.
Post tax profit: Post tax profit is the amount of earnings that is available after deducting the taxes,
also known as profit after tax
Operating margin: This value measures the percent of revenues remaining after paying all
operating expenses. It is calculated as annual operating income divided by annual total revenue,
multiplied by 100.
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Shares issued: Number of shares the company has issued out of its authorized capital
Outstanding shares: It represents stock currently held by investors, including restricted shares
owned by the company's officers and insiders, as well as those held by the public. It is also defined
as the difference between shares in issue and treasury shares as of the fiscal year end.
Net assets: Net assets are the difference between the total asset and liabilities that has to be paid to
third parties. It is also known as net worth
Net assets-share ratio: It is defined as net assets divided by number of shares outstanding
Earning per share: Earnings per share (EPS) is calculated by dividing a company's net income by
the outstanding shares
Price earning ratio (P/E): The P/E ratio (price-to-earnings ratio) of a stock (also called its ‘earnings
multiple’, or simply multiple, P/E, or PE) is a measure of the price paid for a share relative to the
income or profit earned by the company per share. P/E ratio is arrived by dividing share price at the
end of the fiscal year with net income per share.
Deal multiples
73
74
APPENDIX
Advisor information
Financial Deals captures detailed advisor information including financial advisor, legal advisor,
placement agent, and public relation (PR) advisors along with respective executives involved in the
deal. The following are the different types of advisors:
Legal advisor: Legal advisors are those who look into the legal matters of a company for that
particular deal.
Financial advisor: Financial advisors are those who look into the financial matters of a company for
that particular deal. Financial advisor is separated into the following types:
Financial due diligence: The process of investigation, performed by investors, into the details
of a potential investment, such as examination of operations and management and
verification of material facts
Accounting: Financial advisor who looks into the accounting matters for a deal
Tax: Financial advisor who looks into the tax matters for a deal
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Corporate Finance: Financial advisor who looks into the financial decisions of a corporation
Book runners: Book runner is the managing or lead underwriter who maintains the books of
securities sold for a new issue
Underwriters: A company or other entity that administers the public issuance and distribution
of securities from a corporation or other issuing body
Brokers: An individual or firm that charges a fee or commission for executing buy and sell
orders submitted
Others: All other financial advisors not falling in the above-mentioned categories are tagged
as other
Placement agent: A company that specializes in finding institutional investors who are willing and
able to invest primarily in unregistered securities
Public Relations (PR) advisor: An entity that advises a company or manages its communication
activities with its stakeholders
74
75
APPENDIX
About MarketLine
In an information-rich world, finding facts you can rely upon isn’t always easy. MarketLine is the
solution.
At MarketLine, we deliver accurate, up-to-date information on 300 industries and 150 countries as
well as detailed profiles of over 2,500 companies. By taking the chore out of business research,
MarketLine gives you more time to focus on what really matters.
Profiling all major companies, industries and geographies, MarketLine is one of the most prolific
publishers of business information today.
Our content is produced by an internal team of analysts, drawing on primary and secondary research
and prepared under an established methodology that’s been tried and tested over 10 years.
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
75
76
APPENDIX
The United India Insurance Company Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Vendor, acquirer, target and partner report for The Oriental Insurance Company Ltd. and its
subsidiaries. Includes Mergers & Acquisitions, Private equity, Venture capital, Joint ventures,
Alliances and Investments
78
COMPANY OVERVIEW AND KEY FACTS
The Oriental Insurance Company Ltd. (Oriental Insurance), a wholly owned subsidiary of Oriental Government
Security Life Assurance Company Ltd, provides various general insurance services in the urban and rural sectors in
India. The company designs insurance coverage for projects, including power plants, petrochemical, steel and
chemical plants among otehrs. Oriental Insurance offers motor insurance policies, personal accident policy, Janata
personal accident policy, shopkeeper policy, householder policy, Nagarik suraksha policy and health insaurance
policies among others. It operates in across India and also has overseas operations in Nepal, Kuwait and Dubai.
Oriental Insurance is headquartered in New Delhi, India.
Key facts
State Delhi
Country India
Telephone 91 11 43659595
Website www.orientalinsurance.org.in
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
-
79
COMPANY OVERVIEW AND KEY FACTS
The Oriental Insurance Company Ltd. activity by deal type - The Oriental Insurance Company Ltd. M&A activity by
volume (trailing twelve months (TTM)) geography (TTM)
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Corporate venturing - Asia-Pacific 1
Divestments - Middle East and Africa -
Partnership - South and Central America -
Private equity -
The Oriental Insurance Company Ltd. activity by deal type - The Oriental Insurance Company Ltd. M&A average deal size
volume (2014-YTD2018) - value ($m)
Deal type 2014 2015 2016 2017 2018 Year Number of deals Average deal size ($m)
Acquisition (ACQ) - - - - 1 2014 - -
Capital raising - - - 1 - 2015 - -
(CR) 2016 - -
2017 - -
2018 1 -
Note: Zero deal value indicates transactions with undisclosed deal values
80
TABLE OF CONTENTS
TABLE OF CONTENTS
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
CORPORATE VENTURING .................................................................. 12
Corporate Venturing – Deal reports ................................................................................................. 12
APPENDIX............................................................................................. 29
Contact Us ......................................................................................................................................... 29
81
TABLE OF CONTENTS
LIST OF TABLES
Table 1: The Oriental Insurance Company Ltd. M&A volume and value trend (2014-YTD2018) 7
Table 2: The Oriental Insurance Company Ltd. M&A activity by geography (2014-YTD2018) 7
Table 3: The Oriental Insurance Company Ltd. capital raising volume and value trend (2014-YTD2018) 19
Table 4: The Oriental Insurance Company Ltd. capital raising by deal type (2014-YTD2018) 19
LIST OF FIGURES
Figure 1: The Oriental Insurance Company Ltd. M&A volume and value trend (2014-YTD2018) 7
Figure 2: The Oriental Insurance Company Ltd. M&A activity by geography (2014-YTD2018) 7
Figure 3: The Oriental Insurance Company Ltd. capital raising volume and value trend (2014-YTD2018) 19
Figure 4: The Oriental Insurance Company Ltd. capital raising by deal type (2014-YTD2018) 19
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
82
TARGETS AND PARTNERS
The United India Insurance Company Limited (India) Feb 1, 2018 Merger -
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
83
MERGERS & ACQUISITIONS
Figure 1: The Oriental Insurance Company Ltd. M&A volume Figure 2: The Oriental Insurance Company Ltd. M&A activity
and value trend (2014-YTD2018) by geography (2014-YTD2018)
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE
Note: Zero deal value indicates transactions with undisclosed deal values
Table 1: The Oriental Insurance Company Ltd. M&A volume Table 2: The Oriental Insurance Company Ltd. M&A activity
and value trend (2014-YTD2018) by geography (2014-YTD2018)
2015 - - Europe -
2016 - - Asia-Pacific 1
84
MERGERS & ACQUISITIONS
Deal Report: Oriental Insurance Company and National Insurance to Merge with United
India Insurance
Deal in brief
Oriental Insurance Company Ltd., a provider of general insurance services, and National Insurance
Company Limited., a provider of general insurance for urban and rural customers, to merge with United
India Insurance Co. Ltd., a provider of non-life insurance products and services. All the companies are
based in India.
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal category Merger
Industry
Financial Services-->General Insurance, Property and 8
85
MERGERS & ACQUISITIONS
Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations
City Kolkata
Country India
Website www.nationalinsuranceindia.com
86
MERGERS & ACQUISITIONS
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Industry
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
City Chennai
87
MERGERS & ACQUISITIONS
Country India
Website www.uiic.co.in
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
11
88
CORPORATE VENTURING
CORPORATE VENTURING
Corporate Venturing – Deal reports
Deal Report: Reliance – Anil Dhirubhai Ambani Group to invest INR80,000 million in
Reliance Energy
Deal in brief
Reliance – Anil Dhirubhai Ambani Group (Reliance ADA Group) has agreed to infuse new equity capital of
up to INR80,000 million ($2,018.67 million) into its power utility company Reliance Energy Limited. The new
equity capital infusion is proposed through a preferential offer of equity shares and/or equity related
securities at a price of INR1,812 ($45.72) per share.
Life Insurance Corporation of India, New India Assurance Co., Ltd., The Oriental Insurance Company
Limited, General Insurance Corporation of India, National Insurance Company Limited and United India
Insurance Company Limited have also been provided an opportunity to participate in the proposed offering
on the same terms and conditions.
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Target Reliance Energy Limited
Deal rationale
The new equity capital will substantially enhance Reliance Energy's net worth, and further augment its
borrowing capabilities, to enable greater participation in these growth opportunities in high growth areas. 12
89
CORPORATE VENTURING
Deal financials
EV/Revenues 2.41
EV/EBITDA 11.09
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Security type Common stock
90
CORPORATE VENTURING
Energy-->Production
City Mumbai
State Maharashtra
Country India
Website www.rel.co.in
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Key ratios
Country India
Website www.relianceadagroup.com
14
91
CORPORATE VENTURING
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and
Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Industry Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
15
92
CORPORATE VENTURING
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
City Chennai
Country India
Website www.uiic.co.in
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
services in India. It offers personal, commercial, industrial,
liability, social, and credit insurance services. The company
operates in India through a ntwork of 26 regional offices, 393
Business description
divisional offices, 614 branches and 34 direct agent
branches. New India Assurance Co. also operates operates
in 24 countries with a network of 19 branches, 12 agencies,
2 associate companies and 2 subsidiary companies.
Financial Services
Industry
Financial Services-->General Insurance, Property and
Casualty
City Mumbai
Country India
Website www.niacl.com
93
CORPORATE VENTURING
Financial Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Industry Financial Services-->Reinsurance
Financial Services-->Reinsurance
Financial Services-->Reinsurance-->Marine
Financial Services-->Reinsurance-->Other
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Retail Banking and Lending
Country India
Website www.gicofindia.com
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
The Life Insurance Corporation of India (LIC) is a life
insurance company in India. Its offers various products
Business description
which include insurance plans, pension plans, unit plans,
special plans, and group schemes.
City Mumbai
State Maharashtra
Country India
Website www.licindia.com
94
CORPORATE VENTURING
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Industry
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations
City Kolkata
Country India
Website www.nationalinsuranceindia.com
18
95
CAPITAL RAISING
CAPITAL RAISING
Figure 3: The Oriental Insurance Company Ltd. capital Figure 4: The Oriental Insurance Company Ltd. capital
raising volume and value trend (2014-YTD2018) raising by deal type (2014-YTD2018)
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE
Table 3: The Oriental Insurance Company Ltd. capital raising Table 4: The Oriental Insurance Company Ltd. capital raising
volume and value trend (2014-YTD2018) by deal type (2014-YTD2018)
2015 - -
2016 - -
2017 1 -
2018 - -
19
96
CAPITAL RAISING
Deal in brief
According to Moneycontrol, The Government of India (GOI) has agreed to divest a 25% stake in The
Oriental Insurance Company Limited, an India-based non-life insurance company, through listing the
company on stock exchanges. The listing will be either by fresh equity or offer for sale.
Concurrently, GOI has agreed to sell a 25% stake in each of New India Assurance Co., Ltd., United India
Insurance Co., Ltd., National Insurance Company Limited and General Insurance Corporation of India.
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal category IPO
% to Public 25
97
CAPITAL RAISING
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
State Delhi
Country India
21
98
DIVESTMENTS
Deal in brief
IDBI Bank Limited, a financial holding company, is planning to acquire 81% of stake in Stock Holding
Corporation of India Limited (SHCI), a depository participant. Both the companies are based in India.
IDBI is currently holding approximately a 19% stake in SHCI. The other shareholders of SHCI include IFCI
Ltd, Unit Trust of India, Life Insurance Corporation of India, General Insurance Corporation of India, New
India Assurance Co., Ltd., United India Assurance Co., Ltd., Oriental Insurance Co., Ltd., and National
Insurance Co., Ltd.
The transaction is valued at approximately INR14,000 million ($259.94 million), which will be paid in shares
of IDBI.
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer IDBI Bank Limited
Acquired % 81
22
99
DIVESTMENTS
City Mumbai
State Maharashtra
Country India
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
through its subsidiaries, provides banking, payments,
Business description
investments, institutional banking, general and life insurance
products and services.
City Mumbai
State Maharashtra
Country India
Website www.idbi.com
23
100
DIVESTMENTS
Financial Services
Financial Services-->Private Equity and Venture Capital
Industry Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
State Delhi
Country India
Website www.ifciltd.com
24
101
DIVESTMENTS
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
City Chennai
Country India
Website www.uiic.co.in
25
102
DIVESTMENTS
Financial Services
Industry
Financial Services-->General Insurance, Property and
Casualty
City Mumbai
Country India
Website www.niacl.com
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company type Private
103
DIVESTMENTS
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations
City Kolkata
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Country India
Website www.nationalinsuranceindia.com
City Mumbai
State Maharashtra
Country India
Website www.licindia.com
27
104
DIVESTMENTS
Financial Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Industry Financial Services-->Reinsurance
Financial Services-->Reinsurance
Financial Services-->Reinsurance-->Marine
Financial Services-->Reinsurance-->Other
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Retail Banking and Lending
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Country India
Website www.gicofindia.com
28
105
APPENDIX
APPENDIX
Contact Us
We hope that the data and analysis in this profile will help you make informed and imaginative
business decisions. If you have further requirements feedback please contact us at
assistme@marketline.com.
For further information on MarketLine and our range of business information services please visit
www.marketline.com
• Financial Deals is the most extensive Deals database currently available in the market
• The database provides research and analysis on all types of financial deals including:
– merger and acquisition
– private equity backed buyout and investment
– venture capital investment
– initial public offering (IPO)
– secondary offering
– private placement
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
– partnership deal
• The database is a ‘live’ database and is updated real-time with Deal information
• Database contains more than 250,000 Deal records across all industries
• Every year over 48,000 Deals are added to the database
• The database contains active details of more than 5,000 Advisors and 12,000 Advisor
executives
• 200,000 + companies; 10,000 + VC/ PE firms
• Five year archive of key companies across eight sectors; complete eight year archive of
healthcare companies
• Complete portfolio of top 50 venture firms
• What we offer
– detailed deal transaction data;
– sector/market specific analytical deal reports with analyst opinion;
– customized research and analysis.
• Coverage
– global coverage across all industries through a combination of secondary and primary
research;
– multi-lingual analyst capability ensures strong coverage from regional markets;
– track over 14,000 sources every day.
–
• Content
– detailed deal information with over 50 fields covering all of the key information required
to understand a deal comprehensively;
– detailed advisory information, financial information, deal multiple, deal rationale, and
information related to business operations in addition to basic fields;
– Value addition through a wide network of contacts with top advisors, law firms,
investment banks, and industry experts.
29
106
APPENDIX
• Want to know more? – Should you have any queries, send us an email at
reachus@marketline.com
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
30
107
APPENDIX
Merger
A deal will be classified as Merger when two or more companies combine to form one company.
An amalgamation in the nature of merger is an amalgamation which satisfies all the following
conditions:
All the assets and liabilities of the transferor company become, after amalgamation, the
assets and liabilities of the transferee company.
Shareholders holding not less than 90% of the face value of the equity shares of the
transferor company (other than the equity shares already held therein, immediately before
the amalgamation, by the transferee company or its subsidiaries or their nominees) become
equity shareholders of the transferee company by virtue of amalgamation.
The consideration for the amalgamation receivable by those equity shareholders of the
transferor company who agree to become equity shareholders of the transferee company is
discharged by the transferee company wholly by the issue of equity shares in the transferee
company, except that cash may be paid in respect of any fractional shares.
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
The business of the transferor company is intended to be carried on, after the amalgamation,
by the transferee company.
No adjustment is intended to be made to the book values of the assets and liabilities of the
transferor company when they are incorporated in the financial statements of the transferee
company except to ensure uniformity of accounting policies.
Acquisition
Transactions where a company acquires equity stake in another company. The following are the
different sub-categories under acquisition:
Minority acquisition: The acquisition of less than 50% equity stake in the target
Majority acquisition: The acquisition of 50% or more than 50% and less than 100% equity
stake in the target
100% acquisition: The acquisition of all of the issued capital or 100% of the issued share
capital of the target
Asset Purchase: The acquisition of a business unit or an asset which is a not a legal entity
Private equity
Private equity transactions capture equity investment / buyout by a private equity (PE) firm. The
following are the different sub-categories under private equity:
Institutional buyout: PE firm or a group of PE firms acquiring a company from non-PE firms
or another company
108
APPENDIX
Management buyout (MBO): The management of the target acquires the target with the
backing of a PE firm will back the management in the buyout by providing the necessary
funds
Management buy-in (MBI): A manager or a management team from outside the target
company (target) raises the necessary finance, buys the target and becomes the target's
new management. The necessary financing is provided by private equity firms.
Buy-In Management buyout (BIMBO): A BIMBO is a combination of MBO and MBI, where
an external group of managers buy into the business and joins forces with the internal
management team
Going Private: A public listed company being acquired by PE firms or with the management
and is de-listed form the stock exchange on which it was listed
Private placement
A private placement is a direct private offering of securities by the issuer to a limited number of
investors. Private placement is a primary market transaction.
Venture financing
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Investments made in a start-up or young company by a venture capital or private equity firm in the
primary market (i.e. the target company is issuing new shares and receiving the proceeds directly).
The following are the different sub-categories under venture financing:
Seed: Financing provided for companies which have still not started marketing their product
or services. The purpose of such funding will generally be to assess and develop an initial
business concept
Growth/Expansion: Financing provided for companies to increase their sales, marketing, and
production operations, which have developed and started marketing their products
Late stage: Financing provided for companies which have already established themselves in
the market and are looking for expanding their production capacities
Exit: This node is assigned when a venture capital is selling its stake in a portfolio company
Initial public offering (IPO) occurs when a company first sells its shares to the public. The
following are the different stages under initial public offering:
Filing: When a company announces its plans to go for an IPO or files the prospectus with the
concerned regulator about the IPO
Pricing: When the company fixes the issue price for its offering
32
109
APPENDIX
Secondary offering: When a public listed company’s existing shareholders are offering their
shares to general public or a public listed company itself is making a follow-on public offering
Partnership
A partnership is the relationship existing between two or more entities that join to carry on a trade or
business. The following are the different sub-categories under partnership:
Joint Venture (JV): Two or more companies forming a new entity to undertake an activity
Co-marketing: Two or more companies coming together to collaborate either for product
development, distribution, or for providing services. In a broader sense any alliance related
to products and / or services where products or service of one company are marketed jointly
with product or services of another company is tagged as co-marketing alliance. Agreements
with a distribution company are not considered as Co-Marketing.
Affinity marketing: An agreement by which one company is getting access to the customer
base of another for selling its products and the company which is providing access to its
customer base is not involved in the product/service development or any other obligations
relating to such product/service
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Licensing agreement: An agreement in which one party gives the rights to another party to
use its technology, intellectual property, and brands. Financial Deals does not capture
licensing deal related to software.
Rumor: Neither of the parties involved in the transaction announces the deal but has been
reported by media/market sources
Announced: Either party involved in the transaction announces the deal
Completed: Involved parties complete the transaction
Terminated: Involved parties do not intend to complete the earlier announced transaction
and either terminates the agreement or withdraws the bid
Dead rumor: Rumor denied by either of the parties involved in the transaction
Deal value
Deal value is the consideration paid by the acquirer for acquiring the target.
Financial Deals uses a deal value estimation model (for cases where deal value is not available
through secondary and primary sources), which is based on comparables. The estimation model
analyzes deal values based on market capitalization of the target company on the day prior to the
announcement. In addition, it also includes approximation derived through inputs from advisors
involved in the deal, approximate enterprise value, gross consideration and share price and number
of shares.
All deals values which are mentioned as approximate consideration are tagged as estimated values.
110
APPENDIX
For M&A, private equity, IPO and private placement, FD focuses on transactions where deal value is
more than or equal to $5 million. For venture investment and partnership, FD captures all deals.
Payment type: Payment type indicates the mode by which the purchase consideration has been
paid to the vendor. It includes the following sub-categories:
Cash: It indicates the amount paid in cash (either in %age or absolute value) by the acquirer
Debt: It indicates the amount of debt (either in %age or absolute value) of the target
assumed by the acquirer
Shares: It indicates the amount of shares (either in %age or absolute value) issued by the
acquirer
Quantity type: It indicates the consideration by payment mode in terms of value and
percentage
Share price paid: Price per share offered by the acquirer to the target
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Debt-related fields
Below is the list of fields captured:
Debt provider: Field ‘provider type’ indicates the type of debt provider. It includes the following sub-
categories:
Debt amount: Amount of debt raised by the acquirer to finance the acquisition
Debt category: It represents the nature of the debt that has been used by the acquirer in financing
the acquisition. It includes the following categories:
Mezzanine: Debt that incorporates equity-based options such as warrants with a lower-
priority debt. Mezzanine debt is often used to finance acquisitions and buyouts, where it can
be used to prioritize new owners ahead of existing owners in the event of bankruptcy.
Second lien: Debts that are subordinate to the rights of other, more senior debts issued
against the same collateral, or a portion of the same collateral. If a borrower defaults, second
lien debts stand behind higher lien debts in terms of rights to collect proceeds from the
debt's underlying collateral.
Other debt: Any other debt facility other than the above mentioned debt categories.
34
111
APPENDIX
Capital increase type: It is the type of debt or equity securities issued by the acquirer to raise the
necessary funds to finance the transaction. It includes the following options:
Converted debt: Converted debt is a debt security which can be exchanged for a specified
amount of another, related security, usually shares of stock in the issuing company, at the
option of the issuer and/or the holder
Convertible bond: A convertible bond is a type of debt instrument that can be converted
into shares of stock in the issuing company, usually at some pre-announced ratio
Convertible loan: A convertible loan is a loan issued by companies that can be converted
into ordinary shares or preference shares at a given price at a future date
Open offer: Indicates the manner in which the company raised money by offering its shares
to the public (public offering)
Placing: General term to describe the process of raising money via the issue of new shares
Private placing: Private placing is a process of raising money by the issue of new shares to
institutions and private clients rather than to the general public
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Rights issue: Rights issue is the process of raising money by issuing rights to a company's
existing shareholders to buy a proportional number of additional securities at a given price
within a fixed period
Scrip issue: A scrip issue (also called a capitalization issue or a bonus issue) is the issue of
new shares to existing shareholders at no charge, on a pro-rata basis to their existing
shareholdings
Vendor placing: A method of using shares to fund an acquisition by allotting shares from
the purchaser to the vendor in exchange for shares in the target (or other assets). The
consideration shares are then placed on behalf of the vendor by the purchaser’s bank so
that the vendor receives cash (the proceeds of sale of shares by the purchaser’s bank).
Financial Deals captures all the key financial items from income statement, balance sheet including
key ratios and valuation multiples, which help in providing a detailed understanding of the deal. The
financial information is captured for target companies. All the financial fields are presented in local
currency as well as US Dollar. In addition to financial fields, Financial Deals also captures certain
operational parameters. Below is a list of key fields along with their definitions:
Fiscal year end: Refers to the fiscal year (or financial year or accounting reference date), a 12-
month period used for calculating annual (yearly) financial statements. All the financial fields in
MarketLine Financial Deals database are captured according to the fiscal year-end values.
35
112
APPENDIX
Revenue (non banking): Revenue is the amount of money that a company receives from its
activities in a given period, primarily from sales of products and/or services to customers
Revenue (banking): This value is sum of interest income and non interest income
Operating profit: Operating profit is the earnings before deduction of interest payments and income
taxes; also called EBIT (earnings before interest and taxes) or operating income. For banking
companies interest payments are not deducted.
Post tax profit: Post tax profit is the amount of earnings that is available after deducting the taxes,
also known as profit after tax
Operating margin: This value measures the percent of revenues remaining after paying all
operating expenses. It is calculated as annual operating income divided by annual total revenue,
multiplied by 100.
Shares issued: Number of shares the company has issued out of its authorized capital
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Market capitalization: Market capitalization is calculated by taking the number of outstanding
shares of common stock multiplied by the market price-per-share as on fiscal year end
Outstanding shares: It represents stock currently held by investors, including restricted shares
owned by the company's officers and insiders, as well as those held by the public. It is also defined
as the difference between shares in issue and treasury shares as of the fiscal year end.
Net assets: Net assets are the difference between the total asset and liabilities that has to be paid to
third parties. It is also known as net worth
Net assets-share ratio: It is defined as net assets divided by number of shares outstanding
Earning per share: Earnings per share (EPS) is calculated by dividing a company's net income by
the outstanding shares
Price earning ratio (P/E): The P/E ratio (price-to-earnings ratio) of a stock (also called its ‘earnings
multiple’, or simply multiple, P/E, or PE) is a measure of the price paid for a share relative to the
income or profit earned by the company per share. P/E ratio is arrived by dividing share price at the
end of the fiscal year with net income per share.
Deal multiples
36
113
APPENDIX
Advisor information
Financial Deals captures detailed advisor information including financial advisor, legal advisor,
placement agent, and public relation (PR) advisors along with respective executives involved in the
deal. The following are the different types of advisors:
Legal advisor: Legal advisors are those who look into the legal matters of a company for that
particular deal.
Financial advisor: Financial advisors are those who look into the financial matters of a company for
that particular deal. Financial advisor is separated into the following types:
Financial due diligence: The process of investigation, performed by investors, into the details
of a potential investment, such as examination of operations and management and
verification of material facts
Accounting: Financial advisor who looks into the accounting matters for a deal
Tax: Financial advisor who looks into the tax matters for a deal
Corporate Finance: Financial advisor who looks into the financial decisions of a corporation
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Book runners: Book runner is the managing or lead underwriter who maintains the books of
securities sold for a new issue
Underwriters: A company or other entity that administers the public issuance and distribution
of securities from a corporation or other issuing body
Brokers: An individual or firm that charges a fee or commission for executing buy and sell
orders submitted
Others: All other financial advisors not falling in the above-mentioned categories are tagged
as other
Placement agent: A company that specializes in finding institutional investors who are willing and
able to invest primarily in unregistered securities
Public Relations (PR) advisor: An entity that advises a company or manages its communication
activities with its stakeholders
37
114
APPENDIX
About MarketLine
In an information-rich world, finding facts you can rely upon isn’t always easy. MarketLine is the
solution.
At MarketLine, we deliver accurate, up-to-date information on 300 industries and 150 countries as
well as detailed profiles of over 2,500 companies. By taking the chore out of business research,
MarketLine gives you more time to focus on what really matters.
Profiling all major companies, industries and geographies, MarketLine is one of the most prolific
publishers of business information today.
Our content is produced by an internal team of analysts, drawing on primary and secondary research
and prepared under an established methodology that’s been tried and tested over 10 years.
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
38
115
APPENDIX
The Oriental Insurance Company Ltd.– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Vendor, acquirer, target and partner report for General Insurance Corporation of India and its
subsidiaries. Includes Mergers & Acquisitions, Private equity, Venture capital, Joint ventures,
Alliances and Investments
117
COMPANY OVERVIEW AND KEY FACTS
General Insurance Corporation of India (GIC) is engaged in providing reinsurance services to the general insurers in
India. The company, through its subsidiaries is involved in providing reinsuring solutions for Afro-Asian region. GIC’s
reinsurance portfolio includes oil and energy, aviation, spares/rotor wing, fire and Engineering, Liability, property,
marine cargo and hull, agriculture, credit, and miscellaneous. GIC manages its representative office in Moscow. The
company operates in India, the UK, China, Brazil, the UAE, Malaysia, Europe, South Africa and Russia. GIC is
headquartered in Mumbai, Maharashtra, India.
The company reported revenues of (Rupee) INR422,517.3 million for the fiscal year ended March 2018 (FY2018), an
increase of 36.6% over FY2017. In FY2018, the company’s operating margin was 5.5%, compared to an operating
margin of 11.2% in FY2017. In FY2018, the company recorded a net margin of 7.4%, compared to a net margin of
10.2% in FY2017.
Key facts
Country India
Website www.gicofindia.com
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
-
118
COMPANY OVERVIEW AND KEY FACTS
General Insurance Corporation of India activity by deal type - General Insurance Corporation of India M&A average deal
volume (2014-YTD2018) size - value ($m)
Deal type 2014 2015 2016 2017 2018 Year Number of deals Average deal size ($m)
Acquisition (ACQ) - 1 - - - 2014 - -
Capital raising - - - 1 - 2015 1 500
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
(CR) 2016 - -
Corporate - - - 1 - 2017 - -
venturing (CV)
2018 - -
Deal value
Target/Partner (Country) Announcement date Deal status Deal Type
($m)
SZ DJI Technology Co., Ltd. (China) Sep 24, 2015 Announced Private equity 500
119
TABLE OF CONTENTS
TABLE OF CONTENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
CORPORATE VENTURING .................................................................. 11
Corporate Venturing – Overview ...................................................................................................... 11
APPENDIX........................................................................................... 108
Contact Us ....................................................................................................................................... 108
120
TABLE OF CONTENTS
LIST OF TABLES
Table 1: General Insurance Corporation of India M&A volume and value trend (2014-YTD2018) 7
Table 3: General Insurance Corporation of India corporate venturing volume and value trend (2014-
YTD2018) 11
Table 5: General Insurance Corporation of India capital raising volume and value trend (2014-YTD2018) 49
Table 6: General Insurance Corporation of India capital raising by deal type (2014-YTD2018) 49
LIST OF FIGURES
Figure 1: General Insurance Corporation of India M&A volume and value trend (2014-YTD2018) 7
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Figure 3: General Insurance Corporation of India corporate venturing volume and value trend (2014-
YTD2018) 11
Figure 5: General Insurance Corporation of India capital raising volume and value trend (2014-YTD2018) 49
Figure 6: General Insurance Corporation of India capital raising by deal type (2014-YTD2018) 49
121
TARGETS AND PARTNERS
SZ DJI Technology Co., Ltd. (China) Sep 24, 2015 Private equity 500
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
122
MERGERS & ACQUISITIONS
Figure 1: General Insurance Corporation of India M&A Figure 2: General Insurance Corporation of India M&A
volume and value trend (2014-YTD2018) activity by geography (2014-YTD2018)
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE
Table 1: General Insurance Corporation of India M&A volume Table 2: General Insurance Corporation of India M&A activity
and value trend (2014-YTD2018) by geography (2014-YTD2018)
2016 - - Asia-Pacific 1
123
MERGERS & ACQUISITIONS
Deal in brief
According to China Money Network, sources reported that SZ DJI Technology Co., Ltd., a China-based
manufacturer of consumer drones, has agreed to raise approximately $500 million from New China Life
Insurance Co., Ltd., General Insurance Corporation of India and New Horizon Capital.
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal value (estimated) ($m) 500
City Shenzhen
Country China
Website www.dji.com
8
124
MERGERS & ACQUISITIONS
Financial Services
Financial Services-->General Insurance, Property and
Casualty
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->Life and Pensions-->Life and Protection
Industry
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->Life and Pensions-->Pensions
Financial Services-->Life and Pensions-->Life and Protection
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Country China
Website newchinalife.com
9
125
MERGERS & ACQUISITIONS
Address Suite 903, 9/F, Jin Bao Tower, 89 Jin Bao Street
City Beijing
Country China
Website www.nhfund.com
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
10
126
CORPORATE VENTURING
CORPORATE VENTURING
Corporate Venturing – Overview
Figure 3: General Insurance Corporation of India corporate Figure 4: General Insurance Corporation of India corporate
venturing volume and value trend (2014-YTD2018) venturing by geography (2014-YTD2018)
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE
Table 3: General Insurance Corporation of India corporate Table 4: General Insurance Corporation of India corporate
venturing volume and value trend (2014-YTD2018) venturing by geography (2014-YTD2018)
2015 - - Europe -
2016 - - Asia-Pacific 1
11
127
CORPORATE VENTURING
Deal Report: HDFC ERGO General Insurance Company raises $51.26 million in private
placement of debentures
Deal in brief
HDFC ERGO General Insurance Company Limited, an India-based general insurance company, has raised
INR3,500 million ($51.26 million) in a private placement of unsecured, subordinated and redeemable non-
convertible debentures (NCDs) having a face value of INR1 million ($0.015 million) each from ERGO
Insurance Group AG, General Insurance Corporation of India, Life Insurance Corporation of India and other
investors.
The NCDs will have an interest rate of 7.6% annum and a maturity period of 10 years with a call option at
the end of five years.
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer 1 ERGO Insurance Group AG
Deal rationale
128
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
million for the fiscal year 2016 (FY2016), representing an
increase of 6.4% over FY2015. Its net written premium was
INR18,980 million in FY2016, an increase of 6.7% over
FY2015.
City Mumbai
State Maharashtra
Country India
Website www.hdfcergo.com
13
129
CORPORATE VENTURING
Financial Services
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and
Industry Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Casualty-->Personal Insurance-->Property
Financial Services-->Institutional Investment Management
Address Victoriaplatz 2
City Duesseldorf
Country Germany
Website www.ergo.com
City Mumbai
State Maharashtra
Country India
Website www.licindia.com 14
130
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Industry Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
15
131
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
16
132
CORPORATE VENTURING
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
17
133
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
18
134
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
19
135
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
20
136
CORPORATE VENTURING
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
21
137
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
22
138
CORPORATE VENTURING
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
23
139
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
24
140
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing-->Packaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
25
141
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
26
142
CORPORATE VENTURING
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
27
143
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
28
144
CORPORATE VENTURING
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
29
145
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
30
146
CORPORATE VENTURING
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Biomaterials and Tissue Regeneration
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
31
147
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
32
148
CORPORATE VENTURING
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
33
149
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
34
150
CORPORATE VENTURING
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
35
151
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
36
152
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
37
153
CORPORATE VENTURING
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
38
154
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
39
155
CORPORATE VENTURING
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
40
156
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
41
157
CORPORATE VENTURING
Deal Report: Reliance – Anil Dhirubhai Ambani Group to invest INR80,000 million in
Reliance Energy
Deal in brief
Reliance – Anil Dhirubhai Ambani Group (Reliance ADA Group) has agreed to infuse new equity capital of
up to INR80,000 million ($2,018.67 million) into its power utility company Reliance Energy Limited. The new
equity capital infusion is proposed through a preferential offer of equity shares and/or equity related
securities at a price of INR1,812 ($45.72) per share.
Life Insurance Corporation of India, New India Assurance Co., Ltd., The Oriental Insurance Company
Limited, General Insurance Corporation of India, National Insurance Company Limited and United India
Insurance Company Limited have also been provided an opportunity to participate in the proposed offering
on the same terms and conditions.
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer 3 The Oriental Insurance Company Ltd.
Deal rationale
The new equity capital will substantially enhance Reliance Energy's net worth, and further augment its
borrowing capabilities, to enable greater participation in these growth opportunities in high growth areas.
Deal financials
158
CORPORATE VENTURING
EV/Revenues 2.41
EV/EBITDA 11.09
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Target: Reliance Energy Limited
City Mumbai
State Maharashtra
43
159
CORPORATE VENTURING
Country India
Website www.rel.co.in
Key ratios
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company type Private
Country India
Website www.relianceadagroup.com
160
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and
Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Industry
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
45
161
CORPORATE VENTURING
City Chennai
Country India
Website www.uiic.co.in
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
headquartered in New Delhi, India.
State Delhi
Country India
Website www.orientalinsurance.org.in
162
CORPORATE VENTURING
Financial Services
Industry
Financial Services-->General Insurance, Property and
Casualty
City Mumbai
Country India
Website www.niacl.com
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company type Private
City Mumbai
State Maharashtra
Country India
Website www.licindia.com
163
CORPORATE VENTURING
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Industry
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations
City Kolkata
Country India
Website www.nationalinsuranceindia.com
48
164
CAPITAL RAISING
CAPITAL RAISING
Figure 5: General Insurance Corporation of India capital Figure 6: General Insurance Corporation of India capital
raising volume and value trend (2014-YTD2018) raising by deal type (2014-YTD2018)
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE
Table 5: General Insurance Corporation of India capital raising Table 6: General Insurance Corporation of India capital
volume and value trend (2014-YTD2018) raising by deal type (2014-YTD2018)
2015 - -
2016 - -
2017 1 -
2018 - -
49
165
CAPITAL RAISING
Deal Report: Government of India to divest 25% stake in General Insurance Corporation
of India
Deal in brief
According to Moneycontrol, The Government of India (GOI) has agreed to divest a 25% stake in General
Insurance Corporation of India, an India-based general insurance company, through listing the company on
stock exchanges. The listing will be either by fresh equity or offer for sale.
Concurrently, GOI has agreed to sell a 25% stake in each of New India Assurance Co., Ltd., United India
Insurance Co., Ltd., The Oriental Insurance Company Ltd. and National Insurance Company Limited.
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal status Announced
% to Public 25
166
CAPITAL RAISING
Fuels
Environmental and Waste Management Services-->Sewage
Treatment Facilities
Construction and Real Estate-->Heavy Construction
Construction and Real Estate-->Real Estate Transactions
Energy and Utilities-->Utilities-->Power Generation
Transport and Logistics-->Transport Infrastructure--
>Highway Operators
Transport and Logistics-->Transport Infrastructure
Transport and Logistics-->Transport Infrastructure-->Port
and Harbor Operations
Transport and Logistics-->Transport Infrastructure-->Rail
Infrastructure
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
State Delhi
Country India
51
167
DIVESTMENTS
Deal in brief
IDBI Bank Limited, a financial holding company, is planning to acquire 81% of stake in Stock Holding
Corporation of India Limited (SHCI), a depository participant. Both the companies are based in India.
IDBI is currently holding approximately a 19% stake in SHCI. The other shareholders of SHCI include IFCI
Ltd, Unit Trust of India, Life Insurance Corporation of India, General Insurance Corporation of India, New
India Assurance Co., Ltd., United India Assurance Co., Ltd., Oriental Insurance Co., Ltd., and National
Insurance Co., Ltd.
The transaction is valued at approximately INR14,000 million ($259.94 million), which will be paid in shares
of IDBI.
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer IDBI Bank Limited
Acquired % 81
52
168
DIVESTMENTS
City Mumbai
State Maharashtra
Country India
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
through its subsidiaries, provides banking, payments,
Business description
investments, institutional banking, general and life insurance
products and services.
City Mumbai
State Maharashtra
Country India
Website www.idbi.com
53
169
DIVESTMENTS
Financial Services
Financial Services-->Private Equity and Venture Capital
Industry Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
State Delhi
Country India
Website www.ifciltd.com
54
170
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
City Chennai
Country India
Website www.uiic.co.in
55
171
DIVESTMENTS
Financial Services
Industry
Financial Services-->General Insurance, Property and
Casualty
City Mumbai
Country India
Website www.niacl.com
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company type Private
State Delhi
Country India
Website www.orientalinsurance.org.in
56
172
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Industry
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations
57
173
DIVESTMENTS
City Kolkata
Country India
Website www.nationalinsuranceindia.com
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Address
Bima Marg
City Mumbai
State Maharashtra
Country India
Website www.licindia.com
58
174
DIVESTMENTS
Deal Report: Daiichi Sankyo acquires 20% stake in Ranbaxy Laboratories through open
offer
Deal in brief
Daiichi Sankyo has acquired 92,519,126 shares at a price of INR737 ($17.17) per share. The transaction
is valued at approximately INR68,186.59 million ($1,588.55 million).
Life Insurance Corporation of India, which holds a 15% stake in Ranbaxy, has sold off a 6.91% stake in the
open offer. General Insurance Corporation of India has sold its 1.42% stake in the open offer.
The Cabinet Committee on Economic Affairs (CCEA) has approved the Daiichi Sankyo’s plan to acquire a
controlling stake in Ranbaxy Laboratories Limited.
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Daiichi Sankyo has announced that its open offer to acquire 20% stake in Ranbaxy Laboratories has been
oversubscribed.
The European Commission has approved the proposed acquisition of Ranbaxy Laboratories by Daiichi
Sankyo.
Daiichi Sankyo has revised the schedule of its public offer for the acquisition of a 20% stake in Ranbaxy
Laboratories.
The offer will open on August 16, 2008 and close on September 4, 2008.
Daiichi Sankyo Company has made an open offer to acquire 20% stake in Ranbaxy Laboratories. Daiichi
Sankyo will acquire 92.51 million fully paid-up equity shares from the remaining shareholders at a price of
INR737 ($17.17) for each fully paid-up equity share in the open offer. The transaction is valued at
approximately INR68,186.59 million ($1,588.55 million).
The offer will open on August 8, 2008 and close on August 27, 2008.
Daiichi Sankyo has also made an offer to acquire a 34.8% stake in Ranbaxy Laboratories. Under local
stock market rules, Daiichi Sankyo is required to make an open offer for the additional 20% stake in
Ranbaxy Laboratories.
59
175
DIVESTMENTS
Rumor (June 6, 2008):
Daiichi Sankyo Company is planning to make an open offer to the public shareholders for 20% stake in
Ranbaxy Laboratories Limited.
ICICI Securities Limited is acting as the manager to the public offer and Nomura Securities Co., Ltd. is
acting as financial advisor to Daiichi. Karvy Computershare Pvt., Ltd. is acting as the registrar to the offer.
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquired % 20
Deal rationale
The proposed acquisition of Ranbaxy provides Daiichi Sankyo an opportunity to complement its strong
presence in innovation with a new, strong presence in the fast growing business of non-proprietary
pharmaceuticals.
Deal financials
EV/Revenues 3.36
EV/EBITDA 16.30
176
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
Industry >Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
61
177
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases--
>Stroke
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Cardiovascular Diseases
62
178
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology-->Alzheimer's Disease
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology-->Parkinson's Disease
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology-->Insomnia
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
63
179
DIVESTMENTS
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Neurology-->Migraine
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain-->Fibromyalgia
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain-->Neuropathic Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Pain
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
Pharmaceuticals and Healthcare-->Therapy Area-->Central
Nervous System-->Psychiatry
64
180
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Parasitic Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Dermatology
Pharmaceuticals and Healthcare-->Therapy Area--
65
181
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
66
182
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Gastroenterology
Pharmaceuticals and Healthcare-->Therapy Area--
67
183
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Hematology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
68
184
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Immunology and Inflammation
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation-->Rheumatology--
>Osteoarthritis
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation
Pharmaceuticals and Healthcare-->Therapy Area--
>Immunology and Inflammation
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
69
185
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
70
186
DIVESTMENTS
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
71
187
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
72
188
DIVESTMENTS
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antifungals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Parasitic Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Parasitic Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Parasitic Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Parasitic Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Parasitic Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Parasitic Diseases-->Malaria
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Parasitic Diseases
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials-->Community
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials-->Community
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials-->Skin and Soft Tissue
Infections
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials-->Skin and Soft Tissue
Infections
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials-->Skin and Soft Tissue
Infections
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials-->Skin and Soft Tissue
Infections
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antibacterials-->Urinary Tract
Infections
Pharmaceuticals and Healthcare-->Therapy Area--
73
189
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antivirals-->Herpes
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antivirals-->Human
Immunodeficiency Virus
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antivirals
Pharmaceuticals and Healthcare-->Therapy Area--
>Infectious Diseases-->Antivirals
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Sexual Health
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Urology-->Benign
Prostatic Hyperplasia
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Urology-->Benign
Prostatic Hyperplasia
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Sexual Health-->Sexual
Dysfunction
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology-->Diabetic Complications
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology-->Diabetic Complications
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology-->Diabetic Complications
Pharmaceuticals and Healthcare-->Therapy Area--
74
190
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology-->Obesity
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health--
>Osteoporosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area--
>Cardiovascular and Diabetes-->Diabetes and
Endocrinology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Dental
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Dental
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Dental
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Dental
75
191
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Vitamin Deficiency
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Vitamin Deficiency
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Vitamin Deficiency
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Vitamin Deficiency
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Vitamin Deficiency
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Vitamin Deficiency
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Hematology-->Leukemias
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Hematology-->Lymphomas
Pharmaceuticals and Healthcare-->Therapy Area--
76
192
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Oncology-->Solid Tumors-->Urological Cancer-->Prostate
Cancer
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Solid Tumors-->Urological Cancer-->Prostate
Cancer
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Solid Tumors-->Urological Cancer
Pharmaceuticals and Healthcare-->Therapy Area--
>Oncology-->Solid Tumors-->Urological Cancer-->Bladder
Cancer
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology-->Conjunctivitis
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology-->Conjunctivitis
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology-->Conjunctivitis
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology-->Keratitis
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Ophthalmology
77
193
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Respiratory-->Chronic Obstructive Pulmonary Disease
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory-->Asthma
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory-->Asthma
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
78
194
DIVESTMENTS
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area--
>Respiratory
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Poisoning
Pharmaceuticals and Healthcare-->Therapy Area-->Other
Diseases-->Poisoning
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health--
>Hormonal Contraception
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
Pharmaceuticals and Healthcare-->Therapy Area--
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Genitourinary and Osteoporosis-->Women's Health
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health--
>Endometriosis
Pharmaceuticals and Healthcare-->Therapy Area--
>Genitourinary and Osteoporosis-->Women's Health
State Punjab
Country India
Key ratios
195
DIVESTMENTS
City CHUO-KU
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
State Tokyo
Country Japan
Website www.daiichisankyo.com
80
196
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
81
197
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
82
198
DIVESTMENTS
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
83
199
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
84
200
DIVESTMENTS
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
85
201
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
86
202
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
87
203
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
88
204
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
89
205
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
90
206
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
91
207
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
92
208
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
93
209
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
94
210
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
95
211
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Biomaterials and Tissue Regeneration
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
96
212
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
97
213
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
98
214
DIVESTMENTS
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
99
215
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
100
216
DIVESTMENTS
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
101
217
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
102
218
DIVESTMENTS
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Healthcare
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
103
219
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
104
220
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
105
221
DIVESTMENTS
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
222
DIVESTMENTS
Bima Marg
City Mumbai
State Maharashtra
Country India
Website www.licindia.com
Advisor information
Financial advisors
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
107
223
APPENDIX
APPENDIX
Contact Us
We hope that the data and analysis in this profile will help you make informed and imaginative
business decisions. If you have further requirements feedback please contact us at
assistme@marketline.com.
For further information on MarketLine and our range of business information services please visit
www.marketline.com
• Financial Deals is the most extensive Deals database currently available in the market
• The database provides research and analysis on all types of financial deals including:
– merger and acquisition
– private equity backed buyout and investment
– venture capital investment
– initial public offering (IPO)
– secondary offering
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
– private placement
– partnership deal
• The database is a ‘live’ database and is updated real-time with Deal information
• Database contains more than 250,000 Deal records across all industries
• Every year over 48,000 Deals are added to the database
• The database contains active details of more than 5,000 Advisors and 12,000 Advisor
executives
• 200,000 + companies; 10,000 + VC/ PE firms
• Five year archive of key companies across eight sectors; complete eight year archive of
healthcare companies
• Complete portfolio of top 50 venture firms
• What we offer
– detailed deal transaction data;
– sector/market specific analytical deal reports with analyst opinion;
– customized research and analysis.
• Coverage
– global coverage across all industries through a combination of secondary and primary
research;
– multi-lingual analyst capability ensures strong coverage from regional markets;
– track over 14,000 sources every day.
–
• Content
– detailed deal information with over 50 fields covering all of the key information required
to understand a deal comprehensively;
– detailed advisory information, financial information, deal multiple, deal rationale, and
information related to business operations in addition to basic fields;
– Value addition through a wide network of contacts with top advisors, law firms,
investment banks, and industry experts.
108
224
APPENDIX
• Want to know more? – Should you have any queries, send us an email at
reachus@marketline.com
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
109
225
APPENDIX
Merger
A deal will be classified as Merger when two or more companies combine to form one company.
An amalgamation in the nature of merger is an amalgamation which satisfies all the following
conditions:
All the assets and liabilities of the transferor company become, after amalgamation, the
assets and liabilities of the transferee company.
Shareholders holding not less than 90% of the face value of the equity shares of the
transferor company (other than the equity shares already held therein, immediately before
the amalgamation, by the transferee company or its subsidiaries or their nominees) become
equity shareholders of the transferee company by virtue of amalgamation.
The consideration for the amalgamation receivable by those equity shareholders of the
transferor company who agree to become equity shareholders of the transferee company is
discharged by the transferee company wholly by the issue of equity shares in the transferee
company, except that cash may be paid in respect of any fractional shares.
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
The business of the transferor company is intended to be carried on, after the amalgamation,
by the transferee company.
No adjustment is intended to be made to the book values of the assets and liabilities of the
transferor company when they are incorporated in the financial statements of the transferee
company except to ensure uniformity of accounting policies.
Acquisition
Transactions where a company acquires equity stake in another company. The following are the
different sub-categories under acquisition:
Minority acquisition: The acquisition of less than 50% equity stake in the target
Majority acquisition: The acquisition of 50% or more than 50% and less than 100% equity
stake in the target
100% acquisition: The acquisition of all of the issued capital or 100% of the issued share
capital of the target
Asset Purchase: The acquisition of a business unit or an asset which is a not a legal entity
Private equity
Private equity transactions capture equity investment / buyout by a private equity (PE) firm. The
following are the different sub-categories under private equity:
Institutional buyout: PE firm or a group of PE firms acquiring a company from non-PE firms
or another company
226
APPENDIX
Management buyout (MBO): The management of the target acquires the target with the
backing of a PE firm will back the management in the buyout by providing the necessary
funds
Management buy-in (MBI): A manager or a management team from outside the target
company (target) raises the necessary finance, buys the target and becomes the target's
new management. The necessary financing is provided by private equity firms.
Buy-In Management buyout (BIMBO): A BIMBO is a combination of MBO and MBI, where
an external group of managers buy into the business and joins forces with the internal
management team
Going Private: A public listed company being acquired by PE firms or with the management
and is de-listed form the stock exchange on which it was listed
Private placement
A private placement is a direct private offering of securities by the issuer to a limited number of
investors. Private placement is a primary market transaction.
Venture financing
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Investments made in a start-up or young company by a venture capital or private equity firm in the
primary market (i.e. the target company is issuing new shares and receiving the proceeds directly).
The following are the different sub-categories under venture financing:
Seed: Financing provided for companies which have still not started marketing their product
or services. The purpose of such funding will generally be to assess and develop an initial
business concept
Growth/Expansion: Financing provided for companies to increase their sales, marketing, and
production operations, which have developed and started marketing their products
Late stage: Financing provided for companies which have already established themselves in
the market and are looking for expanding their production capacities
Exit: This node is assigned when a venture capital is selling its stake in a portfolio company
Initial public offering (IPO) occurs when a company first sells its shares to the public. The
following are the different stages under initial public offering:
Filing: When a company announces its plans to go for an IPO or files the prospectus with the
concerned regulator about the IPO
Pricing: When the company fixes the issue price for its offering
111
227
APPENDIX
Secondary offering: When a public listed company’s existing shareholders are offering their
shares to general public or a public listed company itself is making a follow-on public offering
Partnership
A partnership is the relationship existing between two or more entities that join to carry on a trade or
business. The following are the different sub-categories under partnership:
Joint Venture (JV): Two or more companies forming a new entity to undertake an activity
Co-marketing: Two or more companies coming together to collaborate either for product
development, distribution, or for providing services. In a broader sense any alliance related
to products and / or services where products or service of one company are marketed jointly
with product or services of another company is tagged as co-marketing alliance. Agreements
with a distribution company are not considered as Co-Marketing.
Affinity marketing: An agreement by which one company is getting access to the customer
base of another for selling its products and the company which is providing access to its
customer base is not involved in the product/service development or any other obligations
relating to such product/service
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Licensing agreement: An agreement in which one party gives the rights to another party to
use its technology, intellectual property, and brands. Financial Deals does not capture
licensing deal related to software.
Rumor: Neither of the parties involved in the transaction announces the deal but has been
reported by media/market sources
Announced: Either party involved in the transaction announces the deal
Completed: Involved parties complete the transaction
Terminated: Involved parties do not intend to complete the earlier announced transaction
and either terminates the agreement or withdraws the bid
Dead rumor: Rumor denied by either of the parties involved in the transaction
Deal value
Deal value is the consideration paid by the acquirer for acquiring the target.
Financial Deals uses a deal value estimation model (for cases where deal value is not available
through secondary and primary sources), which is based on comparables. The estimation model
analyzes deal values based on market capitalization of the target company on the day prior to the
announcement. In addition, it also includes approximation derived through inputs from advisors
involved in the deal, approximate enterprise value, gross consideration and share price and number
of shares.
All deals values which are mentioned as approximate consideration are tagged as estimated values.
228
APPENDIX
For M&A, private equity, IPO and private placement, FD focuses on transactions where deal value is
more than or equal to $5 million. For venture investment and partnership, FD captures all deals.
Payment type: Payment type indicates the mode by which the purchase consideration has been
paid to the vendor. It includes the following sub-categories:
Cash: It indicates the amount paid in cash (either in %age or absolute value) by the acquirer
Debt: It indicates the amount of debt (either in %age or absolute value) of the target
assumed by the acquirer
Shares: It indicates the amount of shares (either in %age or absolute value) issued by the
acquirer
Quantity type: It indicates the consideration by payment mode in terms of value and
percentage
Share price paid: Price per share offered by the acquirer to the target
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Debt-related fields
Below is the list of fields captured:
Debt provider: Field ‘provider type’ indicates the type of debt provider. It includes the following sub-
categories:
Debt amount: Amount of debt raised by the acquirer to finance the acquisition
Debt category: It represents the nature of the debt that has been used by the acquirer in financing
the acquisition. It includes the following categories:
Mezzanine: Debt that incorporates equity-based options such as warrants with a lower-
priority debt. Mezzanine debt is often used to finance acquisitions and buyouts, where it can
be used to prioritize new owners ahead of existing owners in the event of bankruptcy.
Second lien: Debts that are subordinate to the rights of other, more senior debts issued
against the same collateral, or a portion of the same collateral. If a borrower defaults, second
lien debts stand behind higher lien debts in terms of rights to collect proceeds from the
debt's underlying collateral.
Other debt: Any other debt facility other than the above mentioned debt categories.
113
229
APPENDIX
Capital increase type: It is the type of debt or equity securities issued by the acquirer to raise the
necessary funds to finance the transaction. It includes the following options:
Converted debt: Converted debt is a debt security which can be exchanged for a specified
amount of another, related security, usually shares of stock in the issuing company, at the
option of the issuer and/or the holder
Convertible bond: A convertible bond is a type of debt instrument that can be converted
into shares of stock in the issuing company, usually at some pre-announced ratio
Convertible loan: A convertible loan is a loan issued by companies that can be converted
into ordinary shares or preference shares at a given price at a future date
Open offer: Indicates the manner in which the company raised money by offering its shares
to the public (public offering)
Placing: General term to describe the process of raising money via the issue of new shares
Private placing: Private placing is a process of raising money by the issue of new shares to
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
institutions and private clients rather than to the general public
Rights issue: Rights issue is the process of raising money by issuing rights to a company's
existing shareholders to buy a proportional number of additional securities at a given price
within a fixed period
Scrip issue: A scrip issue (also called a capitalization issue or a bonus issue) is the issue of
new shares to existing shareholders at no charge, on a pro-rata basis to their existing
shareholdings
Vendor placing: A method of using shares to fund an acquisition by allotting shares from
the purchaser to the vendor in exchange for shares in the target (or other assets). The
consideration shares are then placed on behalf of the vendor by the purchaser’s bank so
that the vendor receives cash (the proceeds of sale of shares by the purchaser’s bank).
Financial Deals captures all the key financial items from income statement, balance sheet including
key ratios and valuation multiples, which help in providing a detailed understanding of the deal. The
financial information is captured for target companies. All the financial fields are presented in local
currency as well as US Dollar. In addition to financial fields, Financial Deals also captures certain
operational parameters. Below is a list of key fields along with their definitions:
Fiscal year end: Refers to the fiscal year (or financial year or accounting reference date), a 12-
month period used for calculating annual (yearly) financial statements. All the financial fields in
MarketLine Financial Deals database are captured according to the fiscal year-end values.
114
230
APPENDIX
Revenue (non banking): Revenue is the amount of money that a company receives from its
activities in a given period, primarily from sales of products and/or services to customers
Revenue (banking): This value is sum of interest income and non interest income
Operating profit: Operating profit is the earnings before deduction of interest payments and income
taxes; also called EBIT (earnings before interest and taxes) or operating income. For banking
companies interest payments are not deducted.
Post tax profit: Post tax profit is the amount of earnings that is available after deducting the taxes,
also known as profit after tax
Operating margin: This value measures the percent of revenues remaining after paying all
operating expenses. It is calculated as annual operating income divided by annual total revenue,
multiplied by 100.
Shares issued: Number of shares the company has issued out of its authorized capital
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Market capitalization: Market capitalization is calculated by taking the number of outstanding
shares of common stock multiplied by the market price-per-share as on fiscal year end
Outstanding shares: It represents stock currently held by investors, including restricted shares
owned by the company's officers and insiders, as well as those held by the public. It is also defined
as the difference between shares in issue and treasury shares as of the fiscal year end.
Net assets: Net assets are the difference between the total asset and liabilities that has to be paid to
third parties. It is also known as net worth
Net assets-share ratio: It is defined as net assets divided by number of shares outstanding
Earning per share: Earnings per share (EPS) is calculated by dividing a company's net income by
the outstanding shares
Price earning ratio (P/E): The P/E ratio (price-to-earnings ratio) of a stock (also called its ‘earnings
multiple’, or simply multiple, P/E, or PE) is a measure of the price paid for a share relative to the
income or profit earned by the company per share. P/E ratio is arrived by dividing share price at the
end of the fiscal year with net income per share.
Deal multiples
115
231
APPENDIX
Advisor information
Financial Deals captures detailed advisor information including financial advisor, legal advisor,
placement agent, and public relation (PR) advisors along with respective executives involved in the
deal. The following are the different types of advisors:
Legal advisor: Legal advisors are those who look into the legal matters of a company for that
particular deal.
Financial advisor: Financial advisors are those who look into the financial matters of a company for
that particular deal. Financial advisor is separated into the following types:
Financial due diligence: The process of investigation, performed by investors, into the details
of a potential investment, such as examination of operations and management and
verification of material facts
Accounting: Financial advisor who looks into the accounting matters for a deal
Tax: Financial advisor who looks into the tax matters for a deal
Corporate Finance: Financial advisor who looks into the financial decisions of a corporation
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Book runners: Book runner is the managing or lead underwriter who maintains the books of
securities sold for a new issue
Underwriters: A company or other entity that administers the public issuance and distribution
of securities from a corporation or other issuing body
Brokers: An individual or firm that charges a fee or commission for executing buy and sell
orders submitted
Others: All other financial advisors not falling in the above-mentioned categories are tagged
as other
Placement agent: A company that specializes in finding institutional investors who are willing and
able to invest primarily in unregistered securities
Public Relations (PR) advisor: An entity that advises a company or manages its communication
activities with its stakeholders
116
232
APPENDIX
About MarketLine
In an information-rich world, finding facts you can rely upon isn’t always easy. MarketLine is the
solution.
At MarketLine, we deliver accurate, up-to-date information on 300 industries and 150 countries as
well as detailed profiles of over 2,500 companies. By taking the chore out of business research,
MarketLine gives you more time to focus on what really matters.
Profiling all major companies, industries and geographies, MarketLine is one of the most prolific
publishers of business information today.
Our content is produced by an internal team of analysts, drawing on primary and secondary research
and prepared under an established methodology that’s been tried and tested over 10 years.
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
117
233
APPENDIX
General Insurance Corporation of India– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Vendor, acquirer, target and partner report for Reliance Group and its subsidiaries. Includes
Mergers & Acquisitions, Private equity, Venture capital, Joint ventures, Alliances and
Investments
235
COMPANY OVERVIEW AND KEY FACTS
RELIANCE GROUP
Reliance Group (Reliance) is a industrial conglomerate engaged in providing services that range from
communications and financial services, to generation, transmission and distribution of power, infrastructure,
healthcare sectors, media and entertainment. The group operates through its subsidiaries, Reliance Capital Limited,
Reliance Communications Limited, Reliance Infrastructure, Reliance BigEntertainment, Reliance Naval and
Engineering Ltd and Reliance Power Limited. It operates in Asia Pacific, Africa, the Americas and Europe. Reliance is
headquartered in Mumbai, Maharashtra, India.
Key facts
Country India
Website www.relianceadagroup.com
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
236
COMPANY OVERVIEW AND KEY FACTS
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal type 2014 2015 2016 2017 2018
Partnership (Pship) - - 1 - -
237
TABLE OF CONTENTS
TABLE OF CONTENTS
PARTNERSHIP ..................................................................................... 21
Partnership – Overview ..................................................................................................................... 21
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Partnership – Deal reports ................................................................................................................ 22
APPENDIX............................................................................................. 34
Contact Us ......................................................................................................................................... 34
238
TABLE OF CONTENTS
LIST OF TABLES
LIST OF FIGURES
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
239
TARGETS AND PARTNERS
Reliance Group-Target/Partner name Deal Date Deal type Deal value ($m)
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
240
TARGETS AND PARTNERS
Deal Report: Reliance – Anil Dhirubhai Ambani Group acquires 15% stake in new Kerala
airport
Deal in brief
Reliance – Anil Dhirubhai Ambani Group, an Indian diversified business group, has acquired a 15% stake
in a new international airport at Aranmula in Pathanamthitta district of central Kerala, India, for a
consideration of INR2,250 million ($48.3 million).
The airport is promoted by Promoted by KGS Aranmula Airport, Ltd. and the promoters hold a 51% stake
in the project. Aranmula Aviation, Ltd., a company promoted by a consortium of Keralite organizations in
North America and Mount Zion Trust, promoted by businessman Abraham Kalamannil, holds 30% stake.
The state government-owned Kerala Industrial Infrastructure Development Corporation is also likely to
acquire around 10% stake in the project.
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal value (Indian Rupee)(m) 2,250
Acquired % 15
Address Aranmula
City Pathanamthitta
7
241
TARGETS AND PARTNERS
State Kerala
Country India
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
242
TARGETS AND PARTNERS
Deal in brief
Reliance Anil Dhirubhai Ambani Group (ADAG), a holding company operating in financial, communications,
infrastructure and entertainment sectors, intends to acquire PT Berau Coal, a company engaged in coal
production in Indonesia.
PT Berau is a three-way joint venture between PT Armadian Tritunggal (51%), a Dutch company dan
Rognar Holding BV (39%) and a Japanese firm Sojitz Corp (10%).
JSW Energy Limited is also considering a proposal to acquire a stake in the PT Berau. Merrill Lynch & Co.,
Inc. is acting as advisor for PT Berau in the transaction.
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal rationale
The acquisition of PT Berau is a perfect fit for ADAG's power generation business.
City Berau
Country Indonesia
Website www.beraucoal.co.id
9
243
TARGETS AND PARTNERS
Advisor information
Financial advisors
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
10
244
CORPORATE VENTURING
CORPORATE VENTURING
Corporate Venturing – Deal reports
Deal in brief
Reliance Infrastructure, Ltd., an energy company, is planning to raise approximately INR43,000 million
($913 million) through a private placement.
Reliance Infrastructure will issue 42.9 million warrants convertible into shares, to Reliance – Anil Dhirubhai
Ambani Group, a diversified holding company, at a price of INR1,000 ($21.44) per share. Both the
companies are based in India.
Under the terms of the agreement, Reliance Infrastructure will receive 25% of the amount on allotment
through an upfront payment of around INR10,750 million ($288 million), and the balance upon the
conversion.
Life Insurance Corporation of India, and other insurance companies will be provided an opportunity to
participate in the proposed offering, on the same terms and conditions.
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Following the completion, Reliance – Anil Dhirubhai Ambani Group will increase its stake in Reliance
Infrastructure from 38% to 48%.
Simultaneously, the Board has approved the cancellation of 43 million equity warrants issued to the
promoter group on January 20, 2008. The purchase cost to the promoter group, after taking into
consideration of INR7,830 million ($199.24 million) already received on warrants issued earlier, which now
have been cancelled, to be approximately INR1,183 ($25.4) per share, representing a premium of 83% to
the average price of the preceding three months.
Deal rationale
The transaction would allow Reliance Infrastructure to increase its net worth and borrowing ability. It would
11
also allow the company to participate in the infrastructure sector for future growth opportunities.
245
CORPORATE VENTURING
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Energy and Utilities
Energy and Utilities-->Commodity-->Coal
Energy and Utilities-->Commodity-->Power
Energy and Utilities-->Utilities-->Power Generation-->Fossil
Fuels
Energy and Utilities-->Utilities-->Power Generation--
>Renewables
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Production
Energy and Utilities-->Utilities-->Utilities Networks--
Industry >Distribution
Energy and Utilities-->Utilities-->Utilities Networks--
>Transmission
Energy and Utilities-->Utilities-->Utilities Retail-->Energy
Services
Energy and Utilities-->Utilities-->Utilities Retail-->Major
Energy User Retail
Energy and Utilities-->Utilities-->Utilities Retail-->Residential
Retail
Energy and Utilities-->Utilities-->Utilities Retail-->SME Retail
Energy and Utilities-->Utilities-->Wholesale Energy--
>Trading and Risk Management
Country India
Website www.rinfra.com/home.html
12
246
CORPORATE VENTURING
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
13
247
CORPORATE VENTURING
Deal Report: Reliance – Anil Dhirubhai Ambani Group to invest INR80,000 million in
Reliance Energy
Deal in brief
Reliance – Anil Dhirubhai Ambani Group (Reliance ADA Group) has agreed to infuse new equity capital of
up to INR80,000 million ($2,018.67 million) into its power utility company Reliance Energy Limited. The new
equity capital infusion is proposed through a preferential offer of equity shares and/or equity related
securities at a price of INR1,812 ($45.72) per share.
Life Insurance Corporation of India, New India Assurance Co., Ltd., The Oriental Insurance Company
Limited, General Insurance Corporation of India, National Insurance Company Limited and United India
Insurance Company Limited have also been provided an opportunity to participate in the proposed offering
on the same terms and conditions.
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer 7 National Insurance Company Limited
Deal rationale
The new equity capital will substantially enhance Reliance Energy's net worth, and further augment its
borrowing capabilities, to enable greater participation in these growth opportunities in high growth areas.
Deal financials
248
CORPORATE VENTURING
EV/Revenues 2.41
EV/EBITDA 11.09
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
company enagaged in the generation, transmission,
distribution, and trading of power in India. It operates gas,
Business description
coal, wind, and hydro-based power generation projects with
aggregate capacity of approximately 13,510 megawatts. The
company is headquartered at Maharashtra, India.
City Mumbai
State Maharashtra
15
249
CORPORATE VENTURING
Country India
Website www.rel.co.in
Key ratios
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
insurance, credit insurance, home insurance, personal
accident insurance, and travel insurance. Its commercial
policies include fire insurance policies, marine policies,
motor insurance, industry equipments insurance. It also
offers accident and hospitalization policies; social policies,
Business description rural policies, travel policies, package policies, and business
policies. In addition, the company provides advisory and
brokerage services. It has presence across various cities in
India. UIIC is headquartered at Chennai, India.
250
CORPORATE VENTURING
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
City Chennai
Country India
Website www.uiic.co.in
251
CORPORATE VENTURING
State Delhi
Country India
Website www.orientalinsurance.org.in
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
divisional offices, 614 branches and 34 direct agent
branches. New India Assurance Co. also operates operates
in 24 countries with a network of 19 branches, 12 agencies,
2 associate companies and 2 subsidiary companies.
Financial Services
Industry
Financial Services-->General Insurance, Property and
Casualty
City Mumbai
Country India
Website www.niacl.com
252
CORPORATE VENTURING
Financial Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Industry Financial Services-->Reinsurance
Financial Services-->Reinsurance
Financial Services-->Reinsurance-->Marine
Financial Services-->Reinsurance-->Other
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Retail Banking and Lending
Country India
Website www.gicofindia.com
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
special plans, and group schemes.
City Mumbai
State Maharashtra
Country India
Website www.licindia.com
253
CORPORATE VENTURING
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations
City Kolkata
Country India
Website www.nationalinsuranceindia.com
254
PARTNERSHIP
PARTNERSHIP
Partnership – Overview
Figure 1: Reliance Group partnership volume and value Figure 2: Reliance Group partnership trend by key deal type
trend (2014-YTD2018) (2014-YTD2018)
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Note: Zero deal value indicates transactions with undisclosed deal values
Table 1: Reliance Group partnership volume and value trend Table 2: Reliance Group partnership trend by key deal type
(2014-YTD2018) (2014-YTD2018)
2015 - -
2016 1 -
2017 - -
2018 - -
Note: One patnership agreement can have multiple deal types
21
255
PARTNERSHIP
Deal in brief
Reliance - Anil Dhirubhai Ambani Group, an India-based diversified holding company, has formed a joint
venture (JV) with Jasper, Inc., a US-based provider of cloud-based Internet of Things (loT) service platform.
The new JV called Unlimit will provide IoT services to Indian enterprises.
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Partner 1: Jasper Wireless, Inc.
Communications
Communications-->Telecoms Market
Industry
Technology and Services
Technology and Services
Technology and Services
City Sunnyvale
State California
Website www.jasperwireless.com
22
256
PARTNERSHIP
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
23
257
PARTNERSHIP
Deal Report: Reliance – Anil Dhirubhai Ambani to form joint venture with Dalian Wanda
Group
Deal in brief
Reliance – Anil Dhirubhai Ambani Group has signed an agreement to form a joint venture (JV) with Dalian
Wanda Group Co., Ltd. to build integrated township projects in India.
Reliance is an India-based diversified holding company and Wanda Group is a China-based developer of
commercial properties, luxury hotels, cultural industries, film screens, and chain stores.
The JV will initially develop 135 acres owned by Reliance Communications, Ltd. in Navi Mumbai, India and
80 acreas with Reliance Infrastructure in Hyderabad, India.
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company information: Partners
City Dalian
Country China
Website www.wanda.com.cn
24
258
PARTNERSHIP
Deal Report: Reliance – Anil Dhirubhai Ambani Group forms joint venture with Krishak
Bharati Cooperative
Deal in brief
Reliance – Anil Dhirubhai Ambani Group (Reliance ADAG), a diversified holding company, has formed a
joint venture with Krishak Bharati Cooperative Limited (KRIBHCO), a manufacturer of urea, ammonia, and
bio-fertilizers. Both the companies are based in India.
The joint venture, Kribhco Reliance Kisan Limited, will market telecom products of Reliance
Communications, both GSM and CDMA, and also distribute products and services of other business
enterprises of Reliance ADAG, including Reliance Capital, Reliance Entertainment, and BIG TV DTH.
KRIBHCO would hold a 60% stake in the joint venture, while the balance 40% would be held by Reliance
ADAG.
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company information: Partners
Industry Chemicals
Chemicals-->Agrochemicals-->Fertilizer
City Noida
Country India
Website www.kribhco.net
25
259
PARTNERSHIP
Deal Report: DreamWorks to form joint venture with Reliance – Anil Dhirubhai Ambani
Group
Deal in brief
Reliance – Anil Dhirubhai Ambani Group (Reliance ADAG), an India-based diversified holding company,
has agreed to invest $550 million in the joint venture to be formed with DreamWorks Animation SKG, Inc., a
US-based company engaged in developing and producing computer generated animated feature films.
JPMorgan Securities is leading a syndicate of banks to raise approximately $700 million.
The 50:50 joint venture will be launched by January 2009 and will produce 30 to 35 films over the next five
years. The transaction is valued at approximately $1,500 million.
DreamWorks Animation SKG, Inc. has signed an agreement with Reliance ADAG to set up a new $1,200
million film company.
Under the terms of the agreement, Reliance will invest about $500 million in equity, while JP Morgan Chase
& Co., Inc. will provide another $700 million in debt towards the new venture.
According to the Wall Street Journal, the proposed joint venture between DreamWorks Animation SKG
and Reliance ADAG to set up a new movie company is nearing completion.
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Under the terms of the joint venture, Reliance ADAG is likely to invest $500 million in the new movie
venture and another $500 million in debt through JP Morgan Chase & Co. Dreamworks plans to produce
about six films with Reliance ADAG and is likely to get them distributed by Universal Pictures.
According to Hemscott, the Wall Street Journal reported that DreamWorks Animation SKG, Inc. is planning
to enter into a joint venture agreement with Reliance – Anil Dhirubhai Ambani Group, to form a new movie
venture.
DreamWorks is planning for another $500 million in debt financing to give the venture enough money and
to make about six films a year.
26
260
PARTNERSHIP
Deal rationale
The transaction would give Spielberg the cash to finance DreamWorks' departure from Viacom Inc.'s
Paramount Pictures. It would also enable Reliance ADAG to strengthen its media business.
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Media-->Advertising-->Film and Cinema Advertising
Media
Media-->Broadcasting-->Television Broadcasting
Media-->Motion Pictures and Sound Recording
Media-->Motion Pictures and Sound Recording-->Cinema
Film Production
Media-->Motion Pictures and Sound Recording-->Video
Industry Production
Media-->Motion Pictures and Sound Recording-->Cinema
Film Distribution
Media-->Motion Pictures and Sound Recording-->Video
Distribution
Media-->Multimedia Services
Technology and Services-->Consumer IT-->Consumer
Software
Leisure and Arts
Website www.dreamworksanimation.com
27
261
DIVESTMENTS
Deal in brief
Prysmian S.p.A., an Italian provider of cables and systems for energy and telecommunications, has
acquired a 51% stake in Ravin Cables Limited, an India-based manufacturer of cables, for a consideration
of approximately EUR26 million.
As part of the transaction, Prysmian subscribed for new shares of Ravin and acquired the remaining stake
from existing shareholders including Tano Capital LLC and Reliance – Anil Dhirubhai Ambani Group.
Singhi Advisors Limited acted as financial advisor and Nishith Desai Associates acted as legal advisor to
Ravin, and Allen & Overy LLP acted as legal advisor to Prysmian on the transaction.
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal value (estimated) ($m) 37.37 (min)
Acquired % 51
Deal rationale
The acquisition will give Prysmian a manufacturing presence in India and Middle East, particularly in the
value utilities business.
262
DIVESTMENTS
Address 302, Akruti Trade Centre, MIDC Road. No.7, Andheri (E)
City Mumbai
State Maharashtra
Country India
Website www.primecabkabel.com
Revenues 45 59.43
Key ratios
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer: Prysmian S.p.A.
Country Italy
29
263
DIVESTMENTS
Website prysmiangroup.com
State California
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Country United States
Website www.tanocap.squarespace.com
Advisor information
Financial advisors
Legal advisors
Legal advisors
30
264
DIVESTMENTS
Allen & Overy LLP, UK (Executive: Mazhar Khan; Office: Dubai; Country: United Arab Emirates)
Allen & Overy LLP, UK (Executive: Victoria Honey; Office: Dubai; Country: United Arab Emirates)
Allen & Overy LLP, UK (Executive: Simon Roderick; Office: Dubai; Country: United Arab Emirates)
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
31
265
DIVESTMENTS
Deal Report: George Soros Quantum Fund acquires 3% stake in Reliance Entertainment
Deal in brief
The George Soros Quantum Fund, a fund operated by US-based investment firm Soros Fund Management
LLC, has acquired a 3% stake in Reliance Entertainment Pvt., Ltd., a media and entertainment unit of
Reliance – Anil Dhirubhai Ambani Group, an Indian-based diversified holding company, for INR4,000
million ($100 million).
Acquired % 3
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company information: Target, acquirer, and seller/vendor
Media
Media-->Broadcasting-->Radio Broadcasting
Media-->Motion Pictures and Sound Recording-->Cinema
Film Production
Media-->Motion Pictures and Sound Recording-->Video
Industry Production
Media-->Motion Pictures and Sound Recording-->Cinema
Film Distribution
Media-->Motion Pictures and Sound Recording-->Video
Distribution
Media-->Motion Pictures and Sound Recording
Media-->Motion Pictures and Sound Recording
32
266
DIVESTMENTS
Country India
Industry Venturecapital
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
33
267
APPENDIX
APPENDIX
Contact Us
We hope that the data and analysis in this profile will help you make informed and imaginative
business decisions. If you have further requirements feedback please contact us at
assistme@marketline.com.
For further information on MarketLine and our range of business information services please visit
www.marketline.com
• Financial Deals is the most extensive Deals database currently available in the market
• The database provides research and analysis on all types of financial deals including:
– merger and acquisition
– private equity backed buyout and investment
– venture capital investment
– initial public offering (IPO)
– secondary offering
– private placement
– partnership deal
• The database is a ‘live’ database and is updated real-time with Deal information
• Database contains more than 250,000 Deal records across all industries
• Every year over 48,000 Deals are added to the database
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
• The database contains active details of more than 5,000 Advisors and 12,000 Advisor
executives
• 200,000 + companies; 10,000 + VC/ PE firms
• Five year archive of key companies across eight sectors; complete eight year archive of
healthcare companies
• Complete portfolio of top 50 venture firms
• What we offer
– detailed deal transaction data;
– sector/market specific analytical deal reports with analyst opinion;
– customized research and analysis.
• Coverage
– global coverage across all industries through a combination of secondary and primary
research;
– multi-lingual analyst capability ensures strong coverage from regional markets;
– track over 14,000 sources every day.
–
• Content
– detailed deal information with over 50 fields covering all of the key information required
to understand a deal comprehensively;
– detailed advisory information, financial information, deal multiple, deal rationale, and
information related to business operations in addition to basic fields;
– Value addition through a wide network of contacts with top advisors, law firms,
investment banks, and industry experts.
34
268
APPENDIX
• Want to know more? – Should you have any queries, send us an email at
reachus@marketline.com
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
35
269
APPENDIX
Merger
A deal will be classified as Merger when two or more companies combine to form one company.
An amalgamation in the nature of merger is an amalgamation which satisfies all the following
conditions:
All the assets and liabilities of the transferor company become, after amalgamation, the
assets and liabilities of the transferee company.
Shareholders holding not less than 90% of the face value of the equity shares of the
transferor company (other than the equity shares already held therein, immediately before
the amalgamation, by the transferee company or its subsidiaries or their nominees) become
equity shareholders of the transferee company by virtue of amalgamation.
The consideration for the amalgamation receivable by those equity shareholders of the
transferor company who agree to become equity shareholders of the transferee company is
discharged by the transferee company wholly by the issue of equity shares in the transferee
company, except that cash may be paid in respect of any fractional shares.
The business of the transferor company is intended to be carried on, after the amalgamation,
by the transferee company.
No adjustment is intended to be made to the book values of the assets and liabilities of the
transferor company when they are incorporated in the financial statements of the transferee
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
company except to ensure uniformity of accounting policies.
Acquisition
Transactions where a company acquires equity stake in another company. The following are the
different sub-categories under acquisition:
Minority acquisition: The acquisition of less than 50% equity stake in the target
Majority acquisition: The acquisition of 50% or more than 50% and less than 100% equity
stake in the target
100% acquisition: The acquisition of all of the issued capital or 100% of the issued share
capital of the target
Asset Purchase: The acquisition of a business unit or an asset which is a not a legal entity
Private equity
Private equity transactions capture equity investment / buyout by a private equity (PE) firm. The
following are the different sub-categories under private equity:
Institutional buyout: PE firm or a group of PE firms acquiring a company from non-PE firms
or another company
270
APPENDIX
Management buyout (MBO): The management of the target acquires the target with the
backing of a PE firm will back the management in the buyout by providing the necessary
funds
Management buy-in (MBI): A manager or a management team from outside the target
company (target) raises the necessary finance, buys the target and becomes the target's
new management. The necessary financing is provided by private equity firms.
Buy-In Management buyout (BIMBO): A BIMBO is a combination of MBO and MBI, where
an external group of managers buy into the business and joins forces with the internal
management team
Going Private: A public listed company being acquired by PE firms or with the management
and is de-listed form the stock exchange on which it was listed
Private placement
A private placement is a direct private offering of securities by the issuer to a limited number of
investors. Private placement is a primary market transaction.
Venture financing
Investments made in a start-up or young company by a venture capital or private equity firm in the
primary market (i.e. the target company is issuing new shares and receiving the proceeds directly).
The following are the different sub-categories under venture financing:
Seed: Financing provided for companies which have still not started marketing their product
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
or services. The purpose of such funding will generally be to assess and develop an initial
business concept
Growth/Expansion: Financing provided for companies to increase their sales, marketing, and
production operations, which have developed and started marketing their products
Late stage: Financing provided for companies which have already established themselves in
the market and are looking for expanding their production capacities
Exit: This node is assigned when a venture capital is selling its stake in a portfolio company
Initial public offering (IPO) occurs when a company first sells its shares to the public. The
following are the different stages under initial public offering:
Filing: When a company announces its plans to go for an IPO or files the prospectus with the
concerned regulator about the IPO
Pricing: When the company fixes the issue price for its offering
37
271
APPENDIX
Secondary offering: When a public listed company’s existing shareholders are offering their
shares to general public or a public listed company itself is making a follow-on public offering
Partnership
A partnership is the relationship existing between two or more entities that join to carry on a trade or
business. The following are the different sub-categories under partnership:
Joint Venture (JV): Two or more companies forming a new entity to undertake an activity
Co-marketing: Two or more companies coming together to collaborate either for product
development, distribution, or for providing services. In a broader sense any alliance related
to products and / or services where products or service of one company are marketed jointly
with product or services of another company is tagged as co-marketing alliance. Agreements
with a distribution company are not considered as Co-Marketing.
Affinity marketing: An agreement by which one company is getting access to the customer
base of another for selling its products and the company which is providing access to its
customer base is not involved in the product/service development or any other obligations
relating to such product/service
Licensing agreement: An agreement in which one party gives the rights to another party to
use its technology, intellectual property, and brands. Financial Deals does not capture
licensing deal related to software.
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal status details
Rumor: Neither of the parties involved in the transaction announces the deal but has been
reported by media/market sources
Announced: Either party involved in the transaction announces the deal
Completed: Involved parties complete the transaction
Terminated: Involved parties do not intend to complete the earlier announced transaction
and either terminates the agreement or withdraws the bid
Dead rumor: Rumor denied by either of the parties involved in the transaction
Deal value
Deal value is the consideration paid by the acquirer for acquiring the target.
Financial Deals uses a deal value estimation model (for cases where deal value is not available
through secondary and primary sources), which is based on comparables. The estimation model
analyzes deal values based on market capitalization of the target company on the day prior to the
announcement. In addition, it also includes approximation derived through inputs from advisors
involved in the deal, approximate enterprise value, gross consideration and share price and number
of shares.
All deals values which are mentioned as approximate consideration are tagged as estimated values.
272
APPENDIX
For M&A, private equity, IPO and private placement, FD focuses on transactions where deal value is
more than or equal to $5 million. For venture investment and partnership, FD captures all deals.
Payment type: Payment type indicates the mode by which the purchase consideration has been
paid to the vendor. It includes the following sub-categories:
Cash: It indicates the amount paid in cash (either in %age or absolute value) by the acquirer
Debt: It indicates the amount of debt (either in %age or absolute value) of the target
assumed by the acquirer
Shares: It indicates the amount of shares (either in %age or absolute value) issued by the
acquirer
Quantity type: It indicates the consideration by payment mode in terms of value and
percentage
Share price paid: Price per share offered by the acquirer to the target
Debt-related fields
Below is the list of fields captured:
Debt provider: Field ‘provider type’ indicates the type of debt provider. It includes the following sub-
categories:
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Lead: Represents the lead debt provide
Syndicate: Represents group of lenders that are collectively lending or offering the debt to
the acquirers
Debt amount: Amount of debt raised by the acquirer to finance the acquisition
Debt category: It represents the nature of the debt that has been used by the acquirer in financing
the acquisition. It includes the following categories:
Mezzanine: Debt that incorporates equity-based options such as warrants with a lower-
priority debt. Mezzanine debt is often used to finance acquisitions and buyouts, where it can
be used to prioritize new owners ahead of existing owners in the event of bankruptcy.
Second lien: Debts that are subordinate to the rights of other, more senior debts issued
against the same collateral, or a portion of the same collateral. If a borrower defaults, second
lien debts stand behind higher lien debts in terms of rights to collect proceeds from the
debt's underlying collateral.
Other debt: Any other debt facility other than the above mentioned debt categories.
39
273
APPENDIX
Capital increase type: It is the type of debt or equity securities issued by the acquirer to raise the
necessary funds to finance the transaction. It includes the following options:
Converted debt: Converted debt is a debt security which can be exchanged for a specified
amount of another, related security, usually shares of stock in the issuing company, at the
option of the issuer and/or the holder
Convertible bond: A convertible bond is a type of debt instrument that can be converted
into shares of stock in the issuing company, usually at some pre-announced ratio
Convertible loan: A convertible loan is a loan issued by companies that can be converted
into ordinary shares or preference shares at a given price at a future date
Open offer: Indicates the manner in which the company raised money by offering its shares
to the public (public offering)
Placing: General term to describe the process of raising money via the issue of new shares
Private placing: Private placing is a process of raising money by the issue of new shares to
institutions and private clients rather than to the general public
Rights issue: Rights issue is the process of raising money by issuing rights to a company's
existing shareholders to buy a proportional number of additional securities at a given price
within a fixed period
Scrip issue: A scrip issue (also called a capitalization issue or a bonus issue) is the issue of
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
new shares to existing shareholders at no charge, on a pro-rata basis to their existing
shareholdings
Vendor placing: A method of using shares to fund an acquisition by allotting shares from
the purchaser to the vendor in exchange for shares in the target (or other assets). The
consideration shares are then placed on behalf of the vendor by the purchaser’s bank so
that the vendor receives cash (the proceeds of sale of shares by the purchaser’s bank).
Financial Deals captures all the key financial items from income statement, balance sheet including
key ratios and valuation multiples, which help in providing a detailed understanding of the deal. The
financial information is captured for target companies. All the financial fields are presented in local
currency as well as US Dollar. In addition to financial fields, Financial Deals also captures certain
operational parameters. Below is a list of key fields along with their definitions:
Fiscal year end: Refers to the fiscal year (or financial year or accounting reference date), a 12-
month period used for calculating annual (yearly) financial statements. All the financial fields in
MarketLine Financial Deals database are captured according to the fiscal year-end values.
40
274
APPENDIX
Revenue (non banking): Revenue is the amount of money that a company receives from its
activities in a given period, primarily from sales of products and/or services to customers
Revenue (banking): This value is sum of interest income and non interest income
Operating profit: Operating profit is the earnings before deduction of interest payments and income
taxes; also called EBIT (earnings before interest and taxes) or operating income. For banking
companies interest payments are not deducted.
Post tax profit: Post tax profit is the amount of earnings that is available after deducting the taxes,
also known as profit after tax
Operating margin: This value measures the percent of revenues remaining after paying all
operating expenses. It is calculated as annual operating income divided by annual total revenue,
multiplied by 100.
Shares issued: Number of shares the company has issued out of its authorized capital
Outstanding shares: It represents stock currently held by investors, including restricted shares
owned by the company's officers and insiders, as well as those held by the public. It is also defined
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
as the difference between shares in issue and treasury shares as of the fiscal year end.
Net assets: Net assets are the difference between the total asset and liabilities that has to be paid to
third parties. It is also known as net worth
Net assets-share ratio: It is defined as net assets divided by number of shares outstanding
Earning per share: Earnings per share (EPS) is calculated by dividing a company's net income by
the outstanding shares
Price earning ratio (P/E): The P/E ratio (price-to-earnings ratio) of a stock (also called its ‘earnings
multiple’, or simply multiple, P/E, or PE) is a measure of the price paid for a share relative to the
income or profit earned by the company per share. P/E ratio is arrived by dividing share price at the
end of the fiscal year with net income per share.
Deal multiples
41
275
APPENDIX
Advisor information
Financial Deals captures detailed advisor information including financial advisor, legal advisor,
placement agent, and public relation (PR) advisors along with respective executives involved in the
deal. The following are the different types of advisors:
Legal advisor: Legal advisors are those who look into the legal matters of a company for that
particular deal.
Financial advisor: Financial advisors are those who look into the financial matters of a company for
that particular deal. Financial advisor is separated into the following types:
Financial due diligence: The process of investigation, performed by investors, into the details
of a potential investment, such as examination of operations and management and
verification of material facts
Accounting: Financial advisor who looks into the accounting matters for a deal
Tax: Financial advisor who looks into the tax matters for a deal
Corporate Finance: Financial advisor who looks into the financial decisions of a corporation
Book runners: Book runner is the managing or lead underwriter who maintains the books of
securities sold for a new issue
Underwriters: A company or other entity that administers the public issuance and distribution
of securities from a corporation or other issuing body
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Brokers: An individual or firm that charges a fee or commission for executing buy and sell
orders submitted
Others: All other financial advisors not falling in the above-mentioned categories are tagged
as other
Placement agent: A company that specializes in finding institutional investors who are willing and
able to invest primarily in unregistered securities
Public Relations (PR) advisor: An entity that advises a company or manages its communication
activities with its stakeholders
42
276
APPENDIX
About MarketLine
In an information-rich world, finding facts you can rely upon isn’t always easy. MarketLine is the
solution.
At MarketLine, we deliver accurate, up-to-date information on 300 industries and 150 countries as
well as detailed profiles of over 2,500 companies. By taking the chore out of business research,
MarketLine gives you more time to focus on what really matters.
Profiling all major companies, industries and geographies, MarketLine is one of the most prolific
publishers of business information today.
Our content is produced by an internal team of analysts, drawing on primary and secondary research
and prepared under an established methodology that’s been tried and tested over 10 years.
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
43
277
APPENDIX
Reliance Group– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Vendor, acquirer, target and partner report for Edelweiss Financial Services Ltd and its
subsidiaries. Includes Mergers & Acquisitions, Private equity, Venture capital, Joint ventures,
Alliances and Investments
279
COMPANY OVERVIEW AND KEY FACTS
Edelweiss Financial Services Ltd (Edelweiss) is a financial services company. It is engaged in financial markets,
franchise business, credit business, asset management services, commodities, life insurance and retail finance. The
company offers various financial products and services which include investment banking, institutional equities,
mutual fund, home loans, insurance broking and retail brokerage services. These financial products and services are
offered corporations, institutions and individuals. The company operates in India. Edelweiss is headquartered in
Mumbai.
The company reported revenues of (Rupee) INR85,809.9 million for the fiscal year ended March 2018 (FY2018), an
increase of 30.2% over FY2017. In FY2018, the company’s operating margin was 16.1%, compared to an operating
margin of 13.9% in FY2017. In FY2018, the company recorded a net margin of 10.4%, compared to a net margin of
9.2% in FY2017.
The company reported revenues of INR24,354.7 million for the first quarter ended June 2018, a decrease of 6.6%
over the previous quarter.
Key facts
State Maharashtra
Country India
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Telephone 91 22 40094400
Fax 91 22 40863759
Website www.edelweissfin.com
280
COMPANY OVERVIEW AND KEY FACTS
Edelweiss Financial Services Ltd activity by deal type - Edelweiss Financial Services Ltd M&A average deal size -
volume (2014-YTD2018) value ($m)
Deal type 2014 2015 2016 2017 2018 Year Number of deals Average deal size ($m)
Acquisition (ACQ) 1 - 1 - - 2014 1 -
Capital raising - - 1 - - 2015 - -
(CR) 2016 1 -
Corporate - 2 1 2 - 2017 - -
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
venturing (CV)
2018 - -
Divestments (DIV) - 1 - - -
Private equity - 1 - - -
(PE)
Note: Zero deal value indicates transactions with undisclosed deal values
Deal value
Target/Partner (Country) Announcement date Deal status Deal Type
($m)
Private
National Insurance Company Limited (India) Mar 27, 2017 Completed 136.45
placement
Venture
Wonderschool (United States) Jun 19, 2017 Completed 2
financing
Private
Edelweiss Financial Services Ltd (India) May 13, 2016 Announced 374.64
placement
Private
VGN Developers Private Limited (India) Apr 10, 2015 Completed 107.6
placement
Private
Parsvnath Developers Limited (India) Mar 30, 2015 Completed 56.56
placement
281
TABLE OF CONTENTS
TABLE OF CONTENTS
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Corporate Venturing – Overview ...................................................................................................... 20
PARTNERSHIP ..................................................................................... 60
Partnership – Deal reports ................................................................................................................ 60
DIVESTMENTS ..................................................................................... 94
Divestments – Overview .................................................................................................................... 94
282
TABLE OF CONTENTS
APPENDIX........................................................................................... 109
Contact Us ....................................................................................................................................... 109
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
283
TABLE OF CONTENTS
LIST OF TABLES
Table 1: Edelweiss Financial Services Ltd M&A volume and value trend (2014-YTD2018) 8
Table 3: Edelweiss Financial Services Ltd corporate venturing volume and value trend (2014-YTD2018) 20
Table 5: Edelweiss Financial Services Ltd capital raising volume and value trend (2014-YTD2018) 63
Table 6: Edelweiss Financial Services Ltd capital raising by deal type (2014-YTD2018) 63
Table 7: Edelweiss Financial Services Ltd divestments volume and value trend (2014-YTD2018) 94
Table 9: Edelweiss Financial Services Ltd private equity and ownership volume and value trend (2014-
YTD2018) 99
Table 10: Edelweiss Financial Services Ltd private equity and ownership activity by deal type (2014-
YTD2018) 99
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
LIST OF FIGURES
Figure 1: Edelweiss Financial Services Ltd M&A volume and value trend (2014-YTD2018) 8
Figure 3: Edelweiss Financial Services Ltd corporate venturing volume and value trend (2014-YTD2018) 20
Figure 5: Edelweiss Financial Services Ltd capital raising volume and value trend (2014-YTD2018) 63
Figure 6: Edelweiss Financial Services Ltd capital raising by deal type (2014-YTD2018) 63
Figure 7: Edelweiss Financial Services Ltd divestments volume and value trend (2014-YTD2018) 94
Figure 9: Edelweiss Financial Services Ltd private equity and ownership volume and value trend (2014-
YTD2018) 99
Figure 10: Edelweiss Financial Services Ltd private equity and ownership by deal type (2014-YTD2018) 99
284
TARGETS AND PARTNERS
National Insurance Company Limited (India) Mar 27, 2017 Private placement 136.45
VGN Developers Private Limited (India) Apr 10, 2015 Private placement 107.6
Parsvnath Developers Limited (India) Mar 30, 2015 Private placement 56.56
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
285
MERGERS & ACQUISITIONS
Figure 1: Edelweiss Financial Services Ltd M&A volume and Figure 2: Edelweiss Financial Services Ltd M&A activity by
value trend (2014-YTD2018) geography (2014-YTD2018)
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE
Note: Zero deal value indicates transactions with undisclosed deal values
Table 1: Edelweiss Financial Services Ltd M&A volume and Table 2: Edelweiss Financial Services Ltd M&A activity by
value trend (2014-YTD2018) geography (2014-YTD2018)
2015 - - Europe -
2016 1 - Asia-Pacific 2
286
MERGERS & ACQUISITIONS
Deal in brief
Edelweiss Financial Services, Ltd., a diversified financial services Group, has agreed to acquire Ambit
Alpha Fund, an alternate investment fund (AIF) managed by Ambit Investment Advisors Pvt., Ltd., a
provider of investment management and advisory services. All the entities are based in India.
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Date of completion Sep 22, 2016
Deal rationale
The transaction will enable Edelweiss to strengthen its global assets management (GAM) business.
Country India
Website www.ambitfundsindia.com
287
MERGERS & ACQUISITIONS
City Mumbai
State Maharashtra
Country India
Website www.ambitfundsindia.com
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
10
288
MERGERS & ACQUISITIONS
Deal in brief
Edelweiss Financial Services, Ltd., a provider of diversified financial services, has acquired Forefront
Capital Management Pvt., Ltd., an asset management company. Both the entities are based in India.
Deal rationale
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
The acquisition will further strengthen and diversify Edelweiss’s presence in the asset management space,
and provide additional investment solutions to its clients.
City Mumbai
State Maharashtra
Country India
Website www.forefrontcap.com
11
289
MERGERS & ACQUISITIONS
Deal in brief
Edelweiss has acquired the Millet brand in Korea from Groupe Lafuma, a France-based manufacturer of
sports and outdoors equipment, for EUR5.8 million.
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Date of completion Mar 12, 2009
290
MERGERS & ACQUISITIONS
Address BP 60
City Anneyron
Country France
Website www.groupe-lafuma.com
Phone number 33 04 75 31 31 31
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
13
291
MERGERS & ACQUISITIONS
Deal Report: Percept Limited raises $35.64 million from private equity firms
Deal in brief
Percept Limited, an entertainment, media, and communications company, has raised INR 1,500 million
($35.64 million) through private equity, from Edelweiss Capital Limited, a financial services company,
Passport Capital LLC, an investment firm, and Indivision India Partners (IIP).
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal sub-category Majority acquisition
Deal rationale
The transaction would scale up Percept's content and IPR businesses, and the funds would be used in
building presence and strength in the entertainment, media and communications domain, including creation
of knowledge practices, proprietary tools and assets, and creation of asset and talent ownership. The funds
would also be deployed in acquisitions and partnerships, for the creation of knowledge practices,
proprietary tools and assets, and for asset and talent ownership.
292
MERGERS & ACQUISITIONS
Media-->Advertising
Media-->Advertising-->Media Buying Services
Industry
Media-->Advertising-->Media Planning and Representation
Business and Consumer Services-->Marketing Services
Business and Consumer Services-->Public Relations
City Mumbai
State Maharashtra
Country India
Website www.perceptindia.com
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Passport Capital, LLC is an employee owned hedge fund
sponsor. The company provides services to pooled
Business description
investment vehicles. The company also invests in public
equity and alternative investments markets across the globe.
State California
Website www.passportcapital.com
Country Mauritius
15
293
MERGERS & ACQUISITIONS
Deal Report: Edelweiss Capital and Lehman Brothers invests in ECL Finance
Deal in brief
Edelweiss Capital Limited, a financial services company, along with Lehman Brothers Holdings, Inc,
Government of Singapore, Galleon Partners, L.P., and SHUAA Capital p.s.c., have invested approximately
INR4,000 million ($101.87 million) in ECL Finance Limited, a non-banking finance company of Edelweiss
Capital, through a subscription to fresh equity issuance which comprise 23.3% of the post issued capital.
Through this transaction, Edelweiss Capital's shareholding in ECL Finance will reduce to 62.5% from the
existing 74% stake.
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer 5 Galleon Partners, L.P.
Acquired % 23.3
Deal rationale
ECL Finance intends to utilize the proceeds for its on going business plans.
294
MERGERS & ACQUISITIONS
Financial Services
Industry Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending--
>Consumer Lending
City Mumbai
State Maharashtra
Country India
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
and Non-Residents which represents focus and efficiency in
the system with custom made solutions for all three
segments. The government's Prime Minister’s Office (PMO)
is headquartered in Singapore.
City Istana
Country Singapore
Website www.gov.sg
295
MERGERS & ACQUISITIONS
Financial Services
Financial Services-->Private Equity and Venture Capital
Industry Financial Services-->Capital Markets and Trading--
>Brokerage
Financial Services-->Retail Banking and Lending
Financial Services-->Institutional Investment Management
City Dubai
Website www.shuaa.com
Financial Services
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->Private Equity and Venture Capital
Financial Services-->Capital Markets and Trading
Financial Services-->Cards
Industry
Financial Services-->Retail Banking and Lending
Financial Services-->Corporate and Investment Banking
Financial Services-->Institutional Investment Management
Financial Services-->Wealth Management and Private
Banking
Website www.lehman.com
Website www.galleongrp.com
18
296
MERGERS & ACQUISITIONS
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
19
297
CORPORATE VENTURING
CORPORATE VENTURING
Corporate Venturing – Overview
Figure 3: Edelweiss Financial Services Ltd corporate Figure 4: Edelweiss Financial Services Ltd corporate
venturing volume and value trend (2014-YTD2018) venturing by geography (2014-YTD2018)
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE
Note: Zero deal value indicates transactions with undisclosed deal values
Table 3: Edelweiss Financial Services Ltd corporate venturing Table 4: Edelweiss Financial Services Ltd corporate venturing
volume and value trend (2014-YTD2018) by geography (2014-YTD2018)
2016 1 - Asia-Pacific 3
20
298
CORPORATE VENTURING
Deal in brief
Wonderschool, a US-based operator of online marketplace helps parents find in-home child care education
programs, has secured USD2 million in seed funding led by First Round Capital with participation from
Cross Culture Ventures, SoftTech VC, Lerer Ventures, FundersClub, Inc. and Edelweiss Financial Services
Ltd.
Target Wonderschool
Acquirer 2 SoftTech VC
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer 3 Edelweiss Financial Services Ltd
Deal rationale
21
299
CORPORATE VENTURING
Target: Wonderschool
State California
Website www.wonderschool.com
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer 1: First Round Capital
State California
Website www.firstround.com
Acquirer 2: SoftTech VC
Venture capital firm, quasi-government organization, nasd
Industry
member broker/dealer
300
CORPORATE VENTURING
State California
Website www.softtechvc.com
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
State California
Website fundersclub.com
State California
Website www.crossculturevc.com
301
CORPORATE VENTURING
Website www.lererventures.com
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
24
302
CORPORATE VENTURING
Deal in brief
National Insurance Company, Ltd. an India-based non-life insurance company, has raised INR8,930 million
(USD136.45 million) through an issue of subordinated debt to Edelweiss Financial Services, Ltd., ICICI
Securities Limited, AK Trust and other investors.
The ten-year paper with call at five years carries a coupon of 8.35%.
Acquirer 4 AK Trust
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal value (Indian Rupee)(m) 8,930
303
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Government and Non-Profit Organisations-->Governmental
Organizations
City Kolkata
Country India
Website www.nationalinsuranceindia.com
304
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Industry Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
27
305
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
28
306
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
29
307
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
30
308
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
31
309
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
32
310
CORPORATE VENTURING
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
33
311
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
34
312
CORPORATE VENTURING
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
35
313
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
36
314
CORPORATE VENTURING
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing-->Packaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
37
315
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
38
316
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
39
317
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
40
318
CORPORATE VENTURING
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
41
319
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
42
320
CORPORATE VENTURING
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Biomaterials and Tissue Regeneration
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
43
321
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
44
322
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
45
323
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
46
324
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
47
325
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
48
326
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
49
327
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
50
328
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
51
329
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
52
330
CORPORATE VENTURING
Financial Services
Financial Services-->Capital Markets and Trading--
>Brokerage
Financial Services-->Capital Markets and Trading-->Equity
Markets
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->Corporate and Investment Banking
Industry Financial Services-->Corporate and Investment Banking--
>Capital Raising
Financial Services-->Corporate and Investment Banking--
>Mergers and Acquisitions (M&A)
Financial Services-->Corporate and Investment Banking--
>Private Placements and Financial Sponsors
Financial Services-->Corporate and Investment Banking--
>Capital Raising
City Mumbai
State Maharashtra
Country India
Website www.icicisecurities.com
Acquirer 4: AK Trust
Industry
Financial Services
53
331
CORPORATE VENTURING
Deal in brief
GOQii, a US-based wearable technology company that provides wrist band that measures the user’s
activities, has secured funding from the venture capital arm of Edelweiss Financial Services, Ltd., an India-
based diversified financial services group.
Target GOQii
Deal rationale
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
GOQii will use the funds to scale up its operations in the US and China.
Target: GOQii
332
CORPORATE VENTURING
State California
Website www.goqii.com
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
55
333
CORPORATE VENTURING
Deal in brief
VGN Developers Private Limited, an India-based real estate developer and residential apartment builder,
has raised INR6,700 million ($107.6 million) from Piramal Capital and Edelweiss Financial Services through
non-convertible debentures.
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Security type information
City Chennai 56
334
CORPORATE VENTURING
Country India
Website www.vgn.in
Industry
Financial Services
Country India
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
57
335
CORPORATE VENTURING
Deal in brief
Parsvnath Developers Limited, an India-based real estate developer, has raised INR3,550 million ($56.56
million) by issuing 7,100 unlisted, secured, redeemable, non-convertible debentures at a face value of
INR0.5 million ($0.007 million) in a private placement.
According to the Economic Times, the funds have been raised from Edelweiss Capital Limited, an India-
based financial services company.
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Date of completion Mar 30, 2015
Deal rationale
336
CORPORATE VENTURING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Address 6th Floor Arunachal Building, 19 Barakhamba Road
State Delhi
Country India
Website www.parsvnath.com
59
337
CORPORATE VENTURING
PARTNERSHIP
Partnership – Deal reports
Deal Report: Edelweiss Capital to form life insurance joint venture with Tokio Marine
Holdings
Deal in brief
Edelweiss Capital Limited has entered into an agreement with Tokio Marine Holdings, Inc. to establish a life
insurance joint venture in India to be called Edelweiss Tokio Life Insurance.
Edelweiss Capital is an India-based provider of investment banking, stock broking, wealth management
and asset management services, while Tokio Marine is a Japan-based provider of property and casualty
insurance, reinsurance and life insurance services.
According to The Economic Times, industry sources reported that Edelweiss Capital is in talks with Tokio
Marine for a possible life insurance joint venture in India.
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Reportedly, Ernst & Young is acting as financial advisor and Crawford Bayley is acting as legal advisor to
Tokio Marine on their India strategy. AZB & partners is acting as advisor to Edelweiss.
338
CORPORATE VENTURING
Chemicals
Financial Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Casualty-->Commercial Insurance-->Group Accident and
Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Industry
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Creditor and Pecuniary
Loss
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Industrial Goods and Machinery-->Chemical Industry
Machinery
City Tokyo
State Tokyo
Country Japan
61
339
CORPORATE VENTURING
Website www.tokiomarinehd.com
Advisor information
Financial advisors
Legal advisors
Legal advisors
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
62
340
CAPITAL RAISING
CAPITAL RAISING
Figure 5: Edelweiss Financial Services Ltd capital raising Figure 6: Edelweiss Financial Services Ltd capital raising by
volume and value trend (2014-YTD2018) deal type (2014-YTD2018)
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE
Table 5: Edelweiss Financial Services Ltd capital raising Table 6: Edelweiss Financial Services Ltd capital raising by
volume and value trend (2014-YTD2018) deal type (2014-YTD2018)
2015 - -
2016 1 374.64
2017 - -
2018 - -
63
341
CAPITAL RAISING
Deal Report: Edelweiss Financial Services to raise $374.64 million in private placement
of non-convertible debentures
Deal in brief
Edelweiss Financial Services, Ltd., an India-based diversified financial services company, has agreed to
raise INR25,000 million ($374.64 million) in a private placement of non-convertible debentures in one or
more tranches.
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal category Private placement
342
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and 65
343
CAPITAL RAISING
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging 66
344
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and 67
345
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment 68
346
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare 69
347
CAPITAL RAISING
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices 70
348
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and 71
349
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy 72
350
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and 73
351
CAPITAL RAISING
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices 74
352
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing-->Packaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and 75
353
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices 76
354
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and 77
355
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging 78
356
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and 79
357
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Biomaterials and Tissue Regeneration 80
358
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and 81
359
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging 82
360
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and 83
361
CAPITAL RAISING
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics 84
362
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and 85
363
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices 86
364
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices 87
365
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and 88
366
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment 89
367
CAPITAL RAISING
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
90
368
CAPITAL RAISING
Deal in brief
Edelweiss Capital Ltd., a provider of investment banking, asset management and wealth management
services, has completed its initial public offering (IPO). The company issued 8,386,147 million shares at a
price of INR825 ($20.91) per share, raising gross proceeds of INR6,918.57 million ($175.84 million),
diluting about 11% of its stake through the IPO.
The issue consisted of 8.18 million equity shares and a reservation of 2.04 million equity shares for
employees of the company.
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal sub-category Completed , ipo
% to Public 11
Deal rationale
The proceeds of the issue would be used, inter alia, towards enhancement of margin maintenance with
stock exchanges, establishment of additional offices and acquisition of office infrastructure, enhancement
of existing technological capacity and loan prepayment.
91
369
CAPITAL RAISING
Deal in brief
A group of investors, led by Lehman Brothers and Thomas Schmidheiny, the chairman of Holcim Group,
are together purchasing a 5% stake in Edelweiss Capital Limited, a financial services company engaged in
securities broking, investment management and private client services. The stake is valued at $50 million.
Acquired % 5
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Date of announcement Jul 09, 2007
Deal rationale
The proceeds from the pre-IPO placement would be used to expand Edelweiss Capital's mutual fund and
wealth management business.
Industry
Financial Services 92
370
CAPITAL RAISING
Website www.lehman.com
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
93
371
DIVESTMENTS
DIVESTMENTS
Divestments – Overview
Figure 7: Edelweiss Financial Services Ltd divestments Figure 8: Edelweiss Financial Services Ltd divestments by
volume and value trend (2014-YTD2018) geography (2014-YTD2018)
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE
Note: Zero deal value indicates transactions with undisclosed deal values
Table 7: Edelweiss Financial Services Ltd divestments volume Table 8: Edelweiss Financial Services Ltd divestments activity
and value trend (2014-YTD2018) by geography (2014-YTD2018)
2015 1 - Europe -
2016 - - Asia-Pacific 1
94
372
DIVESTMENTS
Deal Report: Tokio Marine to acquire additional 23% stake in Edelweiss Tokio Life
Insurance
Deal in brief
Tokio Marine Holdings, Inc. has agreed to acquire an additional 23% stake in Edelweiss Tokio Life
Insurance Company Limited, a provider of life insurance products and services, from Edelweiss Capital
Limited. Edelweiss Tokio and Edelweiss Capital are based in India.
Tokio Marine is a Japan-based provider of property and casualty insurance, reinsurance and life insurance
services. Edelweiss Capital is engaged in retail finance and debt capital markets, commodities, financial
markets, asset management and life insurance businesses.
Following the transaction, Tokio Marine will hold a 49% stake in Edelweiss Tokio Life Insurance.
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Seller/Vendor Edelweiss Financial Services Ltd
Acquired % 23
Financial Services
Financial Services-->General Insurance, Property and
Industry
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->Life and Pensions-->Life and Protection
City Mumbai
95
373
DIVESTMENTS
State Maharashtra
Country India
Website www.edelweisstokio.in
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
and Middle East; and Asia and Oceania regions. Marine is
headquartered in Tokyo, Japan.
Chemicals
Financial Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Accident and Health
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Industry Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and
Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
96
374
DIVESTMENTS
City Tokyo
State Tokyo
Country Japan
Website www.tokiomarinehd.com
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
97
375
DIVESTMENTS
Deal Report: Edelweiss Financial to sell 26% stake in Edelweiss Housing Finance
Deal in brief
Edelweiss Financial Services Limited (formerly Edelweiss Capital Limited), a financial services company, is
planning to sell a 26% stake in its housing finance arm Edelweiss Housing Finance, Ltd., a provider of
mortgage loans.
Acquired % 26
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Date of announcement Dec 21, 2012
Country India
98
376
PRIVATE EQUITY & OWNERSHIP
Figure 9: Edelweiss Financial Services Ltd private equity and Figure 10: Edelweiss Financial Services Ltd private equity
ownership volume and value trend (2014-YTD2018) and ownership by deal type (2014-YTD2018)
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Source: Financial Deals MARKETLINE Source: Financial Deals MARKETLINE
Note: Zero deal value indicates transactions with undisclosed deal values
Table 9: Edelweiss Financial Services Ltd private equity and Table 10: Edelweiss Financial Services Ltd private equity and
ownership volume and value trend (2014-YTD2018) ownership activity by deal type (2014-YTD2018)
2015 1 -
2016 - -
2017 - -
2018 - -
99
377
PRIVATE EQUITY & OWNERSHIP
Deal in brief
GIC Private Limited, a Singapore-based investment management firm, has exited its investment in
Edelweiss Financial Services, Ltd., an India-based diversified financial services company.
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Date of completion Jul 24, 2015
Deal financials
EV/Revenues 6.90
EV/EBITDA 52.52
378
PRIVATE EQUITY & OWNERSHIP
Key ratios
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Asset management firm, quasi-government organization,
Industry
nasd member broker/dealer, swaps dealer
City Singapore
Country Singapore
Website www.gic.com.sg
101
379
PRIVATE EQUITY & OWNERSHIP
Deal Report: Carlyle Group acquires 3.85% stake of Edelweiss Financial from Reliance
Growth Fund
Deal in brief
The Carlyle Group, a US-based private equity firm, has acquired a 3.85% stake in Edelweiss Financial
Services Limited (formerly Edelweiss Capital Limited), an India-based financial services company, from
Reliance Growth Fund for INR859 million ($17.53 million) in a bulk deal on the National Stock Exchange of
India.
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquired % 3.85
City WASHINGTON
State WashingtonD.C.
380
PRIVATE EQUITY & OWNERSHIP
City Mumbai
State Maharashtra
Country India
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
103
381
PRIVATE EQUITY & OWNERSHIP
Deal Report: Galleon International Master Fund and Galleon Special Opportunities
Master Fund sell 7.02% stake in Edelweiss Capital
Deal in brief
Galleon International Master Fund and Galleon Special Opportunities Master Fund have sold 5.268 million
shares, representing a 7.02% stake, in Edelweiss Capital Limited, an India-based financial services
company, for INR485 ($10.43) per share or INR2,554.98 million ($54.93 million).
Galleon International Master Fund and Galleon Special Opportunities Master Fund are subsidiaries of
Galleon Group, LLC, a US-based hedge fund.
As of September 2009, Galleon International Master Fund held 4.42% and Galleon Special Opportunities
Master Fund held 2.6% stake in Edelweiss Capital.
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal status Completed
Acquired % 7.02
382
PRIVATE EQUITY & OWNERSHIP
Key ratios
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
105
383
PRIVATE EQUITY & OWNERSHIP
Deal Report: Reliance Capital acquires 1.6% stake in Edelweiss Capital from Shuaa
Capital
Deal in brief
Reliance Capital, Ltd. has acquired 1.23 million shares, representing a 1.6% stake, in Edelweiss Capital
Limited, an India-based financial services company, from Shuaa Capital PJSC at INR482 ($10.37 million)
per share, for a total consideration of INR593 million ($12.76 million).
Reliance Capital is an India-based non-banking financial company, while Shuaa Capital is UAE-based
financial services company.
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal category Acquisition
Acquired % 1.6
Key ratios
384
PRIVATE EQUITY & OWNERSHIP
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Reliance Group, a private sector business group based in
India, having operations in telecommunications, financial
services, power, infrastructure, healthcare sectors, and
media and entertainment industries. RCL is headquartered
in Mumbai, Maharashtra, India.
385
PRIVATE EQUITY & OWNERSHIP
City MUMBAI
Country India
Website www.reliancecapital.co.in
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Phone number 91 22 30336591
Financial Services
Financial Services-->Private Equity and Venture Capital
Industry Financial Services-->Capital Markets and Trading--
>Brokerage
Financial Services-->Retail Banking and Lending
Financial Services-->Institutional Investment Management
City Dubai
Website www.shuaa.com
108
386
APPENDIX
APPENDIX
Contact Us
We hope that the data and analysis in this profile will help you make informed and imaginative
business decisions. If you have further requirements feedback please contact us at
assistme@marketline.com.
For further information on MarketLine and our range of business information services please visit
www.marketline.com
• Financial Deals is the most extensive Deals database currently available in the market
• The database provides research and analysis on all types of financial deals including:
– merger and acquisition
– private equity backed buyout and investment
– venture capital investment
– initial public offering (IPO)
– secondary offering
– private placement
– partnership deal
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
• The database is a ‘live’ database and is updated real-time with Deal information
• Database contains more than 250,000 Deal records across all industries
• Every year over 48,000 Deals are added to the database
• The database contains active details of more than 5,000 Advisors and 12,000 Advisor
executives
• 200,000 + companies; 10,000 + VC/ PE firms
• Five year archive of key companies across eight sectors; complete eight year archive of
healthcare companies
• Complete portfolio of top 50 venture firms
• What we offer
– detailed deal transaction data;
– sector/market specific analytical deal reports with analyst opinion;
– customized research and analysis.
• Coverage
– global coverage across all industries through a combination of secondary and primary
research;
– multi-lingual analyst capability ensures strong coverage from regional markets;
– track over 14,000 sources every day.
–
• Content
– detailed deal information with over 50 fields covering all of the key information required
to understand a deal comprehensively;
– detailed advisory information, financial information, deal multiple, deal rationale, and
information related to business operations in addition to basic fields;
– Value addition through a wide network of contacts with top advisors, law firms,
investment banks, and industry experts.
109
387
APPENDIX
• Want to know more? – Should you have any queries, send us an email at
reachus@marketline.com
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
110
388
APPENDIX
Merger
A deal will be classified as Merger when two or more companies combine to form one company.
An amalgamation in the nature of merger is an amalgamation which satisfies all the following
conditions:
All the assets and liabilities of the transferor company become, after amalgamation, the
assets and liabilities of the transferee company.
Shareholders holding not less than 90% of the face value of the equity shares of the
transferor company (other than the equity shares already held therein, immediately before
the amalgamation, by the transferee company or its subsidiaries or their nominees) become
equity shareholders of the transferee company by virtue of amalgamation.
The consideration for the amalgamation receivable by those equity shareholders of the
transferor company who agree to become equity shareholders of the transferee company is
discharged by the transferee company wholly by the issue of equity shares in the transferee
company, except that cash may be paid in respect of any fractional shares.
The business of the transferor company is intended to be carried on, after the amalgamation,
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
by the transferee company.
No adjustment is intended to be made to the book values of the assets and liabilities of the
transferor company when they are incorporated in the financial statements of the transferee
company except to ensure uniformity of accounting policies.
Acquisition
Transactions where a company acquires equity stake in another company. The following are the
different sub-categories under acquisition:
Minority acquisition: The acquisition of less than 50% equity stake in the target
Majority acquisition: The acquisition of 50% or more than 50% and less than 100% equity
stake in the target
100% acquisition: The acquisition of all of the issued capital or 100% of the issued share
capital of the target
Asset Purchase: The acquisition of a business unit or an asset which is a not a legal entity
Private equity
Private equity transactions capture equity investment / buyout by a private equity (PE) firm. The
following are the different sub-categories under private equity:
Institutional buyout: PE firm or a group of PE firms acquiring a company from non-PE firms
or another company
389
APPENDIX
Management buyout (MBO): The management of the target acquires the target with the
backing of a PE firm will back the management in the buyout by providing the necessary
funds
Management buy-in (MBI): A manager or a management team from outside the target
company (target) raises the necessary finance, buys the target and becomes the target's
new management. The necessary financing is provided by private equity firms.
Buy-In Management buyout (BIMBO): A BIMBO is a combination of MBO and MBI, where
an external group of managers buy into the business and joins forces with the internal
management team
Going Private: A public listed company being acquired by PE firms or with the management
and is de-listed form the stock exchange on which it was listed
Private placement
A private placement is a direct private offering of securities by the issuer to a limited number of
investors. Private placement is a primary market transaction.
Venture financing
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Investments made in a start-up or young company by a venture capital or private equity firm in the
primary market (i.e. the target company is issuing new shares and receiving the proceeds directly).
The following are the different sub-categories under venture financing:
Seed: Financing provided for companies which have still not started marketing their product
or services. The purpose of such funding will generally be to assess and develop an initial
business concept
Growth/Expansion: Financing provided for companies to increase their sales, marketing, and
production operations, which have developed and started marketing their products
Late stage: Financing provided for companies which have already established themselves in
the market and are looking for expanding their production capacities
Exit: This node is assigned when a venture capital is selling its stake in a portfolio company
Initial public offering (IPO) occurs when a company first sells its shares to the public. The
following are the different stages under initial public offering:
Filing: When a company announces its plans to go for an IPO or files the prospectus with the
concerned regulator about the IPO
Pricing: When the company fixes the issue price for its offering
112
390
APPENDIX
Secondary offering: When a public listed company’s existing shareholders are offering their
shares to general public or a public listed company itself is making a follow-on public offering
Partnership
A partnership is the relationship existing between two or more entities that join to carry on a trade or
business. The following are the different sub-categories under partnership:
Joint Venture (JV): Two or more companies forming a new entity to undertake an activity
Co-marketing: Two or more companies coming together to collaborate either for product
development, distribution, or for providing services. In a broader sense any alliance related
to products and / or services where products or service of one company are marketed jointly
with product or services of another company is tagged as co-marketing alliance. Agreements
with a distribution company are not considered as Co-Marketing.
Affinity marketing: An agreement by which one company is getting access to the customer
base of another for selling its products and the company which is providing access to its
customer base is not involved in the product/service development or any other obligations
relating to such product/service
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Licensing agreement: An agreement in which one party gives the rights to another party to
use its technology, intellectual property, and brands. Financial Deals does not capture
licensing deal related to software.
Rumor: Neither of the parties involved in the transaction announces the deal but has been
reported by media/market sources
Announced: Either party involved in the transaction announces the deal
Completed: Involved parties complete the transaction
Terminated: Involved parties do not intend to complete the earlier announced transaction
and either terminates the agreement or withdraws the bid
Dead rumor: Rumor denied by either of the parties involved in the transaction
Deal value
Deal value is the consideration paid by the acquirer for acquiring the target.
Financial Deals uses a deal value estimation model (for cases where deal value is not available
through secondary and primary sources), which is based on comparables. The estimation model
analyzes deal values based on market capitalization of the target company on the day prior to the
announcement. In addition, it also includes approximation derived through inputs from advisors
involved in the deal, approximate enterprise value, gross consideration and share price and number
of shares.
All deals values which are mentioned as approximate consideration are tagged as estimated values.
391
APPENDIX
For M&A, private equity, IPO and private placement, FD focuses on transactions where deal value is
more than or equal to $5 million. For venture investment and partnership, FD captures all deals.
Payment type: Payment type indicates the mode by which the purchase consideration has been
paid to the vendor. It includes the following sub-categories:
Cash: It indicates the amount paid in cash (either in %age or absolute value) by the acquirer
Debt: It indicates the amount of debt (either in %age or absolute value) of the target
assumed by the acquirer
Shares: It indicates the amount of shares (either in %age or absolute value) issued by the
acquirer
Quantity type: It indicates the consideration by payment mode in terms of value and
percentage
Share price paid: Price per share offered by the acquirer to the target
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Debt-related fields
Below is the list of fields captured:
Debt provider: Field ‘provider type’ indicates the type of debt provider. It includes the following sub-
categories:
Debt amount: Amount of debt raised by the acquirer to finance the acquisition
Debt category: It represents the nature of the debt that has been used by the acquirer in financing
the acquisition. It includes the following categories:
Mezzanine: Debt that incorporates equity-based options such as warrants with a lower-
priority debt. Mezzanine debt is often used to finance acquisitions and buyouts, where it can
be used to prioritize new owners ahead of existing owners in the event of bankruptcy.
Second lien: Debts that are subordinate to the rights of other, more senior debts issued
against the same collateral, or a portion of the same collateral. If a borrower defaults, second
lien debts stand behind higher lien debts in terms of rights to collect proceeds from the
debt's underlying collateral.
Other debt: Any other debt facility other than the above mentioned debt categories.
114
392
APPENDIX
Capital increase type: It is the type of debt or equity securities issued by the acquirer to raise the
necessary funds to finance the transaction. It includes the following options:
Converted debt: Converted debt is a debt security which can be exchanged for a specified
amount of another, related security, usually shares of stock in the issuing company, at the
option of the issuer and/or the holder
Convertible bond: A convertible bond is a type of debt instrument that can be converted
into shares of stock in the issuing company, usually at some pre-announced ratio
Convertible loan: A convertible loan is a loan issued by companies that can be converted
into ordinary shares or preference shares at a given price at a future date
Open offer: Indicates the manner in which the company raised money by offering its shares
to the public (public offering)
Placing: General term to describe the process of raising money via the issue of new shares
Private placing: Private placing is a process of raising money by the issue of new shares to
institutions and private clients rather than to the general public
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Rights issue: Rights issue is the process of raising money by issuing rights to a company's
existing shareholders to buy a proportional number of additional securities at a given price
within a fixed period
Scrip issue: A scrip issue (also called a capitalization issue or a bonus issue) is the issue of
new shares to existing shareholders at no charge, on a pro-rata basis to their existing
shareholdings
Vendor placing: A method of using shares to fund an acquisition by allotting shares from
the purchaser to the vendor in exchange for shares in the target (or other assets). The
consideration shares are then placed on behalf of the vendor by the purchaser’s bank so
that the vendor receives cash (the proceeds of sale of shares by the purchaser’s bank).
Financial Deals captures all the key financial items from income statement, balance sheet including
key ratios and valuation multiples, which help in providing a detailed understanding of the deal. The
financial information is captured for target companies. All the financial fields are presented in local
currency as well as US Dollar. In addition to financial fields, Financial Deals also captures certain
operational parameters. Below is a list of key fields along with their definitions:
Fiscal year end: Refers to the fiscal year (or financial year or accounting reference date), a 12-
month period used for calculating annual (yearly) financial statements. All the financial fields in
MarketLine Financial Deals database are captured according to the fiscal year-end values.
115
393
APPENDIX
Revenue (non banking): Revenue is the amount of money that a company receives from its
activities in a given period, primarily from sales of products and/or services to customers
Revenue (banking): This value is sum of interest income and non interest income
Operating profit: Operating profit is the earnings before deduction of interest payments and income
taxes; also called EBIT (earnings before interest and taxes) or operating income. For banking
companies interest payments are not deducted.
Post tax profit: Post tax profit is the amount of earnings that is available after deducting the taxes,
also known as profit after tax
Operating margin: This value measures the percent of revenues remaining after paying all
operating expenses. It is calculated as annual operating income divided by annual total revenue,
multiplied by 100.
Shares issued: Number of shares the company has issued out of its authorized capital
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
shares of common stock multiplied by the market price-per-share as on fiscal year end
Outstanding shares: It represents stock currently held by investors, including restricted shares
owned by the company's officers and insiders, as well as those held by the public. It is also defined
as the difference between shares in issue and treasury shares as of the fiscal year end.
Net assets: Net assets are the difference between the total asset and liabilities that has to be paid to
third parties. It is also known as net worth
Net assets-share ratio: It is defined as net assets divided by number of shares outstanding
Earning per share: Earnings per share (EPS) is calculated by dividing a company's net income by
the outstanding shares
Price earning ratio (P/E): The P/E ratio (price-to-earnings ratio) of a stock (also called its ‘earnings
multiple’, or simply multiple, P/E, or PE) is a measure of the price paid for a share relative to the
income or profit earned by the company per share. P/E ratio is arrived by dividing share price at the
end of the fiscal year with net income per share.
Deal multiples
116
394
APPENDIX
Advisor information
Financial Deals captures detailed advisor information including financial advisor, legal advisor,
placement agent, and public relation (PR) advisors along with respective executives involved in the
deal. The following are the different types of advisors:
Legal advisor: Legal advisors are those who look into the legal matters of a company for that
particular deal.
Financial advisor: Financial advisors are those who look into the financial matters of a company for
that particular deal. Financial advisor is separated into the following types:
Financial due diligence: The process of investigation, performed by investors, into the details
of a potential investment, such as examination of operations and management and
verification of material facts
Accounting: Financial advisor who looks into the accounting matters for a deal
Tax: Financial advisor who looks into the tax matters for a deal
Corporate Finance: Financial advisor who looks into the financial decisions of a corporation
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Book runners: Book runner is the managing or lead underwriter who maintains the books of
securities sold for a new issue
Underwriters: A company or other entity that administers the public issuance and distribution
of securities from a corporation or other issuing body
Brokers: An individual or firm that charges a fee or commission for executing buy and sell
orders submitted
Others: All other financial advisors not falling in the above-mentioned categories are tagged
as other
Placement agent: A company that specializes in finding institutional investors who are willing and
able to invest primarily in unregistered securities
Public Relations (PR) advisor: An entity that advises a company or manages its communication
activities with its stakeholders
117
395
APPENDIX
About MarketLine
In an information-rich world, finding facts you can rely upon isn’t always easy. MarketLine is the
solution.
At MarketLine, we deliver accurate, up-to-date information on 300 industries and 150 countries as
well as detailed profiles of over 2,500 companies. By taking the chore out of business research,
MarketLine gives you more time to focus on what really matters.
Profiling all major companies, industries and geographies, MarketLine is one of the most prolific
publishers of business information today.
Our content is produced by an internal team of analysts, drawing on primary and secondary research
and prepared under an established methodology that’s been tried and tested over 10 years.
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
118
396
APPENDIX
Edelweiss Financial Services Ltd– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Vendor, acquirer, target and partner report for IFCI Limited and its subsidiaries. Includes
Mergers & Acquisitions, Private equity, Venture capital, Joint ventures, Alliances and
Investments
398
COMPANY OVERVIEW AND KEY FACTS
IFCI LIMITED
IFCI Limited (IFCI) is a financial institution that offers a variety of financial products and services. The company offers
a range of financial products that includes debt products and products related to the equity and other business
segments. IFCI offers corporate advisory services, infrastructure advisory services, and monitors public issues. It also
provides balance sheet funding, loan against shares, lease rental discounting and promoter funding. The company
also acts as a debenture trustee for debentures issued by other companies. IFCI is headquartered in New Delhi,
India.
The company reported revenues of (Rupee) INR34,452.4 million for the fiscal year ended March 2018 (FY2018), a
decrease of 3.7% over FY2017. The operating loss of the company was INR17,580.7 million in FY2018, compared to
an operating loss of INR6,779 million in FY2017. The net loss of the company was INR10,050.2 million in FY2018,
compared to a net loss of INR3,775.3 million in FY2017.
Key facts
State Delhi
Country India
Website www.ifciltd.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
-
399
COMPANY OVERVIEW AND KEY FACTS
IFCI Limited activity by deal type - volume (2014-YTD2018) IFCI Limited M&A average deal size - value ($m)
Deal type 2014 2015 2016 2017 2018 Year Number of deals Average deal size ($m)
Acquisition (ACQ) 1 - - - - 2014 1 -
Capital raising - - 1 - - 2015 - -
(CR) 2016 - -
Divestments (DIV) 1 2 3 - - 2017 - -
2018 - -
Note: Zero deal value indicates transactions with undisclosed deal values
Deal value
Target/Partner (Country) Announcement date Deal status Deal Type
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
($m)
Private
IFCI Limited (India) Apr 18, 2016 Announced 86.18
placement
National Stock Exchange of India Ltd. (India) Jul 4, 2016 Completed Acquisition 13.13
National Stock Exchange of India Ltd. (India) Apr 4, 2016 Completed Acquisition 8.93
National Stock Exchange of India Ltd. (India) Sep 17, 2015 Completed Acquisition 39.7
National Stock Exchange of India Ltd. (India) Sep 17, 2015 Completed Private equity 39.66
400
TABLE OF CONTENTS
TABLE OF CONTENTS
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Capital Raising – Overview ............................................................................................................... 38
DIVESTMENTS ..................................................................................... 67
Divestments – Overview .................................................................................................................... 67
APPENDIX........................................................................................... 142
Contact Us ....................................................................................................................................... 142
4
About MarketLine ............................................................................................................................. 151
401
TABLE OF CONTENTS
LIST OF TABLES
Table 3: IFCI Limited capital raising volume and value trend (2014-YTD2018) 38
LIST OF FIGURES
Figure 3: IFCI Limited capital raising volume and value trend (2014-YTD2018) 38
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
402
TARGETS AND PARTNERS
IFCI Limited-Target/Partner name Deal Date Deal type Deal value ($m)
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
403
MERGERS & ACQUISITIONS
Figure 1: IFCI Limited M&A volume and value trend (2014- Figure 2: IFCI Limited M&A activity by geography (2014-
YTD2018) YTD2018)
Note: Zero deal value indicates transactions with undisclosed deal values
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Table 1: IFCI Limited M&A volume and value trend (2014- Table 2: IFCI Limited M&A activity by geography (2014-
YTD2018) YTD2018)
2015 - - Europe -
2016 - - Asia-Pacific 1
404
MERGERS & ACQUISITIONS
Deal Report: IFCI acquires 49% equity stake in Rajasthan Consultancy (RAJCON)
Deal in brief
IFCI Limited, a provider of long-term finance to the industrial sector, has acquired 49% stake in Rajasthan
Consultancy Organization, Ltd. (RAJCON) from Hardicon Limited, a provider of low-cost industrial
consultancy solutions. All the companies are based in India.
Acquired % 49
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company information: Target, acquirer, and seller/vendor
City Jaipur
8
405
MERGERS & ACQUISITIONS
State Rajasthan
Country India
Website www.rajcon.org
Country India
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
406
MERGERS & ACQUISITIONS
Deal in brief
IFCI Limited, a provider of long-term finance to the industrial sector, has acquired an additional 4.35%
stake in Koutons Retail India Limited, an apparel manufacturing and retail company. Both the companies
are based in India.
Following the transaction, IFCI will increase its stake in Koutons Retail from 5.89% to 10.24%.
Acquired % 4.35
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal financials
EV/Revenues 0.89
EV/EBITDA 7.25
Retailing
Retailing-->By Multi-Channel-->In-Store
Industry Retailing-->Clothing, Footwear, Accessories and Luxury
Goods-->Accessories
Retailing-->Clothing, Footwear, Accessories and Luxury
Goods-->Clothing 10
407
MERGERS & ACQUISITIONS
State Delhi
Country India
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Market capitalization 10,587.58 232.93
Key ratios
11
408
MERGERS & ACQUISITIONS
Deal in brief
IFCI Limited, an Indian provider of long-term finance to the industrial sector, is planning to acquire a 7.72%
stake in KSK Mahanadi, a coal based power project of KSK Energy Ventures Limited, for $56 million.
KSK Mahanadi is being promoted by KSK Energy Ventures, an Indian subsidiary of KSK Power Ventur plc,
a UK-based power project development company.
KSK Mahanadi is being funded through a mix of debt and equity wherein the debt of $2,880 million is being
funded through a consortium of 27 Indian banks and financial institutions.
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal sub-category Asset purchase
Acquired % 7.72
409
MERGERS & ACQUISITIONS
people.
Country India
Website www.ksk.co.in
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Industry
Energy
Energy and Utilities-->Utilities-->Power Generation
City Hyderabad
Country India
Website www.ksk.co.in
13
410
MERGERS & ACQUISITIONS
Deal Report: IFCI acquires 5% stake in MCX Stock Exchange from Financial
Technologies
Deal in brief
IFCI Limited has acquired a 5% sake in MCX Stock Exchange Limited, a currency futures exchange, from
Financial Technologies (India), Ltd.(FTIL) for a consideration of approximately INR2,500 million ($51.36
million).
IFCI is a provider of long-term finance to the industrial sector, while FTIL is engaged in providing
transaction automation technologies for equities, derivatives, forex, and commodity markets. All the three
companies are based in India.
The shares were acquired at a price of INR35 ($0.71) per equity share.
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal sub-category Minority acquisition
Acquired % 5
Financial Services
Financial Services-->Capital Markets and Trading-->Clearing
and Settlement
Industry Financial Services-->Capital Markets and Trading--
>Derivatives
Financial Services-->Capital Markets and Trading--
>Exchanges
Financial Services-->Capital Markets and Trading-->Foreign 14
411
MERGERS & ACQUISITIONS
Exchange (FX)
City Mumbai
State Maharashtra
Country India
Website www.mcx-sx.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Zambia, Botswana, Mauritius, and South Africa. It is
headquartered in Mumbai, India and employs around 872
people.
Address FT Tower CTS Number 256 and 257, Suren Road Chakala
Country India
Website www.ftindia.com
15
412
MERGERS & ACQUISITIONS
Deal in brief
IFCI Limited, a provider of long-term finance and advisory services, has acquired 10.25 million shares,
representing a 17.42% stake, in Maytas Infra Limited, an infrastructure development, construction, and
project management company. Both the companies are based in India.
Acquired % 17.42
Deal financials
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Valuation multiples (IL&FS Engineering and Construction Company Limited)
EV/Revenues 2.53
EV/EBITDA 20.89
413
MERGERS & ACQUISITIONS
Country India
Website www.ilfsengg.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial parameters Indian Rupee (INR) (m) ($m)
Key ratios
17
414
MERGERS & ACQUISITIONS
Deal Report: IFCI acquires 46.65% stake in Foremost Factors from Mohan Exports Group
Deal in brief
IFCI, Ltd., a provider of finance and corporate advisory services, has acquired a 46.65% stake in Foremost
Factors, Ltd. (FFL), a provider of domestic and export factoring facilities, from Mohan Exports Group,
thereby increasing its stake to 96.49% in FFL. IFCI also proposes to acquire the balance shareholding of
3.5% from other shareholders to make it a 100% subsidiary.
Acquired % 46.65
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal rationale
Financial Services
Industry
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
Country India
18
415
MERGERS & ACQUISITIONS
Website www.foremostfactors.net
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Industry Financial Services
Industrial Goods and Machinery
Industrial Goods and Machinery-->Food Product Machinery
Manufacturing
Industrial Goods and Machinery-->Metalworking Machinery
Industrial Goods and Machinery-->Textile Machinery
Manufacturing
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare
State Delhi
Country India
Website www.mohanexports.com
19
416
MERGERS & ACQUISITIONS
Deal Report: IFCI proposes to acquire remaining 3.5% stake in Foremost Factors
Deal in brief
IFCI, Ltd., a provider of finance and corporate advisory services, has plans to acquire the balance
shareholding of a 3.5% in Foremost Factors, Ltd. (FFL), a provider of domestic and export factoring
facilities.
Upon the completion of this acquisition, Foremost Factors wil become a 100% subsidiary to IFCI.
On May 21, 2008, IFCI has acquired a 46.65% stake in Foremost Factors from Mohan Exports Group,
thereby increasing its stake to 96.49% in FFL.
Acquired % 3.5
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal rationale
Financial Services
Industry
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
Country India 20
417
MERGERS & ACQUISITIONS
Website www.foremostfactors.net
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
21
418
CORPORATE VENTURING
CORPORATE VENTURING
Corporate Venturing – Deal reports
Deal Report: South Indian Bank raises $80 million in private placement
Deal in brief
South Indian Bank, Ltd., an India-based provider of retail banking services, has raised INR4,430 million
($80 million) in a qualified institutional placement of 200 million equity shares.
The investors include First Carlyle Ventures Mauritius Private Limited, The Carlyle Group, IFCI Limited,
State Bank of India, SBI Life Insurance Co., Ltd., and SBI Mutual Fund.
The placement of new shares represents 15% stake in South Indian Bank.
As part of the transaction, Carlyle Group acquired 2.04% stake for INR22.13 ($0.39) per share, IFCI
acquired 4.99% stake for INR1,475 million ($26.63 million), while two private equity funds have separately
invested a total of INR1,650 million ($29.8 million) for 5.8% stake between them.
State Bank of India acquired 0.34% for INR100 million ($1.81 million), while SBI Life Insurance acquired
0.67% for around INR200 million ($3.61 million) and SBI Mutual Fund acquired 0.85% for INR250 million
($4.51 million).
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Target South Indian Bank Ltd.
Acquired % 15
419
CORPORATE VENTURING
Deal rationale
Deal financials
EV/Revenues 0.19
EV/EBITDA 0.92
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Security type Common stock
420
CORPORATE VENTURING
City Thrissur
State Kerala
Country India
Website www.southindianbank.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Revenues 38,304.95 738.90
Key ratios
421
CORPORATE VENTURING
Financial Services
Financial Services-->Cards-->Card Issuance-->Commercial
Cards
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->Cards-->Card Issuance-->Credit Cards
Financial Services-->Cards-->Card Issuance-->Debit Cards
Financial Services-->Cards-->Card Issuance-->Pre-paid
Cards
Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking--
>Mergers and Acquisitions (M&A)
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
Financial Services-->Corporate and Investment Banking
Financial Services-->Corporate and Investment Banking--
Industry >Treasury and Cash Management
Financial Services-->Corporate and Investment Banking--
>Wholesale Payments
Financial Services-->Retail Banking and Lending-->SME
Banking Services
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->Corporate and Investment Banking
Financial Services-->Retail Banking and Lending
Financial Services-->Payments
Financial Services-->Payments-->Bank Transfers
Financial Services-->Payments-->Cash
Financial Services-->Payments-->Cheque
Financial Services-->Payments-->Direct Debit
25
422
CORPORATE VENTURING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->Savings and Investments-->Mutual
Funds
Financial Services-->Savings and Investments-->Savings
Accounts
Financial Services-->Wealth Management and Private
Banking
Financial Services-->Wealth Management and Private
Banking
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Equipment and Services
Technology and Services
Technology and Services
City Mumbai
State Maharashtra
Country India
Website www.sbi.co.in
423
CORPORATE VENTURING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Insurance Brokers and Intermediaries
City Mumbai
State Maharashtra
Country India
Website www.sbilife.co.in
City Mumbai
State Maharashtra
27
424
CORPORATE VENTURING
Country India
Website www.sbimf.com
Country Mauritius
City WASHINGTON
State WashingtonD.C.
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Phone number 1 202 7295626
28
425
CORPORATE VENTURING
Deal Report: Gayatri Energy Ventures raises $56.2 million from IFCI
Deal in brief
Gayatri Energy Ventures Private Limited (GEVPL), a wholly-owned subsidiary of heavy construction
company Gayatri Projects Limited, has raised INR2,500 million ($56.2 million) from IFCI Limited, through
issue of compulsory convertible debentures. All the entities involved in the transaction are based in India.
Deal rationale
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Gayatri Energy will use the proceeds from the offering for bankrolling proposed investments, announced by
GEVPL in the energy domain.
426
CORPORATE VENTURING
City Hyderabad
State Telangana
Country India
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
30
427
CORPORATE VENTURING
Deal Report: Gujarat State Petroleum Corporation (GSPC) to raise $216.7 million in
private placement
Deal in brief
Gujarat State Petroleum Corporation (GSPC), an India-based oil and gas exploration company, is planning
to raise INR9,900 million ($216.7 million) from three financial institutions and seven public sector units in a
private placement.
As part of the transaction, GSPC will divest 5% of the company at INR810 ($17.73) per share.
The two financial institutions IDBI Bank Limited and IFCI Limited invested INR1,500 million ($32.83 million)
and INR1,000 million ($21.89 million), respectively. SBI Capital will invest INR3,000 million ($65.67 million)
in the form of convertible debentures.
The public sector units Gujarat State Fertilizers & Chemicals Limited invested INR1,498.5 million ($32.8
million), Gujarat State Investment Limited INR1,100 million ($24.08 million), Gujarat Industrial Development
Corporation INR1,000 million ($21.89 million). Narmada Valley Fertilizers Company, Gujarat Mineral
Development Corporation Limited, Gujarat Alkalies Chemicals Limited, Gujarat Industrial Investment
Corporation Limited and Gujarat Gas Company Limited together invested INR50 million ($1.09 million).
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer 2 SBI CAPITAL Co., Ltd.
Acquired % 5
31
428
CORPORATE VENTURING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Energy and Utilities
Energy and Utilities-->Commodity-->Gas
Industry
Energy and Utilities-->Commodity-->Oil
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Production
City Gandhinagar
State Gujarat
Country India
Website www.gujaratpetro.com
429
CORPORATE VENTURING
Key ratios
City Mumbai
State Maharashtra
Country India
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Website www.idbi.com
City Tokyo
Country Japan
430
CORPORATE VENTURING
Financial Services
Industry
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
City Gandhinagar
State Gujarat
Country India
Industry
Government and Non-Profit Organisations
State Gujarat
Country India
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Website www.gidc.gov.in
Industry Chemicals
Chemicals-->Agrochemicals-->Fertilizer
City Vadodara
34
431
CORPORATE VENTURING
State Gujarat
Country India
Website www.gsfclimited.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Metals and Mining-->Metal Ore Mining-->Aluminum Ore
Mining
Metals and Mining-->Coal Mining
Industry
Metals and Mining-->Metal Ore Mining-->Copper Ore and
Nickel Ore Mining
Metals and Mining-->Metal Ore Mining-->Lead Ore and Zinc
Ore Mining
Metals and Mining-->Metal Ore Mining
Metals and Mining-->Metal Ore Mining-->Lead Ore and Zinc
Ore Mining
Metals and Mining
Metals and Mining-->Primary Metal Manufacturing
Country India
Website www.gmdcltd.com
432
CORPORATE VENTURING
Industry Chemicals
Chemicals-->Agrochemicals-->Fertilizer
Address Narmadanagar
City Bharuch
State Gujarat
Country India
Website www.gnfc.in
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
potash, phosphoric acid and others. It manufactures other
basic chemicals, such as sodium cyanide, sodium ferro
Business description
cyanide, chloromethane, hydrochloric acid, potassium
carbonate, phosphoric acid (85%) and hydrogen peroxide,
poly aluminum chloride, anhydrous aluminum chloride and
chlorinated paraffin wax.
Industry
Chemicals
City Vadodara
State Gujarat
Country India
Website www.gujaratalkalies.com
433
CORPORATE VENTURING
Country India
Website http://www.gujaratgas.com
Advisor information
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Target : Gujarat State Petroleum Corporation Limited
Financial advisors
37
434
CAPITAL RAISING
CAPITAL RAISING
Figure 3: IFCI Limited capital raising volume and value trend Figure 4: IFCI Limited capital raising by deal type (2014-
(2014-YTD2018) YTD2018)
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Table 3: IFCI Limited capital raising volume and value trend Table 4: IFCI Limited capital raising by deal type (2014-
(2014-YTD2018) YTD2018)
2015 - -
2016 1 86.18
2017 - -
2018 - -
38
435
CAPITAL RAISING
Deal in brief
IFCI Limited, an India-based provider of long-term finance to the industrial sector, has agreed to raise up to
INR5,750 million ($86.18 million) through an issue of secured, redeemable, non-convertible bonds in the
nature of debentures on a private placement.
The bonds will carry a coupon rate of 8.55% semi-annually, and are of five-and-half-years of tenure. The
bonds will mature on November 3, 2021.
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal status Announced
436
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging 40
437
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and 41
438
CAPITAL RAISING
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment 42
439
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and 43
440
CAPITAL RAISING
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices 44
441
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and 45
442
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology 46
443
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and 47
444
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental 48
445
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and 49
446
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Pharmaceuticals--
>Manufacturing Services and Outsourcing-->Packaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices 50
447
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and 51
448
CAPITAL RAISING
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices 52
449
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and 53
450
CAPITAL RAISING
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices 54
451
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and 55
452
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics 56
453
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and 57
454
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging 58
455
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Disposable Medical Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and 59
456
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Renal, Urology and Reproductive Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices 60
457
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and 61
458
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and 62
459
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices 63
460
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and 64
461
CAPITAL RAISING
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Orthopedic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Hematological Devices and Blood Products
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Cardiovascular Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Dental
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Ophthalmic Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging 65
462
CAPITAL RAISING
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
66
463
DIVESTMENTS
DIVESTMENTS
Divestments – Overview
Figure 5: IFCI Limited divestments volume and value trend Figure 6: IFCI Limited divestments by geography (2014-
(2014-YTD2018) YTD2018)
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Table 5: IFCI Limited divestments volume and value trend Table 6: IFCI Limited divestments activity by geography
(2014-YTD2018) (2014-YTD2018)
67
464
DIVESTMENTS
Deal in brief
IFCI Limited, a provider of long-term finance to the industrial sector, has sold additional 225,000 shares of
National Stock Exchange of India, Ltd. (NSE), an operator of electronic stock exchange, at the rate of
INR3,950 per share. Both the companies are based in India.
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Date of completion Jul 04, 2016
Financial Services
Industry
Financial Services-->Capital Markets and Trading
Technology and Services
68
465
DIVESTMENTS
Country India
Website www.nseindia.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
69
466
DIVESTMENTS
Deal Report: Soach Global Opportunities Fund acquires stake in National Stock
Exchange of India
Deal in brief
Soach Global Opportunities Fund (SGOF) has acquired a stake in National Stock Exchange of India, Ltd.,
(NSE), an operator of electronic stock exchange, from IFCI Limited, a provider of long-term finance to the
industrial sector, for INR592.5 million ($8.88 million). NSE and IFCI are based in India.
SGOF is a fund managed by Soach Global Corporation Limited, a Hong-Kong based fund management
and advisory group.
IDBI Capital Market Services, Ltd. acted as financial advisor to SGOF on the transaction.
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company information: Target, acquirer, and seller/vendor
Financial Services
Industry
Financial Services-->Capital Markets and Trading
Technology and Services
Country India
70
467
DIVESTMENTS
Website www.nseindia.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
71
468
DIVESTMENTS
Deal Report: IFCI sells stake in National Stock Exchange of India (NSE)
Deal in brief
IFCI Limited, a provider of long-term finance to the industrial sector, has sold 150,000 number of equity
shares of National Stock Exchange of India, Ltd. (NSE), an operator of electronic stock exchange, for
INR592.5 million ($8.93 million) or INR3,950 ($59.59) per equity share. Both the companies are based in
India.
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company information: Target, acquirer, and seller/vendor
Financial Services
Industry
Financial Services-->Capital Markets and Trading
Technology and Services
72
469
DIVESTMENTS
Country India
Website www.nseindia.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
73
470
DIVESTMENTS
Deal Report: IFCI sells 1.5% stake in National Stock Exchange of India (NSE)
Deal in brief
According to Livemint, IFCI Limited, a provider of long-term finance to the industrial sector, has sold
675,000 shares, representing a 1.5% stake, in National Stock Exchange of India, Ltd. (NSE), an operator of
electronic stock exchange, to a Mauritius-based fund for approximately INR2,635 million ($39.66 million) or
INR3,900 ($58.71) per equity share. IFCI and NSE are based in India.
Acquired % 1.5
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company information: Target, acquirer, and seller/vendor
Financial Services
Industry
Financial Services-->Capital Markets and Trading
Technology and Services
74
471
DIVESTMENTS
Country India
Website www.nseindia.com
Advisor information
Financial advisors
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
75
472
DIVESTMENTS
Deal Report: IFCI sells 1.5% stake in National Stock Exchange of India (NSE)
Deal in brief
IFCI Limited, a provider of long-term finance to the industrial sector, has sold its 1.5% stake in National
Stock Exchange of India, Ltd. (NSE), an operator of electronic stock exchange, for INR2,632.5 million
($39.7 million). NSE and IFCI are based in India.
Acquired % 1.5
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Target: National Stock Exchange of India Ltd.
Financial Services
Industry
Financial Services-->Capital Markets and Trading
Technology and Services
Country India
76
473
DIVESTMENTS
Website www.nseindia.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
77
474
DIVESTMENTS
Deal Report: SSG Capital Management acquires 49% stake in Assets Care &
Reconstruction (ACRE)
Deal in brief
SSG Capital Management Limited, a Hong Kong-based provider of asset management and financial
restructuring services, has acquired a 49% stake in Assets Care & Reconstruction Enterprise, Ltd., an
India-based asset reconstruction company, for INR410 million ($6.65 million).
ACRE issued preferential shares at a face value of INR10 ($0.16), with a premium of INR12.50 ($0.20)
which were subscribed only by SSG Capital Management.
As part of the transaction, IFCI Limited and Punjab National Bank have reduced their shareholding in
Assets Care & Reconstruction from 40% to 19% and 30% to 15% respectively.
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal value (Indian Rupee)(m) 410
Acquired % 49
Industry
Financial Services
78
475
DIVESTMENTS
Country India
Website acreindia.co
City Central
Website www.ssgcapasia.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Vendor 3: Punjab National Bank
Country India
79
476
DIVESTMENTS
Website www.pnbindia.in
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
80
477
DIVESTMENTS
Deal in brief
IDBI Bank Limited, a financial holding company, is planning to acquire 81% of stake in Stock Holding
Corporation of India Limited (SHCI), a depository participant. Both the companies are based in India.
IDBI is currently holding approximately a 19% stake in SHCI. The other shareholders of SHCI include IFCI
Ltd, Unit Trust of India, Life Insurance Corporation of India, General Insurance Corporation of India, New
India Assurance Co., Ltd., United India Assurance Co., Ltd., Oriental Insurance Co., Ltd., and National
Insurance Co., Ltd.
The transaction is valued at approximately INR14,000 million ($259.94 million), which will be paid in shares
of IDBI.
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Seller/Vendor 6 National Insurance Company Limited
Acquired % 81
81
478
DIVESTMENTS
City Mumbai
State Maharashtra
Country India
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->Institutional Investment Management
City Mumbai
State Maharashtra
Country India
Website www.idbi.com
479
DIVESTMENTS
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->MAT
Financial Services-->General Insurance, Property and
Industry Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Pecuniary Loss
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Liability
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Niche Lines
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Financial Services-->General Insurance, Property and
83
480
DIVESTMENTS
City Chennai
Country India
Website www.uiic.co.in
Financial Services
Industry
Financial Services-->General Insurance, Property and
Casualty
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
City Mumbai
Country India
Website www.niacl.com
481
DIVESTMENTS
State Delhi
Country India
Website www.orientalinsurance.org.in
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
insurance, sheep and goat insurance, elephant insurance,
dog insurance, brackish water prawn insurance, silkworm
Business description
insurance, plantation insurance, and Kisan agriculture
pumpset insurance. The company also offers industrial risk
insurance, machinery insurance, electronic equipment
insurance, commercial risk insurance, workmen
compensation insurance, product liability insurance, and
public liability insurance. It has operations in Guwahati,
Hyderabad, Bangalore, Dharwad, Kolar, Gurgaon, Delhi, and
Naraina, India. NIC is headquartered in Kolkata, West
Bengal, India.
482
DIVESTMENTS
City Kolkata
Country India
Website www.nationalinsuranceindia.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Vendor 7: Life Insurance Corporation of India
City Mumbai
State Maharashtra
Country India
Website www.licindia.com
483
DIVESTMENTS
Financial Services
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty
Industry Financial Services-->Reinsurance
Financial Services-->Reinsurance
Financial Services-->Reinsurance-->Marine
Financial Services-->Reinsurance-->Other
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Retail Banking and Lending
Country India
Website www.gicofindia.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
87
484
DIVESTMENTS
Deal Report: Hero Honda and SREI Infrastructure acquire stake in National Stock
Exchange from IFCI and Stock Holding Corporation
Deal in brief
According to VC Circle, The Economic Times reported that Hero Honda Motors Limited, a manufacturer of
two wheeler vehicle, and SREI Infrastructure Finance Limited have acquired a stake in National Stock
Exchange of India, Ltd. (NSE), a demutualized electronic stock exchange, from IFCI, Ltd. and Stock
Holding Corporation of India Limited (SHCIL). All the companies are based in India. SREI is an
infrastructure equipment finance and infrastructure project finance company.
Hero Honda and SREI have acquired 57,200 shares from SHCIL and 12 million shares from IFCI at a price
of INR3,500 ($83.27) per share. The transaction is valued at INR620.2 million ($14.75 million).
IFCI and SHCIL have sold their stake in NSE as capital market regulator Securities and Exchange Board
of India (SEBI) does not allow more than 5% stake. Prior to this transaction, SHCIL had a 7.11% stake in
the NSE.
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal value ($m) 14.75
485
DIVESTMENTS
Financial Services
Industry
Financial Services-->Capital Markets and Trading
Technology and Services
Country India
Website www.nseindia.com
Automotive
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Automotive-->Automobile Distribution
Automotive-->Automobile Distribution-->New Automobile
Distribution
Industry
Automotive-->Parts, Tires and Aftermarket
Automotive-->Parts, Tires and Aftermarket-->Vehicle Parts
Automotive-->Vehicle Manufacturing
Automotive-->Vehicle Manufacturing-->Motorcycles
Retailing-->Other Specialist Retailers
Country India
Website www.heromotocorp.com
486
DIVESTMENTS
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Energy and Utilities-->Natural Resources-->Upstream
Energy-->Production
City Kolkata
Country India
Website www.srei.com
487
DIVESTMENTS
Funds
City Mumbai
State Maharashtra
Country India
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
91
488
DIVESTMENTS
Deal Report: Hindusthan National Glass acquires glass container manufacturing plant
from IFCI
Deal in brief
Hindusthan National Glass & Industries, Ltd., a manufacturer of glass containers, has acquired a glass
container manufacturing plant from IFCI Limited, a provider of long-term finance to the industrial sector.
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Industry
Paper and Packaging-->Glass Containers and Packaging
92
489
DIVESTMENTS
City KOLKATA
Country India
Website www.hngindia.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
93
490
DIVESTMENTS
Deal Report: New York Stock Exchange to acquire 5% stake in India's National Stock
Exchange
Deal in brief
Industrial Finance Corporation of India Limited (IFCI Ltd.) that holds 12.44% equity shares of National
Stock Exchange of India Ltd. (NSE), has agreed to sell 31.5 million equity shares (constituting 7% holding)
to four institutional investors including Goldman Sachs, NYSE, General Atlantic and Soft Bank.
Earlier on January 10, 2007, NYSE Group, an operator of two securities exchanges, has signed a
definitive agreement to acquire a 5% equity stake in National Stock Exchange of India. Merrill Lynch & Co.
acted as financial advisor to NYSE Group, Inc. in connection with the transaction.
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal sub-category Minority acquisition
Acquired % 5
Industry
94
491
DIVESTMENTS
Financial Services
Financial Services-->Capital Markets and Trading
Technology and Services
Country India
Website www.nseindia.com
Key ratios
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Company type Public
Ticker symbol GS
492
DIVESTMENTS
>Brokerage
Financial Services-->Capital Markets and Trading-->Clearing
and Settlement
Financial Services-->Capital Markets and Trading--
>Commodity Markets
Financial Services-->Capital Markets and Trading--
>Derivatives
Financial Services-->Capital Markets and Trading-->Equity
Markets
Financial Services-->Capital Markets and Trading--
>Exchanges
Financial Services-->Capital Markets and Trading-->Foreign
Exchange (FX)
Financial Services-->Capital Markets and Trading-->Money
Markets
Financial Services-->Retail Banking and Lending
Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking--
>Mergers and Acquisitions (M&A)
Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
Financial Services-->Corporate and Investment Banking--
>Treasury and Cash Management
Financial Services-->Corporate and Investment Banking--
>Wholesale Payments
Financial Services-->Corporate and Investment Banking
Financial Services-->Financial Services Distributors
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Corporate and Investment Banking--
>Mergers and Acquisitions (M&A)
Financial Services-->Corporate and Investment Banking
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->Corporate and Investment Banking--
>Private Placements and Financial Sponsors
Financial Services-->Corporate and Investment Banking--
>Capital Raising
Financial Services-->Retail Banking and Lending
Financial Services-->Savings and Investments-->Equities
Financial Services-->Savings and Investments-->Mutual
Funds
Financial Services-->Institutional Investment Management--
>Pension Funds and Institutional Fund Management
Financial Services-->Savings and Investments-->Savings
Accounts
Financial Services-->Institutional Investment Management--
>Securities Custody
Financial Services-->Wealth Management and Private
Banking
Financial Services-->Wealth Management and Private
Banking
Industrial Goods and Machinery-->Battery Manufacturing
Financial Services-->Capital Markets and Trading
Financial Services-->Retail Banking and Lending-->SME
Banking Services
493
DIVESTMENTS
Website www.goldmansachs.com
Financial Services
Financial Services-->Capital Markets and Trading-->Equity
Markets
Financial Services-->Capital Markets and Trading--
>Exchanges
Industry Financial Services-->Capital Markets and Trading
Financial Services-->Capital Markets and Trading-->Bond
Markets
Financial Services-->Capital Markets and Trading--
>Brokerage
Financial Services-->Capital Markets and Trading-->Money
Markets
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Country United States
Website www.nyse.com
City Greenwich
State Connecticut
Website www.generalatlantic.com
494
DIVESTMENTS
38 Glen Avenue
Address
City Newton
State Massachusetts
Website www.softbank.com
Advisor information
Financial advisors
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
98
495
DIVESTMENTS
Deal in brief
Hyatt group, a US based chain of hotels, has acquired the half-constructed hotel property of Balaji Hotels
and Enterprises Ltd. The consideartion for the transaction is expected to be around INR2000 ($44.95)
million.
Balaji Hotels owes IFCI Limited INR1600 ($35.97)million. Another INR500 ($11.24) million is owed to ICICI
Bank.
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Target: Balaji Hotels and Enterprises Ltd. - Hotel business
Industry
Leisure and Arts-->Hotels and Restaurants-->Hotels
Industry
99
496
DIVESTMENTS
City Chicago
State Illinois
Website www.hyatt.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
100
497
PRIVATE EQUITY & OWNERSHIP
Deal in brief
IFCI Limited, a provider of long-term finance, project finance, non-project specific assistance, and
corporate advisory services, has decided not to sell a 26% stake in the company.
Ernst & Young (E&Y) appointed as the consultant for the proposed stake sale in IFCI.
Kotak Mahindra Bank, Ltd.; a consortium of Sterlite Industries (India), Ltd. and Morgan Stanley & Co.;
Infrastructure Development Finance Company, Ltd.;Natixis; Newbridge Asia IV, L.P; Cargill Financial
Services Corporation; Shinsei Bank, Punjab National Bank and J.C. Flowers & Co.; The Blackstone Group
L.P.; and a consortium of WL Ross & Co. LLC, GS Capital Partners VI Fund, Standard Chartered Bank,
and Housing Development Finance Corporation, Ltd. were in the to acquire the stake in the company.
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer 4 Shinsei Bank, Limited
101
498
PRIVATE EQUITY & OWNERSHIP
Acquired % 26
Deal financials
EV/Revenues 6.64
EV/EBITDA 10.91
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Revenues 20,466.80 471.35
Key ratios
102
499
PRIVATE EQUITY & OWNERSHIP
Industry
Financial Services
Country India
Website www.kotak.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquirer 3: IDFC Limited
Financial Services
Industry
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
Country India
Website www.idfc.com
103
500
PRIVATE EQUITY & OWNERSHIP
Financial Services
Financial Services-->Capital Markets and Trading-->Foreign
Exchange (FX)
Financial Services-->Cards-->Card Issuance-->Credit Cards
Financial Services-->Corporate and Investment Banking--
>Mergers and Acquisitions (M&A)
Financial Services-->Corporate and Investment Banking--
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
>Project, Asset and Structured Finance
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Corporate and Investment Banking--
>Mergers and Acquisitions (M&A)
Financial Services-->Corporate and Investment Banking
Financial Services-->Offshore Financial Services
Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending
Industry Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending
Financial Services-->Cards-->Card Issuance-->Credit Cards
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->Retail Banking and Lending--
>Mortgage Lending
Financial Services-->Retail Banking and Lending--
>Consumer Lending-->Retail Finance
Financial Services-->Savings and Investments-->Savings
Accounts
Financial Services-->Savings and Investments-->Equities
Financial Services-->Savings and Investments-->Mutual
Funds
Financial Services-->Institutional Investment Management--
>Pension Funds and Institutional Fund Management
Financial Services-->Savings and Investments-->Savings
Accounts
104
501
PRIVATE EQUITY & OWNERSHIP
City Tokyo
State Tokyo
Country Japan
Website www.shinseibank.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
French financial services group. The company offers
services including traditional banking, corporate and
institutional banking, private equity, wealth management and
asset management. It also undertakes services business
and receivable management business. It primarily operates
in France, the EU, Canada, OCED countries and the US.
Business description
The company is headquartered in Paris, France, and it
employs about 13,000 people.The company recorded
revenues of E3,091 million during the fiscal year ended
December 2005, an increase of 14.2% over 2004. The
operating profit of the company was E1,034 million during
fiscal year 2005, an increase of 22.8% over 2004. The net
profit was E695 million in fiscal year 2005, an increase of
42.4% over 2004.
502
PRIVATE EQUITY & OWNERSHIP
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
City Panaji
State Goa
Country India
Website www.vedantalimited.com
503
PRIVATE EQUITY & OWNERSHIP
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Address 260 Long Ridge Road
City Stamford
State Connecticut
Website www.ge.com/en/
Financial Services
Industry
Financial Services-->Cards-->Card Issuance
Financial Services-->Retail Banking and Lending
107
504
PRIVATE EQUITY & OWNERSHIP
City London
Website www.standardchartered.com
Ticker symbol MS
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services
Financial Services-->Private Equity and Venture Capital
Financial Services-->Institutional Investment Management--
>Hedge Funds
Financial Services-->Institutional Investment Management
Financial Services-->Private Equity and Venture Capital
Financial Services-->Capital Markets and Trading
Financial Services-->Capital Markets and Trading-->Bond
Markets
Financial Services-->Capital Markets and Trading--
>Brokerage
Financial Services-->Capital Markets and Trading-->Clearing
and Settlement
Industry
Financial Services-->Capital Markets and Trading--
>Commodity Markets
Financial Services-->Capital Markets and Trading--
>Derivatives
Financial Services-->Capital Markets and Trading-->Equity
Markets
Financial Services-->Capital Markets and Trading--
>Exchanges
Financial Services-->Capital Markets and Trading-->Foreign
Exchange (FX)
Financial Services-->Capital Markets and Trading-->Money
Markets
Financial Services-->Retail Banking and Lending
Financial Services-->Financial Services Distributors
Financial Services-->Financial Services Distributors
108
505
PRIVATE EQUITY & OWNERSHIP
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Healthcare-->Healthcare
Information Technology
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
109
506
PRIVATE EQUITY & OWNERSHIP
Website www.morganstanley.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->Corporate and Investment Banking--
>Credit and Trade Finance
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
Financial Services-->Corporate and Investment Banking
Financial Services-->Corporate and Investment Banking--
>Wholesale Payments
Financial Services-->Retail Banking and Lending-->SME
Banking Services
Financial Services-->General Insurance, Property and
Industry Casualty
Financial Services-->Life and Pensions
Financial Services-->General Insurance, Property and
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and
Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
110
507
PRIVATE EQUITY & OWNERSHIP
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
State Maharashtra
Country India
Website www.hdfc.com
508
PRIVATE EQUITY & OWNERSHIP
Website www.blackstone.com
Industry Privateequity
Website www.gs.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Country United States
Website www.newbridgecapital.com
Website www.wlross.com
509
PRIVATE EQUITY & OWNERSHIP
Country India
Website www.pnbindia.in
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
across all sub-sectors of the financial services industry. It
focuses on investment in banks, insurance and re-insurance
firms, asset management and brokerage houses, credit card
companies, consumer finance businesses, mortgage firms,
Business description
non-banking financial services and stock exchanges. With
investments worth US$15 billion, including co-investment, in
45 portfolio companies across 16 countries, JCF seeks to
invest in North America, Asia, Western Europe and the US.
The company operates an additional office in London, the
UK. JCF is headquartered in New York, the US.
Website www.jcfco.com
Advisor information
113
510
PRIVATE EQUITY & OWNERSHIP
Financial advisors
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
114
511
PRIVATE EQUITY & OWNERSHIP
Deal Report: IFCI terminates 26% stake sale to Infrastructure Development Finance
Company
Deal in brief
IFCI Limited, a provider of long-term finance, project finance, non-project specific assistance, and
corporate advisory services, has decided not to sell its 26% stake to Infrastructure Development Finance
Company Limited, a specialized infrastructure finance company.
IFCI has also completely stalled the sale process, in which General Electric Capital Corporation; Kotak
Mahindra Bank, Ltd.; a consortium of Sterlite Industries (India), Ltd. and Morgan Stanley & Co.; Natixis;
Newbridge Asia IV, L.P; Cargill Financial Services Corporation; Shinsei Bank, Punjab National Bank and
J.C. Flowers & Co.; The Blackstone Group L.P.; and a consortium of WL Ross & Co. LLC, GS Capital
Partners VI Fund, Standard Chartered Bank, and Housing Development Finance Corporation, Ltd. were
interested.
Acquired % 26
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal financials
EV/Revenues 6.64
EV/EBITDA 10.91
512
PRIVATE EQUITY & OWNERSHIP
Key ratios
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
group operates in India, where it is headquartered in Mumbai
and employs around 225 people.
Financial Services
Industry
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
Country India
Website www.idfc.com
116
513
PRIVATE EQUITY & OWNERSHIP
Deal in brief
IFCI Limited, a provider of long-term finance, project finance, non-project specific assistance, and
corporate advisory services, has decided not to sell its 26% stake to The Blackstone Group L.P., a private
equity firm.
IFCI has also completely stalled its stake sale process, in which General Electric Capital Corporation;
Kotak Mahindra Bank, Ltd.; a consortium of Sterlite Industries (India), Ltd. and Morgan Stanley & Co.;
Infrastructure Development Finance Company, Ltd.; Newbridge Asia IV, L.P; Cargill Financial Services
Corporation; Shinsei Bank, Punjab National Bank and J.C. Flowers & Co.; Natixis; and a consortium of WL
Ross & Co. LLC, GS Capital Partners VI Fund, Standard Chartered Bank, and Housing Development
Finance Corporation, Ltd. were interested.
Acquired % 26
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal financials
EV/Revenues 6.64
EV/EBITDA 10.91
117
514
PRIVATE EQUITY & OWNERSHIP
Key ratios
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Address 345 Park Avenue, New York City
Website www.blackstone.com
118
515
PRIVATE EQUITY & OWNERSHIP
Deal Report: IFCI terminates 26% stake sale to Standard Chartered Bank consortium
Deal in brief
IFCI Limited, a provider of long-term finance, project finance, non-project specific assistance, and
corporate advisory services, has decided not to sell its 26% stake to the consortium of WL Ross & Co.
LLC, GS Capital Partners VI Fund, Standard Chartered Bank, and Housing Development Finance
Corporation, Ltd.
IFCI has also completely stalled its stake sale process, in which General Electric Capital Corporation;
Kotak Mahindra Bank, Ltd.; a consortium of Sterlite Industries (India), Ltd. and Morgan Stanley & Co.;
Infrastructure Development Finance Company, Ltd.; Newbridge Asia IV, L.P; Cargill Financial Services
Corporation; Shinsei Bank, Punjab National Bank, and J.C. Flowers & Co.; The Blackstone Group L.P.;
and Natixis were interested.
Acquired % 26
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Date of termination Dec 19, 2007
Deal financials
EV/Revenues 6.64
EV/EBITDA 10.91
516
PRIVATE EQUITY & OWNERSHIP
Key ratios
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
small and medium enterprise (SME) banking, corporate
banking, and fund management services.
Financial Services
Financial Services-->Cards-->Card Issuance
Financial Services-->Retail Banking and Lending
Industry
Financial Services-->Retail Banking and Lending
Financial Services-->Institutional Investment Management
Financial Services-->Wealth Management and Private
Banking
City London
Website www.standardchartered.com
517
PRIVATE EQUITY & OWNERSHIP
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Group Accident and
Industry Health
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance-->Property
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Motor
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance-->Property
Financial Services-->Retail Banking and Lending
Financial Services-->Payments-->New Payment
Technologies
Financial Services-->Payments-->Cash
Financial Services-->Payments-->Cheque
Financial Services-->Payments-->Direct Debit
Financial Services-->Retail Banking and Lending
Financial Services-->Retail Banking and Lending-->Current
Accounts
Financial Services-->General Insurance, Property and
Casualty-->Personal Insurance
Financial Services-->Retail Banking and Lending--
>Consumer Lending
Financial Services-->Retail Banking and Lending--
>Mortgage Lending
Financial Services-->Retail Banking and Lending--
121
518
PRIVATE EQUITY & OWNERSHIP
State Maharashtra
Country India
Website www.hdfc.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Industry Privateequity
Website www.gs.com
519
PRIVATE EQUITY & OWNERSHIP
Website www.wlross.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
123
520
PRIVATE EQUITY & OWNERSHIP
Deal Report: IFCI terminates 26% stake sale to General Electric Capital
Deal in brief
IFCI Limited, a provider of long-term finance, project finance, non-project specific assistance, and
corporate advisory services, has decided not to sell its 26% stake to General Electric Capital Corporation,
a financial services company.
IFCI has also completely stalled its stake sale process, in which Kotak Mahindra Bank, Ltd.; a consortium
of Sterlite Industries (India), Ltd. and Morgan Stanley & Co.; Infrastructure Development Finance
Company, Ltd.; Natixis; Newbridge Asia IV, L.P; Cargill Financial Services Corporation; Shinsei Bank,
Punjab National Bank and J.C. Flowers & Co.; The Blackstone Group L.P.; and a consortium of WL Ross
& Co. LLC, GS Capital Partners VI Fund, Standard Chartered Bank, and Housing Development Finance
Corporation, Ltd. were interested.
Acquired % 26
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal financials
EV/Revenues 6.64
EV/EBITDA 10.91
124
521
PRIVATE EQUITY & OWNERSHIP
Key ratios
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
These assets include industrial-related facilities and
equipment; commercial and residential real estate; vehicles;
corporate aircraft; and equipment used in many industries,
including the construction, manufacturing, transportation,
Business description telecommunications, and healthcare industries. GE Money is
a provider of financial services to consumers and retailers. It
offers a range of financial products, including private-label
credit cards; personal loans; bank cards; auto loans and
leases; mortgages; debt consolidation; home equity loans;
corporate travel and purchasing cards; deposit and other
savings products; small and medium enterprise lending; and
credit insurance on a global basis. GE Infrastructure is a
provider of essential technologies to developed, developing,
and emerging countries, with products and services in
aviation, energy, oil and gas, transportation, and water and
process technologies. GE Infrastructure also provides
aviation financing as well as energy and water investing,
lending, and leasing.
522
PRIVATE EQUITY & OWNERSHIP
Casualty
Financial Services-->General Insurance, Property and
Casualty-->Commercial Insurance
Financial Services-->Retail Banking and Lending--
>Consumer Lending
Financial Services-->Retail Banking and Lending--
>Mortgage Lending
Financial Services-->Institutional Investment Management
City Stamford
State Connecticut
Website www.ge.com/en/
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
126
523
PRIVATE EQUITY & OWNERSHIP
Deal Report: IFCI terminates 26% stake sale to Kotak Mahindra Bank
Deal in brief
IFCI Limited, a provider of long-term finance, project finance, non-project specific assistance, and
corporate advisory services, has decided not to sell its 26% stake to Kotak Mahindra Bank Limited, a
financial conglomerate.
IFCI has also completely stalled its stake sale process, in which General Electric Capital Corporation; a
consortium of Sterlite Industries (India), Ltd. and Morgan Stanley & Co.; Infrastructure Development
Finance Company, Ltd.; Natixis; Newbridge Asia IV, L.P; Cargill Financial Services Corporation; Shinsei
Bank, Punjab National Bank and J.C. Flowers & Co.; The Blackstone Group L.P.; and a consortium of WL
Ross & Co. LLC, GS Capital Partners VI Fund, Standard Chartered Bank, and Housing Development
Finance Corporation, Ltd. were interested.
Acquired % 26
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal financials
EV/Revenues 6.64
EV/EBITDA 10.91
127
524
PRIVATE EQUITY & OWNERSHIP
Key ratios
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
India, the UK, the US, Mauritius, the UAE and Singapore. It
is headquartered in Mumbai, India.
Country India
Website www.kotak.com
128
525
PRIVATE EQUITY & OWNERSHIP
Deal Report: IFCI terminates 26% stake sale to Sterlite Industries and Morgan Stanley
Deal in brief
IFCI Limited, a provider of long-term finance, project finance, non-project specific assistance, and
corporate advisory services, has decided not to sell its 26% stake to a consortium of Sterlite Industries
(India), Ltd., a copper producer, and Morgan Stanley & Co, a financial services company.
General Electric Capital Corporation; Kotak Mahindra Bank, Ltd.; Infrastructure Development Finance
Company Limited; Natixis; Newbridge Asia IV, L.P; Cargill Financial Services Corporation; Shinsei Bank,
Punjab National Bank and J.C. Flowers & Co.; The Blackstone Group L.P.; and a consortium of WL Ross
& Co. LLC, GS Capital Partners VI Fund, Standard Chartered Bank, and Housing Development Finance
Corporation, Ltd. were also in the race to acquire the stake in the company.
Acquired % 26
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal financials
EV/Revenues 6.64
EV/EBITDA 10.91
526
PRIVATE EQUITY & OWNERSHIP
Key ratios
Ticker symbol MS
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Americas, Europe, Asia Pacific, the Middle East and Africa.
It is headquartered in New York City, New York, and
employed 56,218 people as on December 31, 2015.
527
PRIVATE EQUITY & OWNERSHIP
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Scientific and Technical Instruments
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Patient Monitoring Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Respiratory and Anesthesia Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->CNS and Neurological Devices
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Diagnostic Devices and Imaging
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Endoscopy
Pharmaceuticals and Healthcare-->Medical Devices and
Diagnostics-->Surgical and Medical Equipment
Pharmaceuticals and Healthcare-->Medical Devices and
131
528
PRIVATE EQUITY & OWNERSHIP
Website www.morganstanley.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
and Liberia. Vedanta is a subsidiary of Vedanta Resources
plc, and headquartered in Panaji, Goa, India.
City Panaji
State Goa
Country India
132
529
PRIVATE EQUITY & OWNERSHIP
Website www.vedantalimited.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
133
530
PRIVATE EQUITY & OWNERSHIP
Deal in brief
IFCI Limited, a provider of long-term finance, project finance, non-project specific assistance, and
corporate advisory services, has decided not to sell its 26% stake to Natixis, a provider of banking and
related services.
IFCI has also completely stalled its stake sale process, in which General Electric Capital Corporation;
Kotak Mahindra Bank, Ltd.; a consortium of Sterlite Industries (India), Ltd. and Morgan Stanley & Co.;
Infrastructure Development Finance Company, Ltd.; Newbridge Asia IV, L.P; Cargill Financial Services
Corporation; Shinsei Bank, Punjab National Bank and J.C. Flowers & Co.; The Blackstone Group L.P.; and
a consortium of WL Ross & Co. LLC, GS Capital Partners VI Fund, Standard Chartered Bank, and
Housing Development Finance Corporation, Ltd. were interested.
Acquired % 26
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal financials
EV/Revenues 6.64
EV/EBITDA 10.91
134
531
PRIVATE EQUITY & OWNERSHIP
Key ratios
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
employs about 13,000 people.The company recorded
revenues of E3,091 million during the fiscal year ended
December 2005, an increase of 14.2% over 2004. The
operating profit of the company was E1,034 million during
fiscal year 2005, an increase of 22.8% over 2004. The net
profit was E695 million in fiscal year 2005, an increase of
42.4% over 2004.
135
532
PRIVATE EQUITY & OWNERSHIP
Deal in brief
Newbridge Asia IV, L.P., a buy-out fund, has withdrawn its bid to acquire a 26% stake in IFCI Limited, a
provider of long-term finance to the industrial sector. The bid has been withdrawn due to the changes in
circumstances.
The other bidders interested in the stake include: General Electric Capital Corporation; Kotak Mahindra
Bank, Ltd.; a consortium of Sterlite Industries (India), Ltd. and Morgan Stanley & Co.; Infrastructure
Development Finance Company, Ltd.; The Blackstone Group L.P; Cargill Financial Services Corporation;
a consortium of Shinsei Bank, Ltd., Punjab National Bank and J.C. Flowers & Co. LLC; Natixis; and a
consortium of WL Ross & Co. LLC, GS Capital Partners VI Fund, Standard Chartered Bank, and Housing
Development Finance Corporation, Ltd.
Acquired % 26
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Deal financials
EV/Revenues 6.64
EV/EBITDA 10.91
136
533
PRIVATE EQUITY & OWNERSHIP
Key ratios
Website www.newbridgecapital.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
137
534
PRIVATE EQUITY & OWNERSHIP
Deal Report: IFCI terminates 26% stake sale to Shinsei Bank, Punjab National Bank and
J.C. Flowers
Deal in brief
IFCI Limited, a provider of long-term finance, project finance, non-project specific assistance, and
corporate advisory services, has decided not to sell its 26% stake to the consortium of Shinsei Bank,
Punjab National Bank and J.C. Flowers & Co.
IFCI has also completely stalled its stake sale process, in which General Electric Capital Corporation;
Kotak Mahindra Bank, Ltd.; a consortium of Sterlite Industries (India), Ltd. and Morgan Stanley & Co.;
Infrastructure Development Finance Company, Ltd.; Newbridge Asia IV, L.P; Cargill Financial Services
Corporation; The Blackstone Group L.P.; Natixis; and a consortium of WL Ross & Co. LLC, GS Capital
Partners VI Fund, Standard Chartered Bank, and Housing Development Finance Corporation, Ltd. were
interested.
Acquired % 26
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Date of announcement Sep 17, 2007
Deal financials
EV/Revenues 6.64
EV/EBITDA 10.91
535
PRIVATE EQUITY & OWNERSHIP
Key ratios
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Shinsei Bank, Limited (Shinsei Bank) is a financial institution.
The bank offers commercial banking and various financial
services. Its financial products and services include deposit
products, corporate loans, consumer and business loans,
credit cards, insurance services, credit guarantees, leasing
services, mergers and acquisition services, securities trading
services, real estate services, foreign exchange and
Business description
derivatives services. It also provides financing, leasing and
rentals, and alliance services to small and medium
businesses. The bank provides various services related to
foreign exchange, derivatives, equity trading, and other
capital markets transactions. The bank operates through a
network of offices in Japan. Shinsei Bank is headquartered
in Tokyo, Japan.
Financial Services
Financial Services-->Capital Markets and Trading-->Foreign
Exchange (FX)
Financial Services-->Cards-->Card Issuance-->Credit Cards
Financial Services-->Corporate and Investment Banking--
Industry >Mergers and Acquisitions (M&A)
Financial Services-->Corporate and Investment Banking--
>Project, Asset and Structured Finance
Financial Services-->Financial Services Distributors--
>Insurance Brokers and Intermediaries
Financial Services-->Corporate and Investment Banking--
>Mergers and Acquisitions (M&A) 139
536
PRIVATE EQUITY & OWNERSHIP
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Services-->Savings and Investments
Energy and Utilities-->Utilities-->Power Generation-->Fossil
Fuels
City Tokyo
State Tokyo
Country Japan
Website www.shinseibank.com
537
PRIVATE EQUITY & OWNERSHIP
Country India
Website www.pnbindia.in
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
invest in North America, Asia, Western Europe and the US.
The company operates an additional office in London, the
UK. JCF is headquartered in New York, the US.
Website www.jcfco.com
141
538
APPENDIX
APPENDIX
Contact Us
We hope that the data and analysis in this profile will help you make informed and imaginative
business decisions. If you have further requirements feedback please contact us at
assistme@marketline.com.
For further information on MarketLine and our range of business information services please visit
www.marketline.com
• Financial Deals is the most extensive Deals database currently available in the market
• The database provides research and analysis on all types of financial deals including:
– merger and acquisition
– private equity backed buyout and investment
– venture capital investment
– initial public offering (IPO)
– secondary offering
– private placement
– partnership deal
• The database is a ‘live’ database and is updated real-time with Deal information
• Database contains more than 250,000 Deal records across all industries
• Every year over 48,000 Deals are added to the database
• The database contains active details of more than 5,000 Advisors and 12,000 Advisor
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
executives
• 200,000 + companies; 10,000 + VC/ PE firms
• Five year archive of key companies across eight sectors; complete eight year archive of
healthcare companies
• Complete portfolio of top 50 venture firms
• What we offer
– detailed deal transaction data;
– sector/market specific analytical deal reports with analyst opinion;
– customized research and analysis.
• Coverage
– global coverage across all industries through a combination of secondary and primary
research;
– multi-lingual analyst capability ensures strong coverage from regional markets;
– track over 14,000 sources every day.
–
• Content
– detailed deal information with over 50 fields covering all of the key information required
to understand a deal comprehensively;
– detailed advisory information, financial information, deal multiple, deal rationale, and
information related to business operations in addition to basic fields;
– Value addition through a wide network of contacts with top advisors, law firms,
investment banks, and industry experts.
142
539
APPENDIX
• Want to know more? – Should you have any queries, send us an email at
reachus@marketline.com
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
143
540
APPENDIX
Merger
A deal will be classified as Merger when two or more companies combine to form one company.
An amalgamation in the nature of merger is an amalgamation which satisfies all the following
conditions:
All the assets and liabilities of the transferor company become, after amalgamation, the
assets and liabilities of the transferee company.
Shareholders holding not less than 90% of the face value of the equity shares of the
transferor company (other than the equity shares already held therein, immediately before
the amalgamation, by the transferee company or its subsidiaries or their nominees) become
equity shareholders of the transferee company by virtue of amalgamation.
The consideration for the amalgamation receivable by those equity shareholders of the
transferor company who agree to become equity shareholders of the transferee company is
discharged by the transferee company wholly by the issue of equity shares in the transferee
company, except that cash may be paid in respect of any fractional shares.
The business of the transferor company is intended to be carried on, after the amalgamation,
by the transferee company.
No adjustment is intended to be made to the book values of the assets and liabilities of the
transferor company when they are incorporated in the financial statements of the transferee
company except to ensure uniformity of accounting policies.
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Acquisition
Transactions where a company acquires equity stake in another company. The following are the
different sub-categories under acquisition:
Minority acquisition: The acquisition of less than 50% equity stake in the target
Majority acquisition: The acquisition of 50% or more than 50% and less than 100% equity
stake in the target
100% acquisition: The acquisition of all of the issued capital or 100% of the issued share
capital of the target
Asset Purchase: The acquisition of a business unit or an asset which is a not a legal entity
Private equity
Private equity transactions capture equity investment / buyout by a private equity (PE) firm. The
following are the different sub-categories under private equity:
Institutional buyout: PE firm or a group of PE firms acquiring a company from non-PE firms
or another company
541
APPENDIX
Management buyout (MBO): The management of the target acquires the target with the
backing of a PE firm will back the management in the buyout by providing the necessary
funds
Management buy-in (MBI): A manager or a management team from outside the target
company (target) raises the necessary finance, buys the target and becomes the target's
new management. The necessary financing is provided by private equity firms.
Buy-In Management buyout (BIMBO): A BIMBO is a combination of MBO and MBI, where
an external group of managers buy into the business and joins forces with the internal
management team
Going Private: A public listed company being acquired by PE firms or with the management
and is de-listed form the stock exchange on which it was listed
Private placement
A private placement is a direct private offering of securities by the issuer to a limited number of
investors. Private placement is a primary market transaction.
Venture financing
Investments made in a start-up or young company by a venture capital or private equity firm in the
primary market (i.e. the target company is issuing new shares and receiving the proceeds directly).
The following are the different sub-categories under venture financing:
Seed: Financing provided for companies which have still not started marketing their product
or services. The purpose of such funding will generally be to assess and develop an initial
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
business concept
Growth/Expansion: Financing provided for companies to increase their sales, marketing, and
production operations, which have developed and started marketing their products
Late stage: Financing provided for companies which have already established themselves in
the market and are looking for expanding their production capacities
Exit: This node is assigned when a venture capital is selling its stake in a portfolio company
Initial public offering (IPO) occurs when a company first sells its shares to the public. The
following are the different stages under initial public offering:
Filing: When a company announces its plans to go for an IPO or files the prospectus with the
concerned regulator about the IPO
Pricing: When the company fixes the issue price for its offering
145
542
APPENDIX
Secondary offering: When a public listed company’s existing shareholders are offering their
shares to general public or a public listed company itself is making a follow-on public offering
Partnership
A partnership is the relationship existing between two or more entities that join to carry on a trade or
business. The following are the different sub-categories under partnership:
Joint Venture (JV): Two or more companies forming a new entity to undertake an activity
Co-marketing: Two or more companies coming together to collaborate either for product
development, distribution, or for providing services. In a broader sense any alliance related
to products and / or services where products or service of one company are marketed jointly
with product or services of another company is tagged as co-marketing alliance. Agreements
with a distribution company are not considered as Co-Marketing.
Affinity marketing: An agreement by which one company is getting access to the customer
base of another for selling its products and the company which is providing access to its
customer base is not involved in the product/service development or any other obligations
relating to such product/service
Licensing agreement: An agreement in which one party gives the rights to another party to
use its technology, intellectual property, and brands. Financial Deals does not capture
licensing deal related to software.
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Financial Deals captures deal status according to following stages:
Rumor: Neither of the parties involved in the transaction announces the deal but has been
reported by media/market sources
Announced: Either party involved in the transaction announces the deal
Completed: Involved parties complete the transaction
Terminated: Involved parties do not intend to complete the earlier announced transaction
and either terminates the agreement or withdraws the bid
Dead rumor: Rumor denied by either of the parties involved in the transaction
Deal value
Deal value is the consideration paid by the acquirer for acquiring the target.
Financial Deals uses a deal value estimation model (for cases where deal value is not available
through secondary and primary sources), which is based on comparables. The estimation model
analyzes deal values based on market capitalization of the target company on the day prior to the
announcement. In addition, it also includes approximation derived through inputs from advisors
involved in the deal, approximate enterprise value, gross consideration and share price and number
of shares.
All deals values which are mentioned as approximate consideration are tagged as estimated values.
543
APPENDIX
For M&A, private equity, IPO and private placement, FD focuses on transactions where deal value is
more than or equal to $5 million. For venture investment and partnership, FD captures all deals.
Payment type: Payment type indicates the mode by which the purchase consideration has been
paid to the vendor. It includes the following sub-categories:
Cash: It indicates the amount paid in cash (either in %age or absolute value) by the acquirer
Debt: It indicates the amount of debt (either in %age or absolute value) of the target
assumed by the acquirer
Shares: It indicates the amount of shares (either in %age or absolute value) issued by the
acquirer
Quantity type: It indicates the consideration by payment mode in terms of value and
percentage
Share price paid: Price per share offered by the acquirer to the target
Debt-related fields
Below is the list of fields captured:
Debt provider: Field ‘provider type’ indicates the type of debt provider. It includes the following sub-
categories:
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Lead: Represents the lead debt provide
Syndicate: Represents group of lenders that are collectively lending or offering the debt to
the acquirers
Debt amount: Amount of debt raised by the acquirer to finance the acquisition
Debt category: It represents the nature of the debt that has been used by the acquirer in financing
the acquisition. It includes the following categories:
Mezzanine: Debt that incorporates equity-based options such as warrants with a lower-
priority debt. Mezzanine debt is often used to finance acquisitions and buyouts, where it can
be used to prioritize new owners ahead of existing owners in the event of bankruptcy.
Second lien: Debts that are subordinate to the rights of other, more senior debts issued
against the same collateral, or a portion of the same collateral. If a borrower defaults, second
lien debts stand behind higher lien debts in terms of rights to collect proceeds from the
debt's underlying collateral.
Other debt: Any other debt facility other than the above mentioned debt categories.
147
544
APPENDIX
Capital increase type: It is the type of debt or equity securities issued by the acquirer to raise the
necessary funds to finance the transaction. It includes the following options:
Converted debt: Converted debt is a debt security which can be exchanged for a specified
amount of another, related security, usually shares of stock in the issuing company, at the
option of the issuer and/or the holder
Convertible bond: A convertible bond is a type of debt instrument that can be converted
into shares of stock in the issuing company, usually at some pre-announced ratio
Convertible loan: A convertible loan is a loan issued by companies that can be converted
into ordinary shares or preference shares at a given price at a future date
Open offer: Indicates the manner in which the company raised money by offering its shares
to the public (public offering)
Placing: General term to describe the process of raising money via the issue of new shares
Private placing: Private placing is a process of raising money by the issue of new shares to
institutions and private clients rather than to the general public
Rights issue: Rights issue is the process of raising money by issuing rights to a company's
existing shareholders to buy a proportional number of additional securities at a given price
within a fixed period
Scrip issue: A scrip issue (also called a capitalization issue or a bonus issue) is the issue of
new shares to existing shareholders at no charge, on a pro-rata basis to their existing
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
shareholdings
Vendor placing: A method of using shares to fund an acquisition by allotting shares from
the purchaser to the vendor in exchange for shares in the target (or other assets). The
consideration shares are then placed on behalf of the vendor by the purchaser’s bank so
that the vendor receives cash (the proceeds of sale of shares by the purchaser’s bank).
Financial Deals captures all the key financial items from income statement, balance sheet including
key ratios and valuation multiples, which help in providing a detailed understanding of the deal. The
financial information is captured for target companies. All the financial fields are presented in local
currency as well as US Dollar. In addition to financial fields, Financial Deals also captures certain
operational parameters. Below is a list of key fields along with their definitions:
Fiscal year end: Refers to the fiscal year (or financial year or accounting reference date), a 12-
month period used for calculating annual (yearly) financial statements. All the financial fields in
MarketLine Financial Deals database are captured according to the fiscal year-end values.
148
545
APPENDIX
Revenue (non banking): Revenue is the amount of money that a company receives from its
activities in a given period, primarily from sales of products and/or services to customers
Revenue (banking): This value is sum of interest income and non interest income
Operating profit: Operating profit is the earnings before deduction of interest payments and income
taxes; also called EBIT (earnings before interest and taxes) or operating income. For banking
companies interest payments are not deducted.
Post tax profit: Post tax profit is the amount of earnings that is available after deducting the taxes,
also known as profit after tax
Operating margin: This value measures the percent of revenues remaining after paying all
operating expenses. It is calculated as annual operating income divided by annual total revenue,
multiplied by 100.
Shares issued: Number of shares the company has issued out of its authorized capital
Outstanding shares: It represents stock currently held by investors, including restricted shares
owned by the company's officers and insiders, as well as those held by the public. It is also defined
as the difference between shares in issue and treasury shares as of the fiscal year end.
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Net assets: Net assets are the difference between the total asset and liabilities that has to be paid to
third parties. It is also known as net worth
Net assets-share ratio: It is defined as net assets divided by number of shares outstanding
Earning per share: Earnings per share (EPS) is calculated by dividing a company's net income by
the outstanding shares
Price earning ratio (P/E): The P/E ratio (price-to-earnings ratio) of a stock (also called its ‘earnings
multiple’, or simply multiple, P/E, or PE) is a measure of the price paid for a share relative to the
income or profit earned by the company per share. P/E ratio is arrived by dividing share price at the
end of the fiscal year with net income per share.
Deal multiples
149
546
APPENDIX
Advisor information
Financial Deals captures detailed advisor information including financial advisor, legal advisor,
placement agent, and public relation (PR) advisors along with respective executives involved in the
deal. The following are the different types of advisors:
Legal advisor: Legal advisors are those who look into the legal matters of a company for that
particular deal.
Financial advisor: Financial advisors are those who look into the financial matters of a company for
that particular deal. Financial advisor is separated into the following types:
Financial due diligence: The process of investigation, performed by investors, into the details
of a potential investment, such as examination of operations and management and
verification of material facts
Accounting: Financial advisor who looks into the accounting matters for a deal
Tax: Financial advisor who looks into the tax matters for a deal
Corporate Finance: Financial advisor who looks into the financial decisions of a corporation
Book runners: Book runner is the managing or lead underwriter who maintains the books of
securities sold for a new issue
Underwriters: A company or other entity that administers the public issuance and distribution
of securities from a corporation or other issuing body
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Brokers: An individual or firm that charges a fee or commission for executing buy and sell
orders submitted
Others: All other financial advisors not falling in the above-mentioned categories are tagged
as other
Placement agent: A company that specializes in finding institutional investors who are willing and
able to invest primarily in unregistered securities
Public Relations (PR) advisor: An entity that advises a company or manages its communication
activities with its stakeholders
150
547
APPENDIX
About MarketLine
In an information-rich world, finding facts you can rely upon isn’t always easy. MarketLine is the
solution.
At MarketLine, we deliver accurate, up-to-date information on 300 industries and 150 countries as
well as detailed profiles of over 2,500 companies. By taking the chore out of business research,
MarketLine gives you more time to focus on what really matters.
Profiling all major companies, industries and geographies, MarketLine is one of the most prolific
publishers of business information today.
Our content is produced by an internal team of analysts, drawing on primary and secondary research
and prepared under an established methodology that’s been tried and tested over 10 years.
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
151
548
APPENDIX
IFCI Limited– Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments -2018
Sprinkler
Harvester
Drip irrigation
Tractor
Power tiller
wheelers is 89%, 56% and 38%, respectively. 80% of households earn
system
<Rs11,000 per month, whereas income rises dramatically for the top
20%, with the 99th percentile at Rs48,833, indicating wide inequalities.
Source: NABARD, IIFL Research
IIFL comment: Punjab, Haryana, Kerala rank at the top
Consumption Figure 18: Average monthly income and consumption expenditure (Rs/month)
Category Income Consumption Expenditure
Agricultural Households 8,931 7,152
Figure 16: Monthly Per Capita Consumption Expenditure, percentiles (Rs)
Non‐Agricultural Households 7,269 6,187
5615 All Households 8,059 6,646
Source: NABARD, IIFL Research
IIFL comment: Agricultural HHs fare a little better than non‐agricultural HHs
Figure 19: Average monthly income and consumption expenditure per HH, by decile (Rs)
2945
Decile Class of Non‐Agricultural
Agricultural Households All Households
2238 MPCE Households
1856
1587 Consumption Consumption Consumption
1185 1375 Income Income Income
997 Expenditure Expenditure Expenditure
765
517 Overall 8,931 7,152 7,269 6,187 8,059 6,646
1 1,293 2,465 793 1,899 1,019 2,156
0 10 20 30 40 50 60 70 80 90 100 2 3,033 3,591 2,498 3,008 2,753 3,286
Source: NABARD, IIFL Research 3 4,963 4,793 3,800 4,173 4,330 4,456
IIFL comment: Sharp jump in monthly consumption expenditure for the top decile 4 5,970 5,711 4,728 4,841 5,342 5,271
5 7,475 6,596 6,231 5,558 6,881 6,101
Figure 17:Expenditure split between food/non‐food items, by size of land holding 6 9,856 7,118 7,011 6,246 8,484 6,697
Expenditure on food items Expenditure on non‐food items 7 9,781 7,584 7,836 6,500 8,817 7,047
100% 8 12,012 8,847 9,169 7,305 10,449 7,999
9 13,702 10,333 10,633 8,716 11,981 9,426
80% 49% 46% 47% 49% 49% 52% 10 22,269 15,134 19,175 13,149 20,548 14,030
60% Source: NABARD, IIFL Research; Note: MPCE = Monthly Per Capita Consumption Expenditure
IIFL comment: Agricultural HHs fare a little better than non‐agricultural HHs across income deciles
40%
51% 54% 53% 51% 51% 48%
20%
0%
combined
0.01‐0.40
0.41‐1.00
1.01‐2.00
<0.01 ha
>2.00 ha
All sizes
ha
ha
ha
Source: NABARD, IIFL Research
IIFL comment: Higher income HHs spend a smaller % of income on food items
Figure 22: Average savings per agricultural HH in the last 1 year 1.01‐2.00 ha
Base Saver
Size Class of
Agricultural Base All Agricultural Households 0.41‐1.00 ha
Land Possessed
Households
All Institutional All Institutional % Share of 0.01‐0.40 ha
Agencies Agencies Agencies Agencies Institutional Savings in
<0.01 ha
(Rs) (Rs) (Rs) (Rs) Total Amount Saved
<0.01 ha 14,547 14,447 7,893 7,840 99
All size classes
0.01‐0.40 ha 12,941 12,349 7,658 7,307 95
0.41‐1.00 ha 14,121 13,219 7,795 7,297 94 0% 5% 10% 15% 20%
1.01‐2.00 ha 22,430 21,150 11,836 11,160 94
Source: NABARD, IIFL Research
>2.00 ha 31,831 30,188 15,984 15,159 95
All Size Classes 17,488 16,576 9,657 9,153 95
Source: NABARD, IIFL Research
Figure 25: Proportion of HHs investing in various kinds of assets (%) Figure 28: % of investor households by source of funds for investments >Rs10,000
Agricultural Non‐Agricultural All Agricultural Non‐Agricultural All
Indicator Indicator
Households Households Households Households Households Households
HHs that made any investment 10.4 8.7 9.5 Own Funds 40 47 43
HHs that invested in any Financial From institutional sources 38 36 37
3.6 1.5 2.5
Assets From non‐institutional sources 22 17 20
HHs that invested in any Physical TOTAL 100 100 100
8.7 7.5 8.1
Assets Source: NABARD, IIFL Research
HHs that invested in both Financial & IIFL comment: More than half of investments are financed via external sources
1.9 0.3 1.0
Physical Assets
Source: NABARD, IIFL Research Figure 29: % of agri HHs by source of funds for Investments <Rs10,000, by land size (ha)
IIFL comment: Physical assets are more commonly purchased than financial assets Indicator <0.01 0.01‐0.4 0.41‐1 1.01‐2 >2
Own Funds 43 31 40 45 37
Figure 26: Average investment reported in last one year by type of asset (Rs)
From institutional sources 30 37 34 34 45
Agricultural Non‐Agricultural All
Indicator From non‐institutional sources 27 32 26 21 18
Households Households Households
Source: NABARD, IIFL Research
All Assets 62,734 (100%) 58,131 (100%) 60,529 (100%) IIFL comment: Even at higher income levels, reliance on external financing remains
Financial Assets 15,731 (25%) 17,595 (30%) 16,624 (27%)
Physical Assets 47,004 (75%) 40,535 (70%) 43,905 (73%)
Source: NABARD, IIFL Research
Figure 27: Average investment reported in last one year by size of land possessed (ha)
All Size
Indicator <0.01 0.01‐0.40 0.41‐1.00 1.01‐2.00 >2.00
Classes
All Assets 41,068 32,054 42,647 77,511 115,448 62,734
Financial Assets 19,923 6,035 11,178 31,764 13,478 15,731
Physical Assets 21,145 26,020 31,469 45,747 101,969 47,004
Source: NABARD, IIFL Research
IIFL comment: Investment in financial assets does not increase with rise in income, whereas
investment in physical assets does
Indebtedness Figure 32: Average outstanding debt by MPCE decile (Rs per HH)
Non‐Agricultural
Agricultural Households All Households
Decile Households
Figure 30: Incidence of indebtedness1 by MPCE decile (%)
Class of Per Per Per
By Decile Class of Agricultural Non‐Agricultural All Per Per Per
MPCE Indebted Indebted Indebted
MPCE Households Households Households Household Household Household
Household Household Household
1 39.5 33.8 36.4
1 41,622 99,410 23,952 64,864 32,081 81,839
2 48.0 41.7 44.7 2 44,218 85,836 29,230 64,671 36,414 75,508
3 49.7 37.0 42.8 3 37,023 69,867 25,823 62,249 31,069 66,283
4 49.5 41.1 45.2
4 38,739 72,245 26,116 56,708 32,464 65,111
5 52.9 42.0 47.7
5 49,042 84,495 29,419 64,323 39,648 76,026
6 49.9 44.5 47.3
6 44,408 79,770 28,614 60,441 36,594 70,988
7 51.5 44.6 48.1 7 69,634 124,788 35,489 75,703 52,445 102,211
8 57.9 46.1 51.4 8 64,308 104,661 41,319 85,047 51,635 94,997
9 59.5 50.9 54.7
9 73,304 116,421 42,895 80,769 56,141 97,804
10 68.0 46.4 56.0
10 132,966 186,457 64,488 134,394 94,653 162,466
All Households 52.5 42.8 47.4 Overall 59,053 104,602 35,302 76,731 46,574 91,407
Source: NABARD, IIFL Research
Source: NABARD, IIFL Research
IIFL comment: Borrowings increase as income levels rise, indicating higher investment and better
access to credit
Figure 33: Breakdown of HHs by number of loans taken from Jul‐15 to Jun‐16 (%)
Figure 31: Incidence of indebtedness among agricultural households by size class of land Category No. of Loans Taken Total
possessed (%) One Loan Two Loans 3‐5 Loans
All size classes 53 Agricultural Households 83.2 13.4 3.4 100
<0.01 ha 49 Non‐Agricultural House‐ 85.3 13.2 1.5 100
0.01‐0.4 ha 48 All Households 84.2 13.3 2.5 100
0.41‐1 ha 52 Source: NABARD, IIFL Research
1.01‐2 ha 56 IIFL comment: >80% of HHs took only one loan
>2 ha 60
Source: NABARD, IIFL Research
IIFL comment: Same conclusion as in figure 30
1
Defined as % of HHs with any outstanding loan on the date of survey
Figure 34: Distribution of loans by source (% of borrowing HHs) Figure 36: Purpose of taking loans by borrowing households
Agricultural Non‐Agricultural All Purpose All HH
Agency
Households Households Households Sundry domestic needs 25%
Institutional Sources Housing 16%
Commercial Bank / RRB 46.2 26.4 36.6 Medical expenses 15%
SHG‐Bank Linked 10.6 14.4 12.4 Capex for agriculture 13%
SHG‐NBFC/MFI 9.2 13.5 11.3 Running expenses for non‐agri enterprises 11%
Co‐op. Society / Bank 6 5.3 5.7 Running expenses for agriculture 10%
Financial Company 1 1.7 1.3 Capex for non‐agriculture 9%
Finance Corporation 0.7 2.1 1.3 Education 5%
Provident Fund 0.5 0.2 0.3 Source: NABARD, IIFL Research
Insurance 0.3 0.2 0.2
Figure 37: Penetration of Kisan Credit Cards (KCC)
Non‐Institutional Sources
Land Size (ha) Proportion of Households having Valid KCC (%)
Relatives & Friends 22.7 26.8 24.7
Overall 10.5
Moneylenders 10.8 12.3 11.5
< 0.01 1.2
Landlord 6.1 4.3 5.2
0.01 ‐ 0.4 5.9
Doctors, Lawyers, etc. 0.1 0.1 0.1
0.41 ‐ 1 10.8
Input Supplier 0.1 0.1 0.1
Source: NABARD, IIFL Research 1.01 ‐ 2 14.1
IIFL comment: Agricultural HHs use banks for borrowing more often than non‐agricultural HHs > 2 23.8
Source: NABARD, IIFL Research
Figure 35: Average loan taken (Rs) IIFL comment: Higher‐income HHs have better access to credit, and hence naturally use KCCs more
frequently
Agricultural Non‐Agricultural All
Source of Loan
Households Households Households Figure 38: Usage of Kisan Credit Card (KCC) (Rs)
From all sources 107,083 (100%) 75,688 (100%) 91,852 (100%) Per Household
From institutional 77,473 (72%) 48,970 (65%) 63,645 (69%) Type of Household Average Sanctioned Average Amount % Limit Utilised
From non‐institutional 29,611 (28%) 26,718 (35%) 28,207 (31%) Limit Drawn
Source: NABARD, IIFL Research
All Agricultural Households 139,208 91,202 65.5
IIFL comment: Agricultural HHs use institutional sources more often
Agricultural households
owning more than 0.4 ha land 164,841 136,970 83.1
and who took loan
Source: NABARD, IIFL Research
Insurance Microfinance
Figure 39: Proportion of HHs with at least one member with insurance Figure 42: Proportion of HHs associated with Microfinance
Type of insurance All HH Agri HH Non‐agri HH HHs with any HHs with any
HHs with HHs with any
Any insurance 25% 26% 25% member member
membership in member
Life insurance 15% 17% 13% Categories associated with associated with
any Microfinance associated with
Joint Liability Livelihood
Accident insurance 2% 2% 2% Group Self Help Groups
Groups Groups
Health insurance 6% 5% 7%
All HH 22.7% 20.3% 1.6% 1.2%
Vehicle insurance 5% 5% 6%
Agricultural HH 23.6% 21.6% 1.3% 1.2%
Source: NABARD, IIFL Research
Non‐
21.9% 19.2% 1.9% 1.2%
Figure 40: Agricultural HHs having crop insurance and livestock insurance (%) Agricultural HH
Source: NABARD, IIFL Research
Size Class of Land Agricultural Households Agricultural Households Having
Possessed (Ha) Having Crop Insurance Livestock Insurance
Figure 43: Services availed from microfinance institutions (% of HHs)
< 0.01 ha 0.1 0.7
All Agricultural Non‐ agricultural
0.01 ‐ 0.4 ha 1.5 0.8 Service availed
Households Households households
0.41 ‐ 1 ha 5.1 1.0
Technical support/training for
1.01 ‐ 2 ha 10.8 1.2 20.1 18.7 21.5
any enterprise
> 2 ha 8.0 5.4 Physical inputs for pursuing
All Size Classes 6.9 1.7 14.6 15.5 13.7
any enterprise
Source: NABARD, IIFL Research Cash loans for promoting any
IIFL comment: Penetration of crop insurance is extremely low 26.5 26.6 26.5
enterprise
Cash loans for meeting
Figure 41: Reasons for not taking insurance 64.4 62.5 66.2
personal needs
Reason All HH Agri HH Non‐agri HH
Assistance in marketing of the
Lack of adequate funds 59.0% 66.8% 62.7% 3.3 3.9 2.6
products
Did not feel the need for any insurance 37.8% 31.5% 34.8% Any other type of support 0.3 0.3 0.2
No regular income 28.5% 32.3% 30.3% Source: NABARD, IIFL Research
Want to take, but do not know where to get it 2.5% 2.7% 2.6%
Lack of trust due to bad experience of some family
1.1% 1.8% 1.4%
in village
Other reasons 3.3% 2.4% 2.9%
Source: NABARD, IIFL Research
IIFL comment: The above responses are for HHs that did not have insurance, but are aware about its
availability
Figure 49: Use of various banking facilities in the last 3 months (% of respondents)
Service type
ATM services 23.6%
Mobile banking services 1.6%
Internet banking services 0.8%
Source: NABARD, IIFL Research
Figure 50: Comfort with various banking services (% of respondents)
Can use it
Type of Can use it with the Don’t know/
independently Afraid of/ not very
Banking help of any family refused to
without comfortable using it
Services member/ friend answer
anyone’s help
ATM/ Micro
73.4 22.3 1.8 2.5
ATM
Mobile Banking 39.1 55.5 1.7 3.7
Internet
51.8 35 2.3 10.9
Banking
Source: NABARD, IIFL Research
Figure 51: Use of various payment mechanisms in the last 3 months (% of respondents)
Mechanism %
Cheque 7.5%
Debit/credit card 7.4%
Money orders 0.6%
Source: NABARD, IIFL Research
Disclosure : Published in 2018, © IIFL Securities Limited (Formerly ‘India Infoline Limited’) 2018
India Infoline Group (hereinafter referred as IIFL) is engaged in diversified financial services business including equity broking, DP services, merchant banking, portfolio management services, distribution of Mutual Fund,
insurance products and other investment products and also loans and finance business. India Infoline Ltd (“hereinafter referred as IIL”) is a part of the IIFL and is a member of the National Stock Exchange of India Limited
(“NSE”) and the BSE Limited (“BSE”). IIL is also a Depository Participant registered with NSDL & CDSL, a SEBI registered merchant banker and a SEBI registered portfolio manager. IIL is a large broking house catering to
retail, HNI and institutional clients. It operates through its branches and authorised persons and sub-brokers spread across the country and the clients are provided online trading through internet and offline trading
through branches and Customer Care.
a) This research report (“Report”) is for the personal information of the authorized recipient(s) and is not for public distribution and should not be reproduced or redistributed to any other person or in any form without
IIL’s prior permission. The information provided in the Report is from publicly available data, which we believe, are reliable. While reasonable endeavors have been made to present reliable data in the Report so far as
it relates to current and historical information, but IIL does not guarantee the accuracy or completeness of the data in the Report. Accordingly, IIL or any of its connected persons including its directors or subsidiaries
or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained, views and opinions expressed in this
publication.
b) Past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regarding future performance. Information, opinions and
estimates contained in this report reflect a judgment of its original date of publication by IIFL and are subject to change without notice. The price, value of and income from any of the securities or financial
instruments mentioned in this report can fall as well as rise. The value of securities and financial instruments is subject to exchange rate fluctuation that may have a positive or adverse effect on the price or income of
such securities or financial instruments.
c) The Report also includes analysis and views of our research team. The Report is purely for information purposes and does not construe to be investment recommendation/advice or an offer or solicitation of an offer to
buy/sell any securities. The opinions expressed in the Report are our current opinions as of the date of the Report and may be subject to change from time to time without notice. IIL or any persons connected with it
do not accept any liability arising from the use of this document.
d) Investors should not solely rely on the information contained in this Report and must make investment decisions based on their own investment objectives, judgment, risk profile and financial position. The recipients
of this Report may take professional advice before acting on this information.
e) IIL has other business segments / divisions with independent research teams separated by 'Chinese walls' catering to different sets of customers having varying objectives, risk profiles, investment horizon, etc and
therefore, may at times have, different and contrary views on stocks, sectors and markets.
f) This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication,
availability or use would be contrary to local law, regulation or which would subject IIL and its affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may
not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this Report may come are required to inform themselves of and to observe such restrictions.
g) As IIL along with its associates, are engaged in various financial services business and so might have financial, business or other interests in other entities including the subject company(ies) mentioned in this Report.
However, IIL encourages independence in preparation of research report and strives to minimize conflict in preparation of research report. IIL and its associates did not receive any compensation or other benefits
from the subject company(ies) mentioned in the Report or from a third party in connection with preparation of the Report. Accordingly, IIL and its associates do not have any material conflict of interest at the time of
publication of this Report.
h) As IIL and its associates are engaged in various financial services business, it might have:-
(a) received any compensation (except in connection with the preparation of this Report) from the subject company in the past twelve months; (b) managed or co-managed public offering of securities for the subject
company in the past twelve months; (c) received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months; (d) received any
compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months; (e) engaged in market making activity for the
subject company.
i) IIL and its associates collectively do not own (in their proprietary position) 1% or more of the equity securities of the subject company mentioned in the report as of the last day of the month preceding the publication
of the research report.
j) The Research Analyst engaged in preparation of this Report or his/her relative:-
(a) does not have any financial interests in the subject company (ies) mentioned in this report; (b) does not own 1% or more of the equity securities of the subject company mentioned in the report as of the last day
of the month preceding the publication of the research report; (c) does not have any other material conflict of interest at the time of publication of the research report.
k) The Research Analyst engaged in preparation of this Report:-
(a) has not received any compensation from the subject company in the past twelve months; (b) has not managed or co-managed public offering of securities for the subject company in the past twelve months; (c)
has not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months; (d) has not received any compensation for products or
services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months; (e) has not received any compensation or other benefits from the subject
company or third party in connection with the research report; (f) has not served as an officer, director or employee of the subject company; (g) is not engaged in market making activity for the subject company.
L) IIFLCAP accepts responsibility for the contents of this research report, subject to the terms set out below, to the extent that it is delivered to a U.S. person other than a major U.S. institutional investor. The analyst
whose name appears in this research report is not registered or qualified as a research analyst with the Financial Industry Regulatory Authority (“FINRA”) and may not be an associated person of IIFLCAP and,
therefore, may not be subject to applicable restrictions under FINRA Rules on communications with a subject NABARD, public appearances and trading securities held by a research analyst account.
We submit that no material disciplinary action has been taken on IIL by any regulatory authority impacting Equity Research Analysis.
A graph of daily closing prices of securities is available at http://www.nseindia.com/ChartApp/install/charts/mainpage.jsp, www.bseindia.com and http://economictimes.indiatimes.com/markets/stocks/stock-quotes.
(Choose a company from the list on the browser and select the “three years” period in the price chart).
Name, Qualification and Certification of Research Analyst: Abhijit R. Akella, CFA (PGDM), Mohit Surana (PGDM)
IIFL Securities Limited (Formerly ‘India Infoline Limited’), CIN No.: U99999MH1996PLC132983, Corporate Office – IIFL Centre, Kamala City, Senapati Bapat Marg, Lower Parel, Mumbai – 400013 Tel: (91-22)
4249 9000 .Fax: (91-22) 40609049, Regd. Office – IIFL House, Sun Infotech Park, Road No. 16V, Plot No. B-23, MIDC, Thane Industrial Area, Wagle Estate, Thane – 400604 Tel: (91-22) 25806650. Fax: (91-22)
25806654 E-mail: mail@indiainfoline.com Website: www.indiainfoline.com, Refer www.indiainfoline.com for detail of Associates.
Stock Broker SEBI Regn.: INZ000164132, PMS SEBI Regn. No. INP000002213, IA SEBI Regn. No. INA000000623, SEBI RA Regn.:- INH000000248
BUY - Stock expected to give a return 10%+ more than average return on a debt instrument over a 1-year horizon.
SELL - Stock expected to give a return 10%+ below the average return on a debt instrument over a 1-year horizon.
Add - Stock expected to give a return 0-10% over the average return on a debt instrument over a 1-year horizon.
Reduce - Stock expected to give a return 0-10% below the average return on a debt instrument over a 1-year horizon.
Distribution of Ratings: Out of 217 stocks rated in the IIFL coverage universe, 112 have BUY ratings, 7 have SELL ratings, 72 have ADD ratings and 25 have REDUCE ratings
Price Target: Unless otherwise stated in the text of this report, target prices in this report are based on either a discounted cash flow valuation or comparison of valuation ratios with companies seen by the analyst as
comparable or a combination of the two methods. The result of this fundamental valuation is adjusted to reflect the analyst’s views on the likely course of investor sentiment. Whichever valuation method is used there is a
significant risk that the target price will not be achieved within the expected timeframe. Risk factors include unforeseen changes in competitive pressures or in the level of demand for the company’s products. Such demand
variations may result from changes in technology, in the overall level of economic activity or, in some cases, in fashion. Valuations may also be affected by changes in taxation, in exchange rates and, in certain industries,
in regulations. Investment in overseas markets and instruments such as ADRs can result in increased risk from factors such as exchange rates, exchange controls, taxation, and political and social conditions. This
discussion of valuation methods and risk factors is not comprehensive – further information is available upon request.
__________________________________________________________________________________________
Key Employees
National Insurance Company Ltd
Name Job Title
Key Competitors
___________________________________________________________________________________________
566
National Insurance Company Ltd
__________________________________________________________________________________________
TABLE OF CONTENTS
1 National Insurance Company Ltd - Business Analysis ................................................................................. 4
1.1 National Insurance Company Ltd - Company Overview ........................................................................................4
1.2 National Insurance Company Ltd - Major Products and Services .........................................................................5
2 National Insurance Company Ltd - Mergers & Acquisitions and Partnerships ............................................. 7
2.1 National Insurance Company Ltd - M&A and Partnerships Strategy .....................................................................7
3 National Insurance Company Ltd - Key Events ............................................................................................ 9
4 National Insurance Company Ltd - Key Employees ................................................................................... 10
5 National Insurance Company Ltd - Locations and Subsidiaries ................................................................. 11
5.1 National Insurance Company Ltd - Head Office ..................................................................................................11
5.2 National Insurance Company Ltd - Other Locations and Subsidiaries ................................................................11
6 Appendix .................................................................................................................................................... 13
6.1 Methodology .........................................................................................................................................................13
6.2 Disclaimer.............................................................................................................................................................13
___________________________________________________________________________________________
567
National Insurance Company Ltd
__________________________________________________________________________________________
LIST OF TABLES
Table 1: National Insurance Company Ltd - Major Products and Services ......................................................... 5
Table 2: National Insurance Company Ltd - Key Events .................................................................................... 9
Table 3: National Insurance Company Ltd - Key Employees ............................................................................ 10
Table 4: National Insurance Company Ltd - Locations ..................................................................................... 11
___________________________________________________________________________________________
568
National Insurance Company Ltd
__________________________________________________________________________________________
National Insurance Company Ltd (NIC), a subsidiary of India based General Insurance Corp of India, is a general
insurance company. The company’s products portfolio includes motor insurance, health insurance, rural insurance,
commercial insurance, and industrial insurance. Its personal insurance products include individual personal accident
insurance, householder’s insurance, and Janata personal accident insurance. NIC’s rural insurance products comprise
livestock insurance, sheep and goat insurance, elephant insurance, dog insurance, brackish water prawn insurance,
silkworm insurance, plantation insurance, and Kisan agriculture pumpset insurance. The company also offers industrial
risk insurance, machinery insurance, electronic equipment insurance, commercial risk insurance, workmen compensation
insurance, product liability insurance, and public liability insurance. It has operations in Guwahati, Hyderabad, Bangalore,
Dharwad, Kolar, Gurgaon, Delhi, and Naraina, India. NIC is headquartered in Kolkata, West Bengal, India.
___________________________________________________________________________________________
569
National Insurance Company Ltd
__________________________________________________________________________________________
NIC is an insurance company. Key products offered by the company include the following:
Householders Insurance
Rural Insurance:
Livestock Insurance
Elephant Insurance
Dog Insurance
Silkworm Insurance
Plantation Insurance
Industrial Insurance:
Machinery Insurance
Commercial Insurance:
Burglary Policy
Shopkeepers Policy
Glass Insurance
Money Insurance
___________________________________________________________________________________________
570
National Insurance Company Ltd
__________________________________________________________________________________________
___________________________________________________________________________________________
571
National Insurance Company Ltd
__________________________________________________________________________________________
Oriental Insurance Company and National Insurance to Merge with United India Insurance
Deal Type Merger Deal Sub Type
Deal Status Announced Announced Date 2018-02-01
Deal in Brief
Oriental Insurance Company Ltd., a provider of general insurance services, and National Insurance Company Limited., a
provider of general insurance for urban and rural customers, to merge with United India Insurance Co. Ltd., a provider of
non-life insurance products and services. All the companies are based in India.
The company reported gross premium income of INR160,628.1 million during fiscal year ended March 2017(FY2017), an
increase of 31.1% over FY2016. The net earned premium of the company was INR120,323.1 million in FY2017, an
increase of 20% over FY2016.
Company Name The Oriental Insurance Company Ltd. Involvement Type Target
Company Overview
The Oriental Insurance Company Ltd. (Oriental Insurance), a wholly owned subsidiary of Oriental Government Security
Life Assurance Company Ltd, provides various general insurance services in the urban and rural sectors in India. The
company designs insurance coverage for projects, including power plants, petrochemical, steel and chemical plants
among otehrs. Oriental Insurance offers motor insurance policies, personal accident policy, Janata personal accident
policy, shopkeeper policy, householder policy, Nagarik suraksha policy and health insaurance policies among others. It
operates in across India and also has overseas operations in Nepal, Kuwait and Dubai. Oriental Insurance is
headquartered in New Delhi, India.
___________________________________________________________________________________________
572
National Insurance Company Ltd
__________________________________________________________________________________________
The Pradhan Mantri Surakhsa Bima Yojana is available across all its 1,821 branches at a cost of INR12 (USD0.18) per
policy per year. All the savings bank account holders in the age group of 18-70 years are eligible to join the Pradhan
Mantri Surakhsa Bima Yojana to avail of a risk cover of INR0.2 million (USD0.003 million).
___________________________________________________________________________________________
573
National Insurance Company Ltd
__________________________________________________________________________________________
2017 Divestiture In January, Government of India sold 25% stake in National Insurance.
Source: Timetric
___________________________________________________________________________________________
574
National Insurance Company Ltd
__________________________________________________________________________________________
Source: Timetric
___________________________________________________________________________________________
575
National Insurance Company Ltd
__________________________________________________________________________________________
2nd Floor
Second Floor
Shubharam Complex, 144 M G Road-908
Arihant Plaza, Kusugal Road
Bangalore
Dharwad
Zip: 90880
Zip: 58002
India
India
Tel: + 91 80 25584081
Fax: + 91 80 25584506
1092-2, New Extension, Near Dome Light Circle SCO 41-43, Sector, 31/32 A, Gurgaon
Kolar Gurgaon
Zip: 563101 Zip: 122001
India India
___________________________________________________________________________________________
576
National Insurance Company Ltd
__________________________________________________________________________________________
___________________________________________________________________________________________
577
National Insurance Company Ltd
__________________________________________________________________________________________
6 Appendix
6.1 Methodology
Timetric company reports are based on a core set of research techniques which ensure the best possible level of quality
and accuracy of data. The key sources used include:
• Company Websites
• Company Annual Reports
• SEC Filings
• Press Releases
• Proprietary Databases
Notes
• Financial information of the company is taken from the most recently published annual reports or SEC filings
• The financial and operational data reported for the company is as per the industry defined standards
• Revenue converted to US$ at average annual conversion rate as of fiscal year end
6.2 Disclaimer
No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means,
electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publisher, Timetric.
The data and analysis within this report is driven by Timetric from its own primary and secondary research of public and
proprietary sources and does not necessarily represent the views of the company profiled.
The facts of this report are believed to be correct at the time of publication but cannot be guaranteed. Please note that the
findings, conclusions and recommendations that Timetric delivers will be based on information gathered in good faith from
both primary and secondary sources, whose accuracy we are not always in a position to guarantee. As such Timetric can
accept no liability whatever for actions taken based on any information that may subsequently prove to be incorrect.
___________________________________________________________________________________________
578
The United India Insurance Co Ltd
__________________________________________________________________________________________
Key Employees
The United India Insurance Co Ltd
Name Job Title
___________________________________________________________________________________________
579
The United India Insurance Co Ltd
__________________________________________________________________________________________
TABLE OF CONTENTS
1 The United India Insurance Co Ltd - Business Analysis .............................................................................. 4
1.1 The United India Insurance Co Ltd - Company Overview .....................................................................................4
1.2 The United India Insurance Co Ltd - Business Description ...................................................................................4
1.2.1 Fire Insurance ....................................................................................................................................................4
1.2.2 Marine Insurance ...............................................................................................................................................4
1.2.3 Miscellaneous Insurance ...................................................................................................................................4
1.3 The United India Insurance Co Ltd - Major Products and Services .......................................................................5
2 The United India Insurance Co Ltd - Mergers & Acquisitions and Partnerships .......................................... 6
2.1 The United India Insurance Co Ltd - M&A and Partnerships Strategy ..................................................................6
3 The United India Insurance Co Ltd - Recent Developments ...................................................................... 10
4 The United India Insurance Co Ltd - SWOT Analysis ................................................................................ 12
4.1 The United India Insurance Co Ltd - SWOT Analysis - Overview .......................................................................12
4.2 The United India Insurance Co Ltd - Strengths....................................................................................................12
4.3 The United India Insurance Co Ltd - Weaknesses ..............................................................................................12
4.4 The United India Insurance Co Ltd - Opportunities..............................................................................................12
4.5 The United India Insurance Co Ltd - Threats .......................................................................................................13
5 The United India Insurance Co Ltd - Company Statement......................................................................... 14
6 The United India Insurance Co Ltd - History .............................................................................................. 15
7 The United India Insurance Co Ltd - Key Employees ................................................................................ 17
8 The United India Insurance Co Ltd - Locations and Subsidiaries .............................................................. 19
8.1 The United India Insurance Co Ltd - Head Office ................................................................................................19
8.2 The United India Insurance Co Ltd - Other Locations and Subsidiaries ..............................................................19
9 Appendix .................................................................................................................................................... 21
9.1 Methodology .........................................................................................................................................................21
9.2 Disclaimer.............................................................................................................................................................21
___________________________________________________________________________________________
580
The United India Insurance Co Ltd
__________________________________________________________________________________________
LIST OF TABLES
Table 1: The United India Insurance Co Ltd - Major Products and Services ...................................................... 5
Table 2: The United India Insurance Co Ltd - History ....................................................................................... 15
Table 3: The United India Insurance Co Ltd - Key Employees ......................................................................... 17
Table 4: The United India Insurance Co Ltd - Subsidiaries............................................................................... 19
Table 5: The United India Insurance Co Ltd - Locations ................................................................................... 19
___________________________________________________________________________________________
581
The United India Insurance Co Ltd
__________________________________________________________________________________________
United India Insurance Company Limited (UIIC) is a general insurance provider. It offers a range of personal and
commercial general insurance products. The company offers personal insurance products for motor, fire, health, liability,
micro, credit, marine, home, personal accident, and travel. Its commercial insurance products include fire insurance,
marine insurance, motor insurance and industry equipment insurance. It also offers accident and hospitalization policies,
social policies, rural policies, travel policies, package policies, and business policies. In addition, the company provides
advisory and brokerage services. It has presence across various cities in India. UIIC is headquartered at Chennai, India.
The company reported gross premium income of INR160,628.1 million during fiscal year ended March 2017(FY2017), an
increase of 31.1% over FY2016. The net earned premium of the company was INR120,323.1 million in FY2017, an
increase of 20% over FY2016.
United India Insurance Company Limited (UIIC) offers a range of personal and commercial general insurance products.
The company markets and sells its products through a network of offices, agents, brokers, corporate agencies, and
bancassurance and online channel. As on March 31, 2017, the company operated through 2,129 offices across India.
The company classifies its operations into three segments: Marine Insurance, Fire Insurance, and Miscellaneous
operations.
Overview
Offers standard fire and special perils policies and fire loss of profit policies.
Overview
Overview
Offers motor insurance, health insurance, and public and product liability policies.
___________________________________________________________________________________________
582
The United India Insurance Co Ltd
__________________________________________________________________________________________
1.3 The United India Insurance Co Ltd - Major Products and Services
UIIC is a general insurance company that provides personal and commercial insurance products. The company's key
products include:
Table 1: The United India Insurance Co Ltd - Major Products and Services
Products:
Motor Insurance
Fire Insurance
Health Insurance
Marine Insurance
Industrial Insurance
Liability Insurance
Micro Insurance
Credit Insurance
Home Insurance
Travel Insurance
Source: Timetric
___________________________________________________________________________________________
583
The United India Insurance Co Ltd
__________________________________________________________________________________________
2.1 The United India Insurance Co Ltd - M&A and Partnerships Strategy
Oriental Insurance Company and National Insurance to Merge with United India Insurance
Deal Type Merger Deal Sub Type
Deal Status Announced Announced Date 2018-02-01
Deal in Brief
Oriental Insurance Company Ltd., a provider of general insurance services, and National Insurance Company Limited., a
provider of general insurance for urban and rural customers, to merge with United India Insurance Co. Ltd., a provider of
non-life insurance products and services. All the companies are based in India.
___________________________________________________________________________________________
584
The United India Insurance Co Ltd
__________________________________________________________________________________________
Kerala Gramin Bank Signs MoU with United India Insurance Company
Deal Type Partnership Deal Sub Type Affinity Marketing
Deal Status Completed Announced Date 2015-04-30
Deal in Brief
Kerala Gramin Bank, a regional rural bank that provides deposits and loans, has signed a memorandum of understanding
(MoU) with United India Insurance Company Limited (UIIC), a general insurance company, to provide life and accidental
insurance cover to all its Savings account holders under Prime Minister Jeevan Jyoti Bima Yojana (PMJJBY) and
Pradhan Mantri Suraksha Bima Yojana (PMSBY). Both companies involved in the transaction are based in India.
PMJBY is a life insurance scheme provides insurance cover for death due to any reason, while PMSBY is the personal
accident insurance scheme provides insurance cover for death or disability due to accident.
PMJBY offers life insurance cover of INR0.2 million (USD0.0032 million) to the bank account holders in the age group of
18-50 years at an annual premium of INR330 (USD5.27) plus service tax, whereas PMSBY cover of INR0.2 million
(USD0.00314 million) to the bank account holders in the age group of 18-70 years at an annual premium of INR12
(USD0.18).
___________________________________________________________________________________________
585
The United India Insurance Co Ltd
__________________________________________________________________________________________
UIIC is a general insurance company, while PMSBY is the personal accident insurance scheme provides insurance cover
for death or disability due to accident.
PMSBY offers insurance cover of INR0.2 million (USD0.00314 million) to the bank account holders in the age group of 18-
70 years at an annual premium of INR12 (USD0.18).
___________________________________________________________________________________________
586
The United India Insurance Co Ltd
__________________________________________________________________________________________
Vijaya Bank partners with United India Insurance to sell non-life insurance products
Deal Type Partnership Deal Sub Type Co-Marketing
Deal Status Completed Announced Date 2010-03-06
Deal in Brief
Vijaya Bank, a provider of wholesale, corporate, and retail banking products and services, has entered into a
memorandum of understanding (MoU) with The United India Insurance Company Limited (UIIC), a general insurance
provider, for distribution of non-life insurance products. Both companies involved in the transaction are based in India.
Undfer the terms of the transaction, Vijaya Bank will distribute general insurance policies through its over 1,200 branches.
Vijaya Bank provides a wide range of banking products and services for individual and corporate customers. Its portfolio
of products and services includes credit cards, debit cards, NRI services, savings bank accounts, current accounts,
recurring deposits, capital gains schemes, tax savings schemes, home loans, vehicle loans, loan against property,
personal loans, education loans, online retail loans, NRE and NRO accounts, loan for traders and jewel loans.
United India offers a range of personal and commercial general insurance products.
Participant Company Information
Company Name Vijaya Bank Involvement Type Target
Company Overview
Vijaya Bank (VB) is a provider of retail and commercial banking, and treasury solutions. Its deposits and cards portfolio
includes savings bank accounts, current accounts, recurring deposits, fixed deposits, term deposits, non-resident rupee
accounts, resident ordinary rupee accounts, credit cards, gift cards, and debit cards. IThe bank provides lending solutions
for home, personal needs, education, online retail, jewelry, corporate, vehicle, property, securities, and trading,. It also
offers government sponsored schemes such as Prime Minister’s Employment Generation Programme, Deen Dayal
Antyodaya National Urban Livelihood, and Self Employment scheme for Rehabilitation of Manual Scavengers. The bank
also provides services such as NRI services, international banking, treasury, foreign exchange, mobile banking, and
remittance. VB is headquartered in Bangalore, India.
___________________________________________________________________________________________
587
The United India Insurance Co Ltd
__________________________________________________________________________________________
United India Insurance Company has reappointed Aqualis Offshore to provide marine warranty services to the Oil and
Natural Gas Corporation Limited’s (ONGC) assets offshore India.This is the third one-year contract Aqualis Offshore has
received after the company first started working for United India Insurance Company and ONGC in 2014.Under the
agreement, Aqualis Offshore will continue to provide marine warranty services to ONGC's fleet of jack-up rigs and mobile
offshore production units (MOPU) in Indian waters."A contract extension such as this is the best possible confirmation that
a client is satisfied with the services we provide. We look forward to continue supporting ONGC and its many assets
operating offshore India," says Rodger Dickson, group marine director in Aqualis Offshore.Aqualis Offshore will support
ONGC with marine warranty surveyors from Aqualis Offshore's office in Dubai. The operations include review of rig move
documentation, issue of certification and on-board attendance.
Aqualis Offshore, part of Aqualis ASA, has been reappointed by United India Insurance Company to provide marine
warranty services to the Oil and Natural Gas Corporation Limited (ONGC) offshore India.Under the agreement,
international offshore marine and engineering consultancy Aqualis Offshore will provide marine warranty services to
ONGC's fleet of six jack-up rigs and three mobile offshore production units (MOPU) in Indian waters."We are proud to
announce this agreement with ONGC, the leading Indian energy company. We started working with ONCG last year, so
we believe this agreement confirms our capability and ability to deliver world-class services to a major offshore oil
company," says Reuben Segal, Director - Middle East, Aqualis Offshore.Aqualis Offshore will support ONGC with marine
warranty surveyors from Aqualis Offshore's office in Dubai. The operations include review of rig move documentation,
issue of certification and on-board attendance.Aqualis Offshore is a specialized marine and offshore engineering
consultancy focusing on the shallow and deep-water segments of the offshore oil, gas and wind industries.Aqualis
Offshore's contract party is Aqualis Offshore Marine Services LLC.
Union Bank of India (UBI) has joined forces with Star Union Dai-ichi Life Insurance and New India Assurance for offering
life and accidental death insurance policies respectively to its account-holders.The yearly premium for the life cover will be
INR330, and the annual premium for the accidental death cover will be INR12.The premium amount will be debited
directly from savings accounts of customers after they opt for it.Both the policies will offer assured sum of INR2 lakh each
to accountholders between the age-group 18 to 50 years.The policies will be offered under the Pradhan Mantri Jeevan
Jyoti Bima Yojana (PMJJBY) and Pradhan Mantri Suraksha Bima Yojana (PMJJBY) schemes. Customers will be allowed
to voluntarily opt for these schemes after paying the applicable premium.Moreover, Dena Bank has tied up with United
India Insurance to offer accidental insurance cover under the Prime Minister's Pradhan Mantri Suraksha Bima Yojana
(PMSBY).The cover, effective from 1 June 2015, will cover risk of INR2 lakh for accidental death and full disability and
INR1 lakh for partial disability.It will have a yearly premium of INR12, which will be auto-debited from the policy holder's
account. The cover will be available to all savings account holders of the bank between 18 to 70 years.
United India Insurance posts Rs.229 crores net profit for first quarter 2014-15
United India Insurance Company, wholly owned by Government of India, has reported a healthy premium of ` 2,729 Crs.
for the first quarter ended 30th June, 2014, posting a growth rate of over 11%.The company has also reported an
impressive first Quarter (Q1) Profit After Tax (PAT) of ` 228.76 Crs., as against a PAT of ` 210.76 Crs. last year.The
Investment income of the company for the first Quarter stood at over ` 531 Crs. as against ` 447 Crs. for the
corresponding period in the previous year. The company, through efficient claims management, was able to reduce the
claims ratio from 83.27% to 81.95% during Q1. The Combined ratio (a measure of the profitability of insurance operations)
was reduced to 111.65% from 116.10% for 2013-14. The Market value of the company's total investment portfolio at the
end of the first quarter was ` 24,155 Crores, up by 12% over the end of last year. The networth of the company stood at a
robust ` 5,589 Crores as on 30.06.2014.The company continues to enjoy strong fundamentals with a solvency ratio of
2.60 as against the regulatory requirement of 1.50. ICRA has accorded iAAA rating for the 12th successive year to the
company, indicating its highest claim paying credentials. The company has also a rating of B++ (positive) from AM Best,
an International Rating Agency. The Q1 results show that the company's strategies are yielding the desired results and
the company is optimistic to comfortably complete a premium of ` 11,000 Crores in the current fiscal.The company would
___________________________________________________________________________________________
588
The United India Insurance Co Ltd
__________________________________________________________________________________________
continue its thrust on the retail, MSME and rural insurance segments. The company is efficiently managing the mammoth
TN Chief Minister's Health Insurance Scheme for BPL families. The company also secured the mandate to implement the
TN Government Pensioners' Health Insurance Scheme in the current year.The company will continue to launch initiatives
to further the insurance inclusion in the Country by opening 200 Micro Offices in tier 4 towns and below, taking the total of
such offices to 1,314. The company has 66,500 agents and plans to take it to 80,000 by the year end. Of this, there are
193 micro insurance agents who take general insurance to the door step of common man in the rural areas. The company
has 51 Bancassurance tie-ups which includes many major nationalized banks. The company has tied up with 100 BCs
and 2,624 BCAs as on date. The company will leverage the Common Service Centres (CSCs) to deliver simple, retail
general insurance products in rural areas.The company continues to innovate on product offerings by recently launching a
revised and improved Family Medicare product with an unique "remote medical opinion" benefit. The company has on-line
customer portals in respect of 8 retail insurance products (Motor, Health, PA, OMP, House holders, Shopkeeper, Crop
insurance and Marine Insurance Open cover). On-line portal facilities have also been extended to our business
intermediaries like agents, motor dealers, bancassurance partners etc. The company has successfully deployed mobile
insurance applications and insurance kiosks to facilitate easy access to buy insurance for the customers.The company
plans to recruit 300 Officers and 630 Assistants during the current year to meet the growing customer service
requirements.The company maintains a robust solvency margin, which displays its strong and inherent fundamentals, and
continues to be in a premier position in rural and social insurance sector and thereby contributing to the insurance
inclusion in the Country.
United India Insurance clocks RS 9709 crores premium and posts RS 528 crores net profit
United India Insurance Company continued to report improved performance, for the year ending 2013-14 by reporting an
impressive Profit Before Tax (PBT) of `633 Crores and a Profit After Tax (PAT) of over`528 Crores.The Company could
reduce the claims ratio to 82.56% for the year against 84.61% in 2012-13 thanks to better underwriting practices and
claims control measures deployed, this was despite the Uttarakhand flood losses. The Market Value of the Company's
total investment portfolio at the end of the year was 21545 Crores as against 19950 Crores last year, the investment
income stood at 1857 Crores. The networth of the Company grew to a robust 5361 crores from 4952.63 Crores last
year.The Company continues to enjoy strong fundamentals with a Solvency Ratio of 2.54 as against the Regulatory
requirement of 1.50. ICRA has accorded iAAA rating for the 11th successive year to the Company, indicating its highest
claim paying credentials. The Company has also secured a rating of B++(Positive) from AM Best, an International Rating
Agency. The results show that the Company's strategies are yielding the desired results. The Company is optimistic to
cross `11,000 Crores premium in the current fiscal.The Company has a network of 2242offices including 1114 micro
offices in remote locations, with a staff strength of 16907. The Company has 66500 agents and plans to take it to 80000
this year. In addition to this there are 193 micro insurance agents who take general insurance to the doorstep of common
man in the rural areas. The Company has the largest bancassurance tie-up with major nationalized and other banks. The
Company has also tied up with 16 BCs and 2624 BCAs as on date. Similarly, tie-up has been made with Common Service
Centres (CSCs) to deliver General Insurance Products in rural areas.The Company continues its thrust on the retail,
MSME and rural insurance segments. The Company is active in the roll-out of the Government of India's flagship health
Insurance programme for the BPL population (RSBY) and efficiently managing the mammoth Tamil Nadu Chief Minister's
Comprehensive Health Insurance Scheme for BPL families.The Company has developed online portals for 8 retail
insurance products (Motor, Health, PA, OMP, House holders, Shopkeeper, Crop Insurance and Marine Insurance Open
cover). Online portal facilities have also been extended to business intermediaries like agents, motor dealers,
bancassurance partners, brokers, etc. The Company has a wide spectrum of general insurance products offerings totaling
235, to meet the various requirements of the insuring public.
Source: Timetric
___________________________________________________________________________________________
589
The United India Insurance Co Ltd
__________________________________________________________________________________________
The United India Insurance Co Ltd (UIIC) is a general insurance company, which provides personal and commercial
general insurance products. The company’s premium earnings, portfolio of products, and solvency margin are its key
strengths, even as its combined ratio and cash position remain areas of concern. In future, interest rates, natural
calamities, and regulation may affect the company’s business operations. However, economy in India, business
expansion, and non-life insurance segment in India may provide growth opportunities for the company.
The company maintains a strong solvency margin and ratio reflecting its ability to meet all its long term obligations. During
FY2017, the company was required to maintain solvency margin of INR39,980.1 million in FY2017. the company reported
solvency margin of INR46,080.2 million, which was well above the minimum requirement. UIIC’s solvency margin was
1.15 times higher than the requirement in FY2017.
Increase in premium earnings reflects growth in demand for the company’s offerings. The company reported strong
growth in premiums during FY2017. Its gross direct premium increased by 31.1% to INR160,628.1 million in FY2017 from
INR122,503.6 million in FY2016. Growth was primarily due to strong performance of Fire and Miscellaneous segments,
which reported 4.1% and 36.2% increase in gross direct premium in FY2017, respectively. It had a market share of 13.4%
in general insurance industry based on gross direct premium in FY2017. It recorded net earned premiums of
INR120,323.1 million in FY2017, an increase of 20% over FY2016.
The company’s strong distribution network helps in generating strong sales. UIIC markets and sells its products through a
network of offices, agents, brokers, corporate agencies, and bancassurance and online channel. As on March 31, 2017,
the company operated through 2,129 offices across India. In FY2017, the company had strengthened its bancassurance
channel through tie ups with one private bank, seven major banks, 20 Non Banking Finance Companies, 31 Gramin and
Cooperative Banks. Furthermore, the company plans to enter into agreements to sell insurance policies online.
Weaknesses - Profitability
The company reported decline in profitably during FY2017, which is an area of concern. The company reported operating
loss of INR22,406.8 in FY2017 compared to INR5,126.1 million in FY2016. Its net loss was INR19,135.3 million in FY2017
compared to net income of INR2,205.9 million in FY2016. The reported losses was primarily due to increase in net claims
incurred, commission expenses, and operating expenses related to insurance business by 47.6%, 21.6%, and 5.3% in
FY2017, respectively. Its operating profit ratio and net earnings ratio declined from -4.6% and 2.1% in FY2016,
respectively, to -19.4% and -14.3% in FY2017, respectively.
The company’s combined ratio in FY2017 reached above the level of 100%, which is a concern area. At the end of
FY2017, the combined ratio of the company stood at 134%, compared to 119.9% in FY2016. The combined ratio above
100% indicates that the company is making underwriting losses. The company reported underwriting loss of INR44,445.8
million in FY2017.
The company may benefit from the growing Indian economy. According to the International Monetary Fund (IMF), GDP
growth rate of India stood is expected to reach 7.4% in 2018 and 8.2% in 2022. Such economic growth is likely to enable
___________________________________________________________________________________________
590
The United India Insurance Co Ltd
__________________________________________________________________________________________
favorable market conditions and encourage spending on housing finance products in the country. The growth is expected
to be driven by robust consumer demand from a general increase in wages that offsets a slowdown in investment.
Growth in the Indian non-life insurance segment will allow the company to capitalize on growing opportunities and cater to
diverse requirements of its customers. According to in- house research, the gross written premium of Indian non-life
insurance segment is expected to value INR1.3 trillion (US$18.1 billion) in 2020. The growth in non-life insurance segment
is expected to be driven by increasing automobile sales, growth in the real estate and construction industries, and
favorable regulatory changes.
UIIC operates in an intensely competitive Indian insurance market, which may adversely affect its market share and
profits. The company competes with various insurance companies based on the factors such as premiums charged and
other terms and conditions offered, products and services provided, financial ratings assigned by independent rating
agencies, speed of claims payment, reputation, selling effort, perceived financial strength and the experience of the
insurer or reinsurer in the line of insurance or reinsurance to be written. Some of the major competitors of the company
include Bajaj Allianz General Insurance Company Limited, ICICI Lombard General Insurance Company Limited, Royal
Sundaram General Insurance Co. Limited, The Oriental Insurance Company Ltd, and HDFC ERGO General Insurance
Company Limited.
The company’s businesses are regulated by various governmental and regulatory authorities. Changes in government
policy, legislation or regulatory interpretation may adversely affect the company’s product range, distribution channels,
capital requirements and, consequently, reported results and financing requirements. These changes include possible
changes in statutory pension arrangements and policies, the regulation of selling practices and solvency requirements.
The Indian insurance industry is supervised and regulated by the Insurance Regulatory and Development Authority of
India (IRDAI). The recent changes made in insurance regulatory framework in March 2017 include issuance of guidelines
on claim processing for group life insurance policies for new categories of master policyholders, and introduction of two
panels of actuaries for life insurers and non-life insurers. In January 2017, IRDAI established a committee to review
regulations governing life insurance products. Thus, the changes in government policies and regulations may have a
negative impact on the company’s growth and expansion strategies.
Fluctuations in interest rates may have an adverse effect on the company’s profitability. The company’s investment
portfolio contains interest rate-sensitive investments, such as municipal and corporate bonds. Interest rates are highly
sensitive to monetary policies of government, domestic and international economic and political conditions, and other
factors beyond the company’s control. Such volatile interest rates may impact the company’s operating performance, as
its income and investment returns depend on the level of interest rates.
___________________________________________________________________________________________
591
The United India Insurance Co Ltd
__________________________________________________________________________________________
During 2016-17, we retained our position in the Industry on premium terms, collecting a record premium of 16,062 Crores
with a growth rate of 31%. The year saw our foray into new segments like Crop Insurance. There was growth in Gross
Direct Premium across all segments. However, the financials were a cause for concern. The Top Management of the
Company is confident about restoring past glory of the Company within the next 12 months. The Company has its
strength in its 16500 + human resources, 60000 + Agency force and a lot of other business partners and associates
spread across the Country, selling non-life insurance in the hinterlands of this great Country. The strategy laid down by
the Management together with disciplined execution by all our employees, particularly the marketing force, is bound to
achieve growth of business in profitable lines of business. This, together with faster and better claims management and
proactive and goal oriented management of our Investment Resources, would certainly help us achieve 'Growth with
Profit', the need of the hour.
We are also working on development of new products to meet our customer needs better and on the Government of
India's financial inclusion objectives. Leveraging all the new distribution channels is certainly the way forward.
I place my sincere appreciation and gratitude to the Board of Directors and the Regulatory Authority for the guidance and
support received from them. I also wish to place on record my gratitude to our customers, employees, business
intermediaries and vendors for their continued support. All these facilitated our Company to deliver credible operational
performance, under challenging circumstances, as also deliver excellence in customer service. With our resolve to adhere
to prudent underwriting and efficient claims management, I look forward to the next financial year with great optimism.
___________________________________________________________________________________________
592
The United India Insurance Co Ltd
__________________________________________________________________________________________
The company received approval for the point of sale distribution of ten new
2017 New Product Approvals
products.
In March, the company was honored with Vigilance Excellence Award 2016-17
2017 Corporate Awards
by the Institute of Public Enterprises, Hyderabad.
2016 New Products/Services In September, the company launched its online portal for individuals.
The company launched four new policies, UNI MSME Protect Insurance Policy,
2015 New Products/Services UNI EXECUTIVE PROTECT-Directors and Officers, Uni Product Liability –
Insurance and Shopkeepers Insurance Policy.
The company and Star Union Dai-Ichi Life New India Insurance entered into an
2015 Contracts/Agreements agreement with Dena Bank and Union Bank of India to provide accidental
insurance cover under the social schemes.
2014 Corporate Changes/Expansions The company opened two new regional offices in Raipur and Puducherry.
2014 Corporate Changes/Expansions The company opened 162 micro offices in the country.
United India Insurance received two Finnoviti Awards in recognition of its two
2012 Corporate Awards innovations in financial services sector in the Finnoviti 2012 Awards Ceremony
by banking frontiers, Glocalinfomart Pvt. Ltd.
The company was awarded ‘General Insurer of the Year–Public Sector’ for the
2012 Corporate Awards
second consecutive year by Bloomberg UTV.
The company won the General Insurer of the year Award – Public Sector by
2011 Corporate Awards
Bloomberg UTV at the Financial Leadership Awards 2011.
The company entered into an agreement with Dena Bank for marketing the
2011 Contracts/Agreements
general insurance policies through their branches.
___________________________________________________________________________________________
593
The United India Insurance Co Ltd
__________________________________________________________________________________________
The company was named as the 'Best Insurer-Non-Life' at the 3rd Dalal Street
2011 Corporate Awards
Investment Journal PSU Awards 2011.
2011 Corporate Awards The company received the 'SKOCH Financial Inclusion Award 2011'.
The company was awarded the Best Non-Life Insurer by NDTV Profit - Business
2010 Corporate Awards
Leadership Awards 2010.
The company signed agreement with LICHFL Financial Services ltd, to distribute
2010 Contracts/Agreements
the non life products of UIIC.
The company was selected as one of the top three general insurance companies
2010 Corporate Awards
at the 14th Asia Insurance Industry Awards 2010.
The company opened four large corporate cells in Pune, Kolkata, Hyderabad
2009 Corporate Changes/Expansions
and Bengaluru to continue its foray into large corporate business.
The company and The Export Credit Guarantee Corporation of India Ltd. signed
2008 Contracts/Agreements
an agreement to provide marine insurance cover for its customers.
The company launched three new health insurance policies under the name of
2007 New Products/Services
Platinum, Gold and Senior Citizens.
2007 Corporate Awards UIIC received best implemented IT projects award from PCQuest.
UIIC along with the National Insurance Company, and New India Insurance
2000 Others
Company operated as a subsidiary of General Insurance Company.
1972 Commercial Operation The company's General Insurance Business was nationalized.
1938 Incorporation/Establishment The United India Insurance Company Limited was incorporated.
Source: Timetric
___________________________________________________________________________________________
594
The United India Insurance Co Ltd
__________________________________________________________________________________________
___________________________________________________________________________________________
595
The United India Insurance Co Ltd
__________________________________________________________________________________________
Source: Timetric
___________________________________________________________________________________________
596
The United India Insurance Co Ltd
__________________________________________________________________________________________
8.2 The United India Insurance Co Ltd - Other Locations and Subsidiaries
Source: Timetric
No.3, Enkay Complex, I Floor Krishi Bhavan, 5th and 6th Floor
Keshwapur Nrupathunga Road
Hubli Banglore
Zip: 560023 Zip: 560001
India India
Tel: + 91 836 2264460 Tel: + 91 80 22534011
Fax: + 91 836 2366983 Fax: + 91 80 22534024
___________________________________________________________________________________________
597
The United India Insurance Co Ltd
__________________________________________________________________________________________
___________________________________________________________________________________________
598
The United India Insurance Co Ltd
__________________________________________________________________________________________
9 Appendix
9.1 Methodology
Timetric company reports are based on a core set of research techniques which ensure the best possible level of quality
and accuracy of data. The key sources used include:
• Company Websites
• Company Annual Reports
• SEC Filings
• Press Releases
• Proprietary Databases
Notes
• Financial information of the company is taken from the most recently published annual reports or SEC filings
• The financial and operational data reported for the company is as per the industry defined standards
• Revenue converted to US$ at average annual conversion rate as of fiscal year end
9.2 Disclaimer
No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means,
electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publisher, Timetric.
The data and analysis within this report is driven by Timetric from its own primary and secondary research of public and
proprietary sources and does not necessarily represent the views of the company profiled.
The facts of this report are believed to be correct at the time of publication but cannot be guaranteed. Please note that the
findings, conclusions and recommendations that Timetric delivers will be based on information gathered in good faith from
both primary and secondary sources, whose accuracy we are not always in a position to guarantee. As such Timetric can
accept no liability whatever for actions taken based on any information that may subsequently prove to be incorrect.
___________________________________________________________________________________________
599